<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Urinary biomarkers for the non‐invasive diagnosis of endometriosis - Liu, E - 2015 | Cochrane Library</title> <meta content="Urinary biomarkers for the non‐invasive diagnosis of endometriosis - Liu, E - 2015 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012019/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Urinary biomarkers for the non‐invasive diagnosis of endometriosis - Liu, E - 2015 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012019/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD012019" name="dc.identifier" scheme="DOI"/> <meta content="Urinary biomarkers for the non‐invasive diagnosis of endometriosis" name="citation_title"/> <meta content="Emily Liu&lt;sup&gt;a&lt;/sup&gt;" name="citation_author"/> <meta content="Auckland District Health Board" name="citation_author_institution"/> <meta content="Vicki Nisenblat&lt;sup&gt;a&lt;/sup&gt;" name="citation_author"/> <meta content="The University of Adelaide" name="citation_author_institution"/> <meta content="vnisenblat@gmail.com" name="citation_author_email"/> <meta content="Cindy Farquhar" name="citation_author"/> <meta content="University of Auckland" name="citation_author_institution"/> <meta content="Ian Fraser" name="citation_author"/> <meta content="University of New South Wales" name="citation_author_institution"/> <meta content="Patrick MM Bossuyt" name="citation_author"/> <meta content="Academic Medical Center, University of Amsterdam" name="citation_author_institution"/> <meta content="Neil Johnson" name="citation_author"/> <meta content="The University of Adelaide" name="citation_author_institution"/> <meta content="M Louise Hull" name="citation_author"/> <meta content="The University of Adelaide" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="12" name="citation_issue"/> <meta content="10.1002/14651858.CD012019" name="citation_doi"/> <meta content="2015" name="citation_date"/> <meta content="2015/12/23" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012019/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012019/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012019/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Biomarkers [urine]; Diagnosis, Differential; Endometriosis [*diagnosis]; Keratin‐19 [*urine]; Peptide Fragments [urine]; Peptides [*urine]; Phosphopyruvate Hydratase [*urine]; Proteomics; Vitamin D‐Binding Protein [*urine]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012019&amp;doi=10.1002/14651858.CD012019&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012019&amp;doi=10.1002/14651858.CD012019&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012019&amp;doi=10.1002/14651858.CD012019&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012019&amp;doi=10.1002/14651858.CD012019&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012019&amp;doi=10.1002/14651858.CD012019&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012019&amp;doi=10.1002/14651858.CD012019&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012019&amp;doi=10.1002/14651858.CD012019&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012019&amp;doi=10.1002/14651858.CD012019&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012019&amp;doi=10.1002/14651858.CD012019&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012019&amp;doi=10.1002/14651858.CD012019&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012019&amp;doi=10.1002/14651858.CD012019&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012019&amp;doi=10.1002/14651858.CD012019&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012019&amp;doi=10.1002/14651858.CD012019&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012019&amp;doi=10.1002/14651858.CD012019&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012019&amp;doi=10.1002/14651858.CD012019&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012019&amp;doi=10.1002/14651858.CD012019&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012019&amp;doi=10.1002/14651858.CD012019&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012019&amp;doi=10.1002/14651858.CD012019&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012019&amp;doi=10.1002/14651858.CD012019&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012019&amp;doi=10.1002/14651858.CD012019&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012019&amp;doi=10.1002/14651858.CD012019&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012019&amp;doi=10.1002/14651858.CD012019&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012019&amp;doi=10.1002/14651858.CD012019&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774054000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774081000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000"}};Liferay.authToken="xNbeAU8n";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD012019\x26doi\x3d10\x2e1002\x2f14651858\x2eCD012019\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012019\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012019\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1559916434000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","fr","th","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD012019",title:"Urinary biomarkers for the non\\u2010invasive diagnosis of endometriosis",firstPublishedDate:"Dec 23, 2015 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Gynaecology and Fertility Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738735355000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=xNbeAU8n&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012019&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD012019';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD012019/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD012019/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012019%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD012019/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD012019/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD012019/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD012019/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD012019" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;บทคัดย่อ&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;ข้้อสรุปภาษาธรรมดา&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD012019/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD012019" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD012019/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD012019/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>3549 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD012019" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012019/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012019/full#CD012019-abs-0004"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012019/full#CD012019-sec-0084"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012019/full#CD012019-sec-0029"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012019/full#CD012019-sec-0030"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012019/full#CD012019-sec-0042"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012019/full#CD012019-sec-0045"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012019/full#CD012019-sec-0067"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012019/full#CD012019-sec-0080"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD012019/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012019/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012019/appendices#CD012019-sec-0089"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012019/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012019/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD012019/media/CDSR/CD012019/table_n/CD012019StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD012019/media/CDSR/CD012019/table_n/CD012019StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012019/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012019/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012019/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD012019/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD012019/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD012019/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2015 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD012019/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Diagnostic</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Urinary biomarkers for the non‐invasive diagnosis of endometriosis</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author custom-tooltip" title="Joint first author"><a href="/cdsr/doi/10.1002/14651858.CD012019/information#CD012019-cr-0002">Emily Liu</a><sup>a</sup></li> <li class="author custom-tooltip" title="Joint first author"><a href="/cdsr/doi/10.1002/14651858.CD012019/information#CD012019-cr-0003"><i class="icon corresponding-author fa fa-envelope"></i>Vicki Nisenblat</a><sup>a</sup></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012019/information#CD012019-cr-0004">Cindy Farquhar</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012019/information#CD012019-cr-0005">Ian Fraser</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012019/information#CD012019-cr-0006">Patrick MM Bossuyt</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012019/information#CD012019-cr-0007">Neil Johnson</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012019/information#CD012019-cr-0008">M Louise Hull</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD012019/information/en#CD012019-sec-0102">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 23 December 2015 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD012019/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD012019">https://doi.org/10.1002/14651858.CD012019</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD012019-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD012019-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD012019-abs-0003">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD012019-abs-0009">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD012019-abs-0002">Français</a> </li> <li class="section-language"> <a class="" href="full/th#CD012019-abs-0007">ภาษาไทย</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD012019-abs-0001" lang="en"> <section id="CD012019-sec-0001"> <h3 class="title" id="CD012019-sec-0001">Background</h3> <p>About 10% of reproductive‐aged women suffer from endometriosis which is a costly chronic disease that causes pelvic pain and subfertility. Laparoscopy is the 'gold standard' diagnostic test for endometriosis, but it is expensive and carries surgical risks. Currently, there are no simple non‐invasive or minimally‐invasive tests available in clinical practice that accurately diagnoses endometriosis. </p> </section> <section id="CD012019-sec-0002"> <h3 class="title" id="CD012019-sec-0002">Objectives</h3> <p>1. To provide summary estimates of the diagnostic accuracy of urinary biomarkers for the diagnosis of pelvic endometriosis compared to surgical diagnosis as a reference standard. </p> <p>2. To assess the diagnostic utility of biomarkers that could differentiate ovarian endometrioma from other ovarian masses. </p> <p>Urinary biomarkers were evaluated as replacement tests for surgical diagnosis and as triage tests to inform decisions to undertake surgery for endometriosis. </p> </section> <section id="CD012019-sec-0003"> <h3 class="title" id="CD012019-sec-0003">Search methods</h3> <p>The searches were not restricted to particular study design, language or publication dates. We searched the following databases to 20 April ‐ 31 July 2015: CENTRAL, MEDLINE, EMBASE, CINAHL, PsycINFO, Web of Science, LILACS, OAIster, TRIP and ClinicalTrials.gov (trial register). MEDION, DARE, and PubMed were also searched to identify reviews and guidelines as reference sources of potentially relevant studies. Recently published papers not yet indexed in the major databases were also sought. The search strategy incorporated words in the title, abstract, text words across the record and the medical subject headings (MeSH) and was modified for each database. </p> </section> <section id="CD012019-sec-0004"> <h3 class="title" id="CD012019-sec-0004">Selection criteria</h3> <p>Published peer‐reviewed, randomised controlled or cross‐sectional studies of any size were considered, which included prospectively collected samples from any population of reproductive‐aged women suspected of having one or more of the following target conditions: ovarian, peritoneal or deep infiltrating endometriosis (DIE). We included studies comparing the diagnostic test accuracy of one or more urinary biomarkers with surgical visualisation of endometriotic lesions. </p> </section> <section id="CD012019-sec-0005"> <h3 class="title" id="CD012019-sec-0005">Data collection and analysis</h3> <p>Two authors independently collected and performed a quality assessment of the data from each study. For each diagnostic test, the data were classified as positive or negative for the surgical detection of endometriosis and sensitivity and specificity estimates were calculated. If two or more tests were evaluated in the same cohort, each was considered as a separate data set. The bivariate model was used to obtain pooled estimates of sensitivity and specificity whenever sufficient data sets were available. The predetermined criteria for a clinically useful urine test to replace diagnostic surgery was one with a sensitivity of 94% and a specificity of 79% to detect endometriosis. The criteria for triage tests were set at sensitivity of equal or greater than 95% and specificity of equal or greater than 50%, which in case of negative result rules out the diagnosis (SnOUT test) or sensitivity of equal or greater than 50% with specificity of equal or greater than 95%, which in case of positive result rules the diagnosis in (SpIN test). </p> </section> <section id="CD012019-sec-0006"> <h3 class="title" id="CD012019-sec-0006">Main results</h3> <p>We included eight studies involving 646 participants, most of which were of poor methodological quality. The urinary biomarkers were evaluated either in a specific phase of menstrual cycle or irrespective of the cycle phase. Five studies evaluated the diagnostic performance of four urinary biomarkers for endometriosis, including three biomarkers distinguishing women with and without endometriosis (enolase 1 (NNE); vitamin D binding protein (VDBP); and urinary peptide profiling); and one biomarker (cytokeratin 19 (CK 19)) showing no significant difference between the two groups. All of these biomarkers were assessed in small individual studies and could not be statistically evaluated in a meaningful way. None of the biomarkers met the criteria for a replacement test or a triage test. Three studies evaluated three biomarkers that did not differentiate women with endometriosis from disease‐free controls. </p> </section> <section id="CD012019-sec-0007"> <h3 class="title" id="CD012019-sec-0007">Authors' conclusions</h3> <p>There was insufficient evidence to recommend any urinary biomarker for use as a replacement or triage test in clinical practice for the diagnosis of endometriosis. Several urinary biomarkers may have diagnostic potential, but require further evaluation before being introduced into routine clinical practice. Laparoscopy remains the gold standard for the diagnosis of endometriosis, and diagnosis of endometriosis using urinary biomarkers should only be undertaken in a research setting. </p> </section> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD012019-abs-0004" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD012019-abs-0004">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD012019-abs-0006">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD012019-abs-0010">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD012019-abs-0005">Français</a> </li> <li class="section-language"> <a class="" href="full/th#CD012019-abs-0008">ภาษาไทย</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD012019-abs-0004" lang="en"> <h3>Urinary biomarkers for the non‐invasive diagnosis of endometriosis</h3> <p><b>Review Question</b> </p> <p>How accurate are urine test in detecting endometriosis? Can any urine test be accurate enough to replace or reduce the need for surgery in the diagnosis of endometriosis? </p> <p><b>Background</b> </p> <p>Women with endometriosis have endometrial tissue (the tissue that lines the womb and is shed during menstruation) growing outside the womb within the pelvic cavity. This tissue responds to reproductive hormones causing painful periods, chronic lower abdominal pain and difficulty conceiving. Currently, the only reliable way of diagnosing endometriosis is to perform laparoscopic surgery and visualise the endometrial deposits inside the abdomen. Because surgery is risky and expensive, urine tests have been evaluated for their ability to detect endometriosis non‐invasively. An accurate urine test could lead to the diagnosis of endometriosis without the need for surgery; or it could reduce the need for diagnostic surgery, so only women who were most likely to have endometriosis would require it. Other non‐invasive ways of diagnosing endometriosis using blood, imaging, endometrial and combination tests are evaluated in separate Cochrane reviews from this series. </p> <p><b>Study characteristics</b> </p> <p>The evidence included in this review is current to July 2015. We included eight studies involving 646 participants. All studies evaluated reproductive‐aged women who were undertaking diagnostic surgery to investigate symptoms of endometriosis or for other indications. Five studies evaluated the diagnostic accuracy of four urinary biomarkers, including four biomarkers that were expressed differently in women with and without endometriosis and one showing no difference between the two groups. Three other studies just identified three biomarkers that did not distinguish the two groups. </p> <p><b>Key results</b> </p> <p>None of the assessed biomarkers, including cytokeratin 19 (CK 19), enolase 1 (NNE), vitamin D binding protein (VDBP) and urinary peptide profiling have been evaluated by enough studies to provide a meaningful assessment of test accuracy. None of the tests were accurate enough to replace diagnostic surgery. Several studies identified biomarkers that might be of value in diagnosing endometriosis, but there are too few reports to be sure of their diagnostic benefit. There is not enough evidence to recommend any urinary biomarker for use in clinical practice for the diagnosis of endometriosis. </p> <p><b>Quality of the evidence</b> </p> <p>Generally, the reports were of low methodological quality and urine tests were only assessed in small individual studies. </p> <p><b>Future research</b> </p> <p>More high quality research trials are needed to accurately assess the diagnostic potential of urinary biomarkers identified in small numbers of studies as having value in detecting endometriosis. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD012019-sec-0084" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD012019-sec-0084"></div> <h3 class="title" id="CD012019-sec-0085">Implications for practice</h3> <section id="CD012019-sec-0085"> <p>There is not enough evidence to recommend any urinary biomarker for use in clinical practice for the diagnosis of endometriosis. None of the biomarkers qualified for either replacement or triage test and all were assessed in individual studies. </p> <p>As there is an absence of well‐established criteria for an adequate diagnostic test, the diagnostic criteria for replacement and triage tests were determined by the authors of this review in a way that we believe will aid the interpretation for clinically active readers. However we encourage readers to apply different criteria according to each clinical population and situation. </p> </section> <h3 class="title" id="CD012019-sec-0086">Implications for research</h3> <section id="CD012019-sec-0086"> <p>Currently, randomised controlled treatment trials require women with and without endometriosis to have had diagnostic surgery for accurate group allocation. For ethical reasons, therapeutic surgery is usually performed at the same time, potentially biasing treatment trial outcomes. Thus our current inability to diagnose and assess the progression of endometriosis in a non‐invasive way before surgery is a significant limitation in the advancement of clinical research in endometriosis. </p> <p>The evaluation of biomarkers in urine is a relatively novel research field and only a few urinary tests have been investigated . Further well‐designed diagnostic studies are required to establish the test accuracy and clinical utility of urinary peptides and other urinary tests. </p> <p>The QUADAS quality assessment of the included studies identified several weakness in study design that can impede an objective evaluation of the findings. We recommend that future authors consider: 1) including large cohorts after predefining the sample size via a power calculation (<a href="./references#CD012019-bbs2-0049" title="LiuA , SchistermanEF , MazumdarM , HuJ . Power and sample size calculation of comparative diagnostic accuracy studies with multiple correlated test results. Biometrical Journal2005;47(2):140‐50. ">Liu 2005</a>); 2) focusing on a 'single‐gate' design that only includes a clinically relevant population (<a href="./references#CD012019-bbs2-0060" title="RutjesAWS , ReitsmaJB , VandenbrouckeJP , GlasAS , BossuytPMM . Case–control and two‐gate designs in diagnostic accuracy studies. Clinical Chemistry2005;51(8):1335‐41. ">Rutjes 2005</a>); 3) utilising a diagnostic accuracy study design that adheres to the recommendations of the Standards for Reporting of Diagnostic Accuracy (STARD) initiative (<a href="./references#CD012019-bbs2-0025" title="BossuytPM , ReitsmaJB , BrunsDE , GatsonisCA , GlasziouPP , IrwigLM , et al. Standards for Reporting of Diagnostic Accuracy. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. BMJ2003;326(7379):41‐4. ">Bossuyt 2003</a>); 4) incorporating the QUADAS checklist into the study design (<a href="./references#CD012019-bbs2-0073" title="WhitingPF , RutjesAW , WestwoodME , MallettS , DeeksJJ , ReitsmaJB , et al. QUADAS‐2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy Studies. Annals of Internal Medicine2011;155(8):529‐36. ">Whiting 2011</a>); 5) formally assessing inter‐and intra‐observer variability of the laboratory methods; 6) establishing universally acceptable laboratory methodologies (<a href="./references#CD012019-bbs2-0057" title="RahmiogluN , FassbenderA , VitonisAF , TworogerSS , HummelshojL , D’HoogheTM , et al. World Endometriosis Research Foundation Endometriosis Phenome and biobanking harmonization project: III. Fluid biospecimen collection, processing, and storage in endometriosis research. Fertility and Sterility2014;102(5):1233‐43. ">Rahimoglu 2014</a>), and diagnostic criteria for a positive test; 7) utilising universally acceptable methods of performing laparoscopy as the reference standard test (<a href="./references#CD012019-bbs2-0024" title="BeckerCM , LauferMR , StrattonP , Hummelshojl , MissmerSA , ZondervanKT , et al. World Endometriosis Research Foundation Endometriosis Phenome and biobanking harmonization project: I. Surgical phenotype data collection in endometriosis research. Fertility and Sterility2014;102(5):1213‐22. ">Becker 2014</a>); 8) implementing validation techniques to assess how the results of a statistical analysis will generalise to an independent data set; 9) undertaking direct comparisons of promising tests in conjunction with a cost effectiveness analysis; 10) applying testing to different clinical phenotypes rather than to women classified according to rASRM staging (<a href="./references#CD012019-bbs2-0071" title="VitonisAF , VincentK , RahmiogluN , FassbenderA , Buck LouisG , HummelshojL , et al. World Endometriosis Research Foundation Endometriosis Phenome and biobanking harmonization project: II. Clinical and covariate phenotype data collection in endometriosis research. Fertility and Sterility2014;102(5):1223‐32. ">Vitonis 2014</a>); and 11) assessing the long‐term outcomes and lifetime healthcare costs of women that have participated in diagnostic test accuracy trials of specific diagnostic tests. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD012019-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD012019-sec-0029"></div> <div class="table" id="CD012019-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Biomarkers evaluated as a diagnostic test for endometriosis</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Review question</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="8" rowspan="1" valign=""> <p>What is the diagnostic accuracy of the urinary biomarkers in detecting pelvic endometriosis [peritoneal endometriosis, endometrioma, DIE]? </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Importance</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="8" rowspan="1" valign=""> <p>A simple and reliable non‐invasive test for endometriosis, with the potential to either replace syrgery or to triage patients in order to reduce surgery, would minimise surgical risk and reduce diagnostic delay </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Patients</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="8" rowspan="1" valign=""> <p>Reproductive‐aged women 1) with suspected endometriosis or 2) with persistent ovarian mass or 3) undergoing infertility workup or gynaecological laparoscopy </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Settings</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="8" rowspan="1" valign=""> <p>Hospitals (public or private of any level): outpatient clinics (general gynaecology, reproductive medicine, pelvic pain); research laboratories </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Reference standard</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="8" rowspan="1" valign=""> <p>Visualisation of endometriosis at surgery (laparoscopy or laparotomy) with or without histological confirmation </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Study design</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="8" rowspan="1" valign=""> <p>Cross sectional studies with a 'single‐gate' design (n = 4) or a 'two‐gate' design (n = 1); prospective enrolment; a single study could assess more than one test </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="5" valign=""> <p><b>Risk of bias</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="8" rowspan="1" valign=""> <p>Overall judgement: Poor quality of most of the studies (no study had a 'low risk' assessment in all 4 domains) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="8" rowspan="1" valign=""> <p>Patient selection bias: High risk ‐ 1 study; Unclear risk ‐ 4 studies; Low risk ‐ 0 studies </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="8" rowspan="1" valign=""> <p>Index test interpretation bias: High risk ‐ 5 studies; Unclear risk ‐ 0 studies; Low risk ‐ 0 studies </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="8" rowspan="1" valign=""> <p>Reference standard interpretation bias: High risk ‐ 0 studies; Unclear risk ‐ 1 study; Low risk ‐ 4 studies </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="8" rowspan="1" valign=""> <p>Flow and timing selection bias: High risk ‐ 1 study; Unclear risk ‐ 0 studies; Low risk ‐ 4 studies </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Applicability concerns</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="8" rowspan="1" valign=""> <p>Concerns regarding patient selection: High concern ‐ 3 studies; Unclear concern ‐ 0 studies; Low concern 2 studies </p> <p>Concerns regarding index test: High concern ‐ 0 studies; Unclear concern ‐ 0 studies; Low concern ‐ 5 studies </p> <p>Concerns regarding reference standard: High concern ‐ 0 studies; Unclear concern ‐ 0 studies; Low concern ‐ 5 studies </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="2" rowspan="2" valign=""> <p><b>Biomarker</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><b>N of studies;</b> </p> <p><b>N of women</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>Outcomes</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><b>Diagnostic estimates [95% CI]</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><b>Implications</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>True positives</p> <p>(endometriosis)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>False negatives (incorrectly</p> <p>classified as disease‐free)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>True negatives (disease‐free)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>False positives (incorrectly</p> <p>classified as endometriosis)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p>NNE (enolase I) cut‐off &gt; 0.96 ng/mgCr</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1; 59</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sensitivity 0.56 [0.40, 0.72]</p> <p>Specificity 0.70 [0.46, 0.88]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Insufficient evidence to draw meaningful conclusions</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p>VDBP</p> <p>cut‐off &gt; 87.83 ng/mgCr</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1; 95</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>33</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sensitivity 0.58 [0.44, 0.71]</p> <p>Specificity 0.55 [0.38, 0.71]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Insufficient evidence to draw meaningful conclusions</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p>CK 19 [CYFRA21‐1]</p> <p>cut‐off &gt; 5.3 ng/ml</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1; 98</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>56</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>33</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sensitivity 0.11 [0.05, 0.22]</p> <p>Specificity 0.94 [0.81, 0.99]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Insufficient evidence to draw meaningful conclusions</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p>Proteome:</p> <p>peptide m/z 1824.3 Da</p> <p>cut‐off ≥ 29.34 au</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1; 28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sensitivity 0.77 [0.46, 0.95]</p> <p>Specificity 0.73 [0.45, 0.92]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Insufficient evidence to draw meaningful conclusions</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p>Proteome:</p> <p>peptide m/z 1767.1 Da</p> <p>cut‐off ≥ 35.22 au</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1; 27</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sensitivity 0.75</p> <p>[0.43, 0.95]</p> <p>Specificity 0.87</p> <p>[0.60, 0.98]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Insufficient evidence to draw meaningful conclusions</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p>Proteome:</p> <p>peptide m/z 2052.3 Da</p> <p>cut‐off not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1; 122</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>43</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sensitivity 0.83</p> <p>[0.71, 0.92]</p> <p>Specificity 0.69</p> <p>[0.56, 0.80]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Insufficient evidence to draw meaningful conclusions</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p>Proteome:</p> <p>peptide m/z 3393.9 Da</p> <p>cut‐off not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1; 122</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sensitivity 0.85</p> <p>[0.73, 0.93]</p> <p>Specificity 0.71</p> <p>[0.58, 0.82]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Insufficient evidence to draw meaningful conclusions</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p>Proteome:</p> <p>peptide m/z 1579.2 Da</p> <p>[collagen alpha 6(IV) chain precursor]</p> <p>cut‐off not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1; 122</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>43</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sensitivity 0.83</p> <p>[0.71, 0.92]</p> <p>Specificity 0.69</p> <p>[0.56, 0.80]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Insufficient evidence to draw meaningful conclusions</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p>Proteome:</p> <p>peptide m/z 891.6 Da</p> <p>[collagen alpha1 chain precursor]</p> <p>cut‐off not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1; 122</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sensitiviy 0.82</p> <p>[0.70, 0.90]</p> <p>Specificity 0.65</p> <p>[0.51, 0.76]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Insufficient evidence to draw meaningful conclusions</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p>Proteome:</p> <p>5 peptides m/z 1433.9 + 1599.4 + 2085.6 + 6798.0 + 3217.2 Da cut‐off not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1; 25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sensitivity 0.91</p> <p>[0.59, 1.00]</p> <p>Specificity 0.93</p> <p>[0.66, 1.00]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Insufficient evidence to draw meaningful conclusions</p> <p>Approaches criteria for a replacement test or SnOUT/SpIN triage tests; further diagnostic test accuracy studies recommended </p> </td> </tr> </tbody> </table> </div> <div class="table" id="CD012019-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Biomarkers that do not distinguish between women with and without endometriosis</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Review question</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p>Which urinary biomarkers are unlikely to serve as a basis of the diagnostic test for endometriosis? </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Importance</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p>Biomarkers that do not show differential expression in women with and without endometriosis are unlikely to be diagnostically useful. Information regarding negative trials can focus research on better diagnostic targets. The biomarkers that display conflicting results (distinguish women with and without endometriosis in some, but not all, studies) can be identified and reported on. Papers that did not show differential expression of a biomarker in endometriosis but were adequately designed and that met inclusion criteria for this review were included. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Patients</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p>Reproductive aged women 1) with suspected endometriosis or 2) with persistent ovarian mass or 3) undergoing infertility workup/gynaecological laparoscopy </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Settings</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p>Hospitals (public or private of any level): outpatient clinics (general gynaecology, reproductive medicine, pelvic pain); research laboratory </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Reference standard</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p>Visualisation of endometriosis at surgery (laparoscopy or laparotomy) with or without histological confirmation </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Study design</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p>Cross‐sectional of 'single‐gate' design (n = 1) or 'two‐gate' design (n = 2); prospective enrolment; one study could assess more than one test </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="5" valign=""> <p><b>Risk of bias</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p>Overall judgement: Poor quality (no studies had 'low risk' assessment in all 4 domains)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p>Patient selection bias: High risk ‐ 2 studies; Unclear risk ‐ 1 study; Low risk ‐ 0 studies </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p>Index test interpretation bias: High risk ‐ 3 studies; Unclear risk ‐ 0 studies; Low risk ‐ 0 studies </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p>Reference standard interpretation bias: High risk ‐ 0 studies; Unclear risk ‐ 0 studies; Low risk ‐ 3 studies </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p>Flow and timing selection bias: High risk ‐ 0 studies; Unclear risk ‐ 0 studies; Low risk ‐ 3 studies </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Applicability concerns</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p>Concerns regarding patient selection: High concern ‐ 2 studies; Unclear concern ‐ 0 studies; Low concern ‐ 1 study </p> <p>Concerns regarding index test: High concern ‐ 0 studies; Unclear concern ‐ 0 studies; Low concern ‐ 3 studies </p> <p>Concerns regarding reference standard: High concern ‐ 0 studies; Unclear concern ‐ 0 studies; Low concern ‐ 3 studies </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Biomarker</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Expression levels</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>rASRM stage</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Menstrual cycle phase</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Reference</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>VEGF</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>endometriosis (n = 46)<sup>1</sup>: 1.11 ± 0.17 pg/mg Cr </p> <p>controls (n = 24): 0.76 ± 0.14 pg/mg Cr</p> <p>p ‐ NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>I‐IV</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>follicular or luteal</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012019-bbs2-0001" title="ChoSH , OhYJ , NamA , KimHY , ParkJH , KimJH , et al. Evaluation of serum and urinary angiogenic factors in patients with endometriosis. American Journal of Reproductive Immunology2007; Vol. 58, issue 6:497‐504. [DOI: 10.1111/j.1600‐0897.2007.00535.x; ISSN 1046‐7408] ">Cho 2007</a> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>VEGF</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>endometriosis (n = 40)<sup>1</sup> 83.6 ± 11.3 pg/mg Cr </p> <p>controls (n = 22): 88.5 ± 10.4 pg/mg Cr</p> <p>P = 0.77</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>I‐IV</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>follicular or luteal</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012019-bbs2-0006" title="Potlog‐NahariC , StrattonP , WinkelC , Widraz , SinaiiN , ConnorsS , et al. Urine vascular endothelial growth factor‐A is not a useful marker for endometriosis. Fertility and Sterility2004; Vol. 81, issue 6:1507‐12. [DOI: 10.1016/j.fertnstert.2003.10.040; ISSN 0015‐0282] ">Potlog‐Naharia 2004</a> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>TNF‐a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>endometriosis (n = 46)<sup>1</sup>: 0.02 ± 0.01 pg/mg Cr </p> <p>controls (n = 24): 0.01 ± 0.002 pg/mg Cr</p> <p>p ‐ NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>I‐IV</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>follicular or luteal</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012019-bbs2-0001" title="ChoSH , OhYJ , NamA , KimHY , ParkJH , KimJH , et al. Evaluation of serum and urinary angiogenic factors in patients with endometriosis. American Journal of Reproductive Immunology2007; Vol. 58, issue 6:497‐504. [DOI: 10.1111/j.1600‐0897.2007.00535.x; ISSN 1046‐7408] ">Cho 2007</a> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CK 19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>endometriosis (n = 44)<sup>2</sup>: 5.4 ± 5.3 </p> <p>controls (n = 32): 6.7 ± 9.9</p> <p>p ‐ NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>follicular or luteal</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012019-bbs2-0004" title="KuesselL , Jaeger‐LanskyA , PateiskyP , RossbergN , SchulzA , SchmitzAA , et al. Cytokeratin‐19 as a biomarker in urine and in serum for the diagnosis of endometriosis‐‐a prospective study. Gynaecological Endocrinology2014; Vol. 30, issue 1:38‐41. [DOI: 10.3109/09513590.2013.856409; ISSN 1473‐0766] ">Kuessel 2014</a> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><sup>1</sup> mean ± SEM </p> <p><sup>2</sup> mean ± SD </p> </td> </tr> </tbody> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD012019-sec-0030" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD012019-sec-0030"></div> <section id="CD012019-sec-0031"> <h3 class="title" id="CD012019-sec-0031">Target condition being diagnosed</h3> <section id="CD012019-sec-0032"> <h4 class="title">Endometriosis</h4> <p>Endometriosis is defined as an inflammatory condition characterised by endometrial‐like tissue at sites outside the uterus (<a href="./references#CD012019-bbs2-0044" title="JohnsonNP , HummelshojL , World Endometriosis Society Montpellier Consortium. Consensus on current management of endometriosis. Human Reproduction2013;28(6):1252‐68. ">Johnson and Hummelshoj 2013</a>). Endometriotic lesions can occur at different locations, including the pelvic peritoneum and the ovary; or they can penetrate pelvic structures below the surface of peritoneum (defined as deeply infiltrating endometriosis (DIE)). Each of these types of endometriosis are thought to represent a separate clinical entity, but can coexist in the same woman. Rarely, endometriotic implants can be found at more distant sites, including lung, liver, pancreas and operative scars, with consequent variations in presenting symptoms. </p> <p>Endometriosis afflicts 10% of reproductive‐aged women causing dysmenorrhoea (painful periods), dyspareunia (painful intercourse), chronic pelvic pain and infertility (<a href="./references#CD012019-bbs2-0070" title="ViganoP , ParazziniF , SomiglianaE , VercelliniP . Endometriosis: epidemiology and aetiological factors. Best Practice &amp; Research: Clinical Obstetrics &amp; Gynaecology2004;18(2):177‐200. ">Vigano 2004</a>). The clinical presentation can vary from asymptomatic and unexplained infertility to severe dysmenorrhoea and chronic pain. These symptoms can occur with bowel or urinary symptoms, an abnormal pelvic examination or the presence of a pelvic mass, however no symptom is specific to endometriosis. The prevalence of endometriosis in symptomatic population is reported as 35‐50% (<a href="./references#CD012019-bbs2-0039" title="GiudiceLC , KaoLC . Endometriosis. Lancet2004;364(9447):1789‐99. ">Giudice 2004</a>). </p> <p>Women with endometriosis are also at increased risk of developing several cancers (<a href="./references#CD012019-bbs2-0065" title="SomiglianaE , ViganoP , ParazziniF , StoppelliS , GiambattistaE , VercelliniP . Association between endometriosis and cancer: a comprehensive review and a critical analysis of clinical and epidemiological evidence. Gynecologic Oncology2006;101(2):331‐41. ">Somigliana 2006</a>) and autoimmune disorders (<a href="./references#CD012019-bbs2-0063" title="SinaiiN , ClearySD , BallwegM , NiemanLK , StrattonP . High rates of autoimmune and endocrine disorders, fibromyalgia, chronic fatigue syndrome and atopic diseases among women with endometriosis: a survey analysis. Human Reproduction2002;17(10):2715‐24. ">Sinaii 2002</a>). The presence of disease is associated with changes in the immune response, vascularisation, neural function, the peritoneal environment and the eutopic endometrium, suggesting that endometriosis is a systemic, rather than localized, condition (<a href="./references#CD012019-bbs2-0039" title="GiudiceLC , KaoLC . Endometriosis. Lancet2004;364(9447):1789‐99. ">Giudice 2004</a>). Endometriosis has a profound effect on psychological and social well being and imposes a substantial economic burden on society. Women with endometriosis incur significant direct medical costs from diagnostic and therapeutic surgeries, hospital admissions and fertility treatments, however these costs are superseded by the indirect costs of endometriosis including absenteeism and loss of productivity (<a href="./references#CD012019-bbs2-0038" title="GaoX , YehYC , OutleyJ , SimonJ , BottemanM , SpaldingJ . Health‐related quality of life burden of women with endometriosis: a literature review. Current Medical Research &amp; Opinion2006;22(9):1787‐97. ">Gao 2006</a>; <a href="./references#CD012019-bbs2-0062" title="SimoensS , DunselmanG , DirksenC , HummelshojL , BokorA , BrandesI , et al. The burden of endometriosis: costs and quality of life of women with endometriosis and treated in referral centres. Human Reproduction2012;27(5):1292‐9. ">Simoens 2012</a>). In the USA, the financial burden of endometriosis is estimated at USD 12,419 per woman (<a href="./references#CD012019-bbs2-0062" title="SimoensS , DunselmanG , DirksenC , HummelshojL , BokorA , BrandesI , et al. The burden of endometriosis: costs and quality of life of women with endometriosis and treated in referral centres. Human Reproduction2012;27(5):1292‐9. ">Simoens 2012</a>). </p> <p>Although the pathogenesis of endometriosis has not been fully elucidated, it is commonly thought that endometriosis occurs when endometrial tissue contained within the menstrual fluid flows back through the fallopian tubes and implants at an ectopic site within the pelvic cavity (<a href="./references#CD012019-bbs2-0061" title="SampsonJA . Peritoneal endometriosis due to menstrual dissemination of endometrial tissue into the peritoneal cavity. American Journal of Obstetrics &amp; Gynecology1927;14(4):422‐69. ">Sampson 1927</a>). However, this theory does not explain the fact that although retrograde menstruation is seen in up to 90% of women only 10% of women develop endometriosis (<a href="./references#CD012019-bbs2-0042" title="HalmeJ , HammondMG , HulkaJF , RajSG , TalbertLM . Retrograde menstruation in healthy women and in patients with endometriosis. Obstetrics &amp; Gynecology1984;64(2):151‐4. ">Halme 1984</a>). There is evidence that a variety of environmental, immunological and hormonal factors are associated with endometriosis (<a href="./references#CD012019-bbs2-0070" title="ViganoP , ParazziniF , SomiglianaE , VercelliniP . Endometriosis: epidemiology and aetiological factors. Best Practice &amp; Research: Clinical Obstetrics &amp; Gynaecology2004;18(2):177‐200. ">Vigano 2004</a>); and genetic loci that confer a risk of endometriosis have been identified (<a href="./references#CD012019-bbs2-0056" title="NyholtDR , LowSK , AndersonCA , PainterJN , UnoS , MorrisAP , et al. Genome‐wide association meta‐analysis identifies new endometriosis risk loci. Nature Genetics2012;44(12):1355‐9. ">Nyholt 2012</a>). The relative contribution of these and other causal factors needs further elucidation. </p> <p>Although it is impossible to time the onset of disease, on average women have a 6‐ to 12‐year history of symptoms before obtaining a surgical diagnosis of endometriosis, indicative of considerable diagnostic delay (<a href="./references#CD012019-bbs2-0052" title="MatsuzakiS , CanisM , PoulyJL , RabischongB , BotchorishviliR , MageG . Relationship between delay of surgical diagnosis and severity of disease in patients with symptomatic deep infiltrating endometriosis. Fertility and Sterility2006;86(5):1314‐6. ">Matsuzaki 2006</a>). Untreated endometriosis is associated with reduced quality of life and contributes to outcomes such as depression, inability to work, sexual dysfunction and missed opportunity for motherhood (<a href="./references#CD012019-bbs2-0038" title="GaoX , YehYC , OutleyJ , SimonJ , BottemanM , SpaldingJ . Health‐related quality of life burden of women with endometriosis: a literature review. Current Medical Research &amp; Opinion2006;22(9):1787‐97. ">Gao 2006</a>). </p> </section> <section id="CD012019-sec-0033"> <h4 class="title">Treatment of endometriosis</h4> <p>There is no cure for endometriosis. Treatment options include expectant management, pharmacological (hormonal) therapy and surgery (<a href="./references#CD012019-bbs2-0044" title="JohnsonNP , HummelshojL , World Endometriosis Society Montpellier Consortium. Consensus on current management of endometriosis. Human Reproduction2013;28(6):1252‐68. ">Johnson and Hummelshoj 2013</a>). Treatment is individualised, taking into consideration the therapeutic goal (pain relief or subfertility) and the location of the disease. Current pharmacological therapies such as the combined oral contraceptive pill, progestogens, weak androgens and GnRH agonists and antagonists act to reduce the effect of oestrogen on endometrial tissues and suppress menstruation. These drugs can ameliorate the symptoms of dysmenorrhoea and chronic pelvic pain, but are associated with side effects such as breast discomfort, irritability, androgenic symptoms and bone loss. Surgical excision of endometriotic lesions can reduce pain symptoms; however it is associated with high recurrence rates of 40% to 50% at 5 years post‐surgery (<a href="./references#CD012019-bbs2-0040" title="GuoSW . Recurrence of endometriosis and its control. Human Reproduction Update2009;15(4):441‐61. ">Guo 2009</a>). Early treatment of endometriosis improves pain levels and physical and psychological functioning. Furthermore, improvements in menstrual management (the use of the Mirena coil and the continuous use of the combined contraceptive pill) and fertility preservation (oocyte vitrification) raise the possibility of suppressing the progression of endometriosis and prospectively managing subfertility in endometriosis sufferers. The potential success of these preventative strategies is dependent on an accurate and early diagnosis. A major impediment to earlier and more efficacious treatment of this disease is diagnostic delay due to the invasive nature of standard diagnostic tests (<a href="./references#CD012019-bbs2-0032" title="DmowskiWP , LesniewiczR , RanaN , PeppingP , NoursalehiM . Changing trends in the diagnosis of endometriosis: a comparative study of women with pelvic endometriosis presenting with chronic pelvic pain or infertility. Fertility and Sterility1997;67(2):238‐43. ">Dmowski 1997</a>). </p> </section> <section id="CD012019-sec-0034"> <h4 class="title">Diagnosis of endometriosis</h4> <p>Clinical history and pelvic examination can raise the possibility of a diagnosis of endometriosis, but the heterogeneity in clinical presentation, the high prevalence of asymptomatic endometriosis (2% to 50%) and the poor association between presenting symptoms and severity of the disease mean that a reliable diagnosis of endometriosis based solely on presenting symptoms is difficult to obtain (<a href="./references#CD012019-bbs2-0066" title="SpaczynskiRZ , DulebaAJ . Diagnosis of endometriosis. Seminars in Reproductive Medicine2003;21(2):193‐208. ">Spaczynski 2003</a>; <a href="./references#CD012019-bbs2-0036" title="FauconnierA , ChapronC . Endometriosis and pelvic pain: epidemiological evidence of the relationship and implications. Human Reproduction Update2005;11(6):595‐606. ">Fauconnier 2005</a>; <a href="./references#CD012019-bbs2-0022" title="BallardKD , SeamanHE , deVriesCS , WrightJT . Can symptomatology help in the diagnosis of endometriosis? Findings from a national case‐control study ‐ Part 1. BJOG2008;115(11):1382‐91. ">Ballard 2008</a>). Although an abnormal pelvic examination correlates with the presence of endometriosis on laparoscopy in 70% to 90% of cases (<a href="./references#CD012019-bbs2-0048" title="LingF . Randomized controlled trial of depot leuprolide in patients with chronic pelvic pain and clinically suspected endometriosis. Obstetrics &amp; Gynecology1999;93(1):51‐8. ">Ling 1999</a>), there is a wide differential diagnosis for most positive physical findings. Furthermore, a normal clinical examination does not exclude endometriosis, as laparoscopically proven disease has been diagnosed in more than 50% women with a clinically normal pelvic examination (<a href="./references#CD012019-bbs2-0034" title="EskenaziB , WarnerM , BosignoreL , OliveD , SamuelsS , VercelliniP . Validation study of nonsurgical diagnosis of endometriosis. Fertility and Sterility2001;76(5):929‐35. ">Eskenazi 2001</a>). A variety of tests utilising pelvic imaging, blood markers, eutopic endometrium characteristics, urinary markers or peritoneal fluid components have been suggested as diagnostic measures for endometriosis. Although large numbers of the reported markers distinguish women with and without endometriosis in small pilot studies, many do not show convincing potential as a diagnostic test when they are evaluated in larger studies by different research groups. The diagnostic value of these tests has not previously been fully systematically evaluated and summarised using Cochrane methodologies. Currently, there is no simple non‐invasive test for the diagnosis of endometriosis that is routinely implemented in clinical practice. </p> <p>Surgical diagnostic procedures for endometriosis include laparoscopy (minimal access surgery) or laparotomy (open surgery via an abdominal incision). In the last several decades, laparoscopy has become an increasingly common procedure and has largely replaced traditional open surgery in women suspected of having endometriosis (<a href="./references#CD012019-bbs2-0075" title="YeungPPJr , ShwayderJ , PasicRP . Laparoscopic management of endometriosis: comprehensive review of best evidence. Journal of Minimally Invasive Gynecology2009;16(3):269‐81. ">Yeung 2009</a>). Laparoscopy has significant advantages over laparotomy, creating fewer complications and shorter recovery times. Furthermore a magnified view at laparoscopy allows better visualisation of the peritoneal cavity. Despite continuing controversy in the literature with regard to the superiority of one surgical modality over another in treating pelvic pathology, laparoscopy is the preferred technique to evaluate the pelvis and abdomen and to treat benign conditions such as ovarian endometriomas (<a href="./references#CD012019-bbs2-0055" title="MedeirosLR , RosaDD , BozzettiMC , FachelJM , FurnessS , GarryR , et al. Laparoscopy versus laparotomy for benign ovarian tumour. Cochrane Database of Systematic Reviews2009, Issue 2. [DOI: 10.1002/14651858.CD004751.pub3; ISSN 1469‐493X (electronic)] ">Medeiros 2009</a>). Surgery is currently also the only accepted way to determine the extent and severity of endometriosis. Several classification systems have been suggested for endometriosis (<a href="./references#CD012019-bbs2-0023" title="BattR , MitwallyMF . Endometriosis from thelarche to midteens: pathogenesis and prognosis, prevention and pedagogy. Journal of Pediatric and Adolescent Gynecology2003;16(6):337‐47. ">Batt 2003</a>; <a href="./references#CD012019-bbs2-0027" title="ChapronC , FauconnierA , VieiraM , Barakat DoussetHB , PansiniV , Vacher‐LavenuMC , et al. Anatomical distribution of deeply infiltrating endometriosis: surgical implications and proposition for a classification. Human Reproduction2003;18(1):157‐61. ">Chapron 2003a</a>; <a href="./references#CD012019-bbs2-0051" title="MartinDC . Applying STARD criteria to the laparoscopic identification of endometriosis (abstract). Fertility and Sterility. 2006; Vol. 86 Suppl 2:270. ">Martin 2006</a>; <a href="./references#CD012019-bbs2-0019" title="AdamsonGD . Endometriosis Fertility Index (EFI): the new validated endometriosis staging system. WCE 2008, Art &amp; Science of Endometriosis. Melbourne, Australia, 11‐14 March, 2008. Poster # 33, Abstract page 7.2. ">Adamson 2008</a>), but most researchers and clinicians use the revised American Society for Reproductive Medicine (rASRM) classification, which is internationally accepted as a respected, currently available tool for the objective assessment of the disease (<a href="./references#CD012019-bbs2-0021" title="American Society for Reproductive Medicine. Revised American Society for Reproductive Medicine classification of endometriosis: 1996. Fertility and Sterility1997;67(5):817‐21. ">American Society for Reproductive Medicine 1997</a>). The rASRM classification system considers appearance, size and depth of peritoneal or ovarian implants and adhesions visualised during laparoscopy (<a href="#CD012019-tbl-0003">Table 1</a>) and allows uniform documentation of the extent of disease. Unfortunately this classification system has little value in clinical practice due to the lack of correlation between laparoscopic staging, the severity of symptoms and response to treatment (<a href="./references#CD012019-bbs2-0069" title="VercelliniP , TrespidiL , DeGiorgiO , CortesiI , ParazziniF , CrosignaniGP . Endometriosis and pelvic pain: relation to disease stage and localization. Fertility and Sterility1996;65(2):299‐304. ">Vercellini 1996</a>; <a href="./references#CD012019-bbs2-0041" title="GuzickDS , SillimanNP , AdamsonGD , ButtramVCJr , CanisM , MalinakLR , et al. Prediction of pregnancy in infertile women based on the American Society for Reproductive Medicines revised classification of endometriosis. Fertility and Sterility1997;67(5):822‐9. ">Guzick 1997</a>; <a href="./references#CD012019-bbs2-0028" title="ChapronC , FauconnierA , DubuissonJB , BarakatH , VieiraM , BréartG . Deep infiltrating endometriosis: relation between severity of dysmenorrhea and extent of disease. Human Reproduction2003;18:760‐6. ">Chapron 2003b</a>). </p> <div class="table" id="CD012019-tbl-0003"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Staging of endometriosis, rASRM classification</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Peritoneum</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Endometriosis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&lt; 1 cm</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1 to 3 cm</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&gt; 3 cm</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Superficial</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Deep</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign=""> <p>Ovary</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>R Superficial</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Deep</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>L Superficial</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Deep</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Posterior Cul‐de‐sac Obliteration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Partial</p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p>Complete</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p>40</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="5" valign=""> <p>Ovary</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adhesions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&lt; 1/3 Enclosure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1/3‐2/3 Enclosure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&gt; 2/3 Enclosure</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>R Filmy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Dense</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>L Filmy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Dense</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign=""> <p>Tube</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>R Filmy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Dense</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>L Filmy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Dense</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p>* If the fimbriated end of the fallopian tube is completely enclosed, change the point assignment to 16 </p> <p><a href="./references#CD012019-bbs2-0021" title="American Society for Reproductive Medicine. Revised American Society for Reproductive Medicine classification of endometriosis: 1996. Fertility and Sterility1997;67(5):817‐21. ">American Society for Reproductive Medicine 1997</a> </p> </td> </tr> </tbody> </table> </div> <p>The European Society of Human Reproduction and Embryology (ESHRE) Special Interest Group for Endometriosis stated in their guidelines for the diagnosis and treatment of endometriosis that for women presenting with symptoms suggestive of endometriosis, a definitive diagnosis of most forms of endometriosis requires visual inspection of the pelvis at laparoscopy as the 'gold standard' investigation (<a href="./references#CD012019-bbs2-0046" title="KennedyS , BergqvistA , ChapronC , D'HoogheT , DunselmanG , ESHRE Special Interest Group for Endometriosis. ESHRE guideline for the diagnosis and treatment of endometriosis. Human Reproduction2005;20(10):2698‐704. ">Kennedy 2005</a>). Currently the visual identification of endometriotic tissue in the pelvic cavity during surgery with or without histological confirmation is not just the best available but the only diagnostic test for endometriosis that is used routinely in clinical practice. </p> <p>The disadvantages of laparoscopic surgery include and are not limited to the high cost, the need for general anaesthesia and the potential for adhesion formation post procedure. Laparoscopy has been associated with a 2% risk of injury to pelvic organs, a 0.001% risk of damaging a major blood vessel and a mortality rate of 0.0001% (<a href="./references#CD012019-bbs2-0029" title="ChapronC , CravelloL , ChopinN , KreikerG , BlancB , DubuissonJB . Complications during set‐up procedures for laparoscopy in gynecology: open laparoscopy does not reduce the risk of major complications. Acta Obstetrica et Gynecologica Scandinavica2003;82:1125‐9. ">Chapron 2003c</a>). Only one third of women who undertake a laparoscopic procedure will receive a diagnosis of endometriosis; therefore many disease‐free women are unnecessarily exposed to surgical risk (<a href="./references#CD012019-bbs2-0037" title="FrishmanGN , SalakJR . Conservative surgical management of endometriosis in women with pelvic pain. Journal of Minimally Invasive Gynecology2006;13(6):546‐58. ">Frishman 2006</a>). </p> <p>The validity of laparoscopy as a reference test for endometriosis has been assessed as being highly dependent on the skills of the surgeon. The diagnostic accuracy of laparoscopic visualisation has been compared with histological confirmation in a sole systematic review and is estimated as having a 94% sensitivity and 79% specificity (<a href="./references#CD012019-bbs2-0074" title="WykesCB , ClarkTJ , KhanKS . Accuracy of laparoscopy in the diagnosis of endometriosis: a systematic quantitative review. BJOG2004;111(11):1204‐12. ">Wykes 2004</a>). Subsequent studies suggested that incorporation of histological verification in the diagnosis of endometriosis may improve diagnostic accuracy (<a href="./references#CD012019-bbs2-0050" title="MarchinoGL , GennarelliG , EnriaR , BongioanniF , LipariG , MassobrioM . Diagnosis of pelvic endometriosis with use of macroscopic versus histologic findings. Fertility and Sterility2005;84(1):12‐5. ">Marchino 2005</a>; <a href="./references#CD012019-bbs2-0020" title="Almeida FilhoDP , OliveiraLJ , AmaralVF . Accuracy of laparoscopy for assessing patients with endometriosis. Sao Paulo Medical Journal2008;126(6):305‐8. ">Almeida Filho 2008</a>; <a href="./references#CD012019-bbs2-0067" title="StegmannBJ , SinaiiN , LiuS , SegarsJ , MerinoM , NiemanLK , et al. Using location, color, size, and depth to characterize and identify endometriosis lesions in a cohort of 133 women. Fertility and Sterility2008;89(6):1632‐6. ">Stegmann 2008</a>) but these papers have not been systematically reviewed. The clinical significance of histological verification remains debatable, and a diagnosis based on visual findings can be considered reliable with an accurate inspection of the abdominal cavity by properly trained, experienced surgeons (<a href="./references#CD012019-bbs2-0058" title="RedwineDB . 'Invisible' microscopic endometriosis: a review. Gynecologic and Obstetric Investigation2003;55(2):63‐7. ">Redwine 2003</a>). Furthermore, excised potential endometriotic tissues are rarely serially sectioned in clinical practice and small lesions can be missed by pathologists in mild disease. Thus sampling inconsistencies are also likely to influence the accuracy of histological reporting. </p> </section> <section id="CD012019-sec-0035"> <h4 class="title">Summary</h4> <p>A diagnostic test without the need for surgery would reduce surgical risks, increase accessibility to a diagnostic test and improve treatment outcomes.  A need for an accurate and non‐invasive diagnostic test for endometriosis continues to encourage extensive research in the field and was endorsed at the international consensus workshop at the 10th World Congress of Endometriosis in 2008 (<a href="./references#CD012019-bbs2-0059" title="RogersPA , D'HoogheTM , FazleabasA , GargettCE , GiudiceLC , MontgomeryGW , et al. Priorities for Endometriosis Research: recommendations from an international consensus workshop. Reproductive Sciences2009;16(4):335‐46. ">Rogers 2009</a>). Although multiple markers and imaging techniques have been explored as diagnostic tests for endometriosis, none of them have been implemented routinely in clinical practice and most of them have not been subject to systematic review. </p> </section> </section> <section id="CD012019-sec-0036"> <h3 class="title" id="CD012019-sec-0036">Index test(s)</h3> <p>This review assesses urinary biomarkers that have been proposed as non‐invasive tests for the diagnosis of endometriosis (<a href="#CD012019-tbl-0004">Table 2</a>), as part of the review series on non‐invasive diagnostic tests for endometriosis. </p> <div class="table" id="CD012019-tbl-0004"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Urinary biomarkers for endometriosis</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Angiogenesis/Growth factors and their receptors</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>VEGF‐A (vascular endothelial growth factor ‐ A)<sup>1</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>sFlt‐1 [sVEGFR‐1] (soluble fms‐like tyrosine kinase or variant of VEGF receptor 1)<sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Cell adhesion molecules and other matrix‐related proteins</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>MMP‐2 (matrix metalloproteinase‐2)<sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>MMP‐9 (matrix metalloproteinase‐9)<sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>MMP‐9/ NGAL (matrix metalloproteinase‐9/neutrophil gelatinase‐associated lipocalin)<sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Cytokines</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>TNF‐alpha (tumour necrosis factor alfa)<sup>1</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Cytoskeleton molecules</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CK‐19 or CYFRA 21‐1 (Cytokeratin‐19)<sup>1</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>High throughput markers</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Proteome</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Oxidative stress markers</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8‐iso‐PGF2a (8‐iso‐prostaglandin F2a)<sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Other Peptides/proteins</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>VDBP (vitamin D binding protein)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NNE (enolase I)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Collagen precursors</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Prealbumin<sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Alpha 1 antitrypsin<sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Chain A solution structure of Bb' domains of human protein disulfide isomerase<sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>1</sup> Urinary biomarkers that did not exhibit differential expression in endometriosis </p> <p><sup>2</sup> Urinary biomarkers that exhibited differential expression in endometriosis, but for which the diagnostic estimates were not available </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> </tbody> </table> </div> <p>The definition of ‘non‐invasive’ varies between medical dictionaries but refers to a procedure that does not involve penetration of skin or physical entrance to the body (<a href="./references#CD012019-bbs2-0054" title="Segen JC(author) . McGraw‐Hill Concise Dictionary of Modern Medicine. The McGraw‐Hill Companies, Inc, 2006. ">McGraw‐Hill Dictionary of Medicine 2006</a>; <a href="./references#CD012019-bbs2-0068" title="Donna Olendorf(Editor) , Christine Jeryan(Editor) , Karen Boyden(Editor) , Gale Group (Corporate Author). The Gale Encyclopedia of Medicine (5 volume set). The Gale Group, Inc, 2008. ">The Gale Encyclopedia of Medicine 2008</a>). Although bladder catheterization for urine collection is invasive by this definition, when compared to diagnostic surgery for endometriosis, urine tests are generally considered to be 'non‐invasive' or 'minimally invasive'. For the purpose of these reviews, we will define all tests that do not involve anaesthesia and surgery as ‘non‐invasive’. </p> <p>The advantages of using a urine test for the diagnosis of endometriosis is that it is non‐invasive, readily available, and can be self‐collected without need for expensive equipment or skilled personnel. It is more acceptable to women, provides a rapid result and is more cost effective when compared to surgery. However urinary testing is dependent on the reliability of laboratory techniques and quality control protocols. Urinary biomarker levels may also be susceptible to variation during the menstrual cycle. </p> <p>Cellular and molecular processes have been identified that characterise ectopic endometrium and peritoneal fluid in human and animal models (<a href="./references#CD012019-bbs2-0030" title="D'HoogheTM , BambraCS , XiaoL , PeixeK , HillJA . Effect of menstruation and intrapelvic injection of endometrium on inflammatory parameters of peritoneal fluid in the baboon (Papio anubis and Papio cynocephalus). American Journal of Obstetrics &amp; Gynecology2001;184(5):917‐25. ">D'Hooghe 2001</a>; <a href="./references#CD012019-bbs2-0045" title="KaoLC , GermeyerA , TulacS , LoboS , YangJP , TaylorRN , et al. Expression profiling of endometrium from women with endometriosis reveals candidate genes for disease‐based implantation failure and infertility. Endocrinology2003;144(7):2870‐81. ">Kao 2003</a>; <a href="./references#CD012019-bbs2-0043" title="HullML , EscarenoCR , GodslandJM , DoigJR , JohnsonCM , PhillipsSC , et al. Endometrial‐peritoneal interactions during endometriotic lesion establishment. American Journal of Pathology2008;173(3):700‐15. ">Hull 2008</a>). Markers of these pathophysiological processes have been evaluated in various tissues, including urine, which is increasingly favoured as a fluid for biological testing. Urinary biomarker discovery is a new and rapidly expanding field with most studies published in the last five years. A limited number of endometriosis urinary biomarkers have been evaluated to date and most were assessed in small individual studies. Categories of markers include 1. angiogenesis and growth factors; 2. cell adhesion molecules and other matrix‐related proteins; 3. cytokines; 4. cytoskeleton molecules; 5. high‐throughput molecular markers; 6. oxidative stress markers; 7. other peptides/proteins shown to influence key events implicated in endometriosis. </p> <p>A large systematic review of all proposed biomarkers for endometriosis in serum, plasma and urine identified over 100 putative biomarkers, but the authors were unable to identify any biomarker (single or in a panel) that could be recommended for use in clinical practice (<a href="./references#CD012019-bbs2-0053" title="MayKE , Conduit‐HulbertSA , VillarJ , KirtleyS , KennedySH , BeckerCM . Peripheral biomarkers of endometriosis: A systematic review. Human Reproduction Update2010;16(6):651‐74. ">May 2010</a>). A more recent narrative review concurred with this conclusion (<a href="./references#CD012019-bbs2-0035" title="FassbenderA , BurneyRO , DorienFO , D’HoogheT , GiudiceL . Update on Biomarkers for the Detection of Endometriosis. BioMed Research International (http://www.hindawi.com/journals/bmri/2015/130854/) (accessed 20 April 2015). ">Fassbender 2015</a>). There is a current need to re‐evaluate the diagnostic test accuracy of urine tests for endometriosis using Cochrane methodologies. </p> </section> <section id="CD012019-sec-0037"> <h3 class="title" id="CD012019-sec-0037">Clinical pathway</h3> <p>Women presenting with symptoms of endometriosis (dysmenorrhoea, dyspareunia, chronic pelvic pain or difficulty conceiving) generally are investigated with a pelvic ultrasound scan to exclude other pathologies, which is in line with international guidelines (<a href="./references#CD012019-bbs2-0033" title="DunselmanGA , VermeulenN , BeckerC , Calhaz‐JorgeC , D'HoogheT , DeBieB , et al. ESHRE guideline: management of women with endometriosis. Human Reproduction2014;29(3):400‐12. ">Dunselman 2014</a>; <a href="./references#CD012019-bbs2-0064" title="Society of Obstetricians Gynaecologists of Canada. Endometriosis: diagnosis and management. SOGC clinical practice guideline no. 244. Journal of Obstetrics and Gynaecology Canada2010;32:S1‐S28. ">SOGC 2010</a>; <a href="./references#CD012019-bbs2-0018" title="The American College of Obstetricians and Gynecologists. Practice Bulletin No. 114: Management of Endometriosis.. Obstetrics and Gynecology2010;116(1):223‐36. ">ACOG 2010</a>). There are no other standard investigative tests and MRI is used conservatively because of its cost. If women seek pain management rather than conception, empirical treatment with progestogens or the combined oral contraceptive pill is commonly started. Diagnostic laparoscopy is considered if empirical treatment fails or if women decline or do not tolerate empirical treatment. In women who have difficulty conceiving, laparoscopy may be undertaken before fertility treatment (particularly if severe pelvic pain or endometrioma are present) or after failed ART (assisted reproductive technology) treatments. Endometriosis can be diagnosed during fertility investigations in women who have minimal or no pain symptomatology. </p> <p>On average there is a delay of between 6 to 12 years from onset of symptoms to definitive diagnosis at surgery. Early referral to a gynaecologist with the capability to perform diagnostic surgery is associated with a shorter time to diagnosis. Collectively, young women, women in remote and rural locations and women of lower socioeconomic status have reduced access to surgery, and are less likely to obtain a prompt diagnosis of endometriosis. </p> <section id="CD012019-sec-0038"> <h4 class="title">Prior test(s)</h4> <p>Most women presenting with symptoms suggestive of endometriosis have a full history and examination and a routine gynaecological ultrasound before a decision is made to have diagnostic surgery. However there is no consensus on whether or not ultrasound or any other test should be routinely used as part of a standardised approach. </p> </section> <section id="CD012019-sec-0039"> <h4 class="title">Role of index test(s)</h4> <p>A new diagnostic test can fulfil one of three roles:</p> <p>1. Replacement: replacing an existing test by having more accuracy, or a similar accuracy with other advantages. </p> <p>2. Triage: used as an initial step in a diagnostic pathway to identify the group of individuals who need further testing with an existing test. Although ideally a triage test has a high sensitivity and specificity, it may have a lower sensitivity but higher specificity than the current test or vice versa. The triage test does not aim to improve the diagnostic accuracy of the existing test but rather to reduce the number of individuals having an unnecessary diagnostic test. </p> <p>3. Add‐on: used in addition to existing testing to improve diagnostic performance (<a href="./references#CD012019-bbs2-0026" title="BossuytPM , LeeflangMM . Chapter 6: Developing Criteria for Including Studies. Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy Version 0.4 [updated September 2008]. The Cochrane Collaboration, 2008. ">Bossuyt 2008</a>). </p> <p>Ideally a diagnostic test is expected to correctly identify all individuals with a disease and to exclude all those without that disease, in other words it should have a sensitivity and specificity of 100%. A high sensitivity indicates that there are a low number of people who have a negative test and do have the disease (i.e. a low number of false‐negative results). High specificity corresponds to a low number of people who have a positive test but do not have the disease (i.e. low false‐positive results). In practice, however, it is extremely rare to find a test with equally high sensitivity and specificity. An acceptable replacement test would need to have a similar or higher sensitivity and specificity than the current gold standard of laparoscopy. The only systematic review that determines the accuracy of laparoscopy in diagnosing endometriosis reported a sensitivity of 94%, and a specificity of 79% and we have taken this as a cut off for a replacement test (<a href="./references#CD012019-bbs2-0074" title="WykesCB , ClarkTJ , KhanKS . Accuracy of laparoscopy in the diagnosis of endometriosis: a systematic quantitative review. BJOG2004;111(11):1204‐12. ">Wykes 2004</a>). </p> <p>The purpose of triage tests can vary depending on the clinical context and individuals’ priorities. One reasonable approach is to exclude the diagnosis to avoid further unnecessary and expensive diagnostic investigation. High sensitivity tests have few false‐negative results and act to rule conditions out (SnOUT). A negative result from a test with high sensitivity will exclude the disease with high certainty independent of the specificity. As women without disease would be assured of having a negative test, unnecessary invasive interventions can be avoided. However, a positive result has less diagnostic value particularly when the specificity is low. We predetermined that a clinically useful 'SnOUT' triage test should have a sensitivity of 95% or more and a specificity of 50% and above. The sensitivity cutoff for a 'SnOUT' triage test was set at 95% and above, assuming that a 5% false negative rate is statistically and clinically acceptable. The specificity cutoff was set at 50% and above, to avoid diagnostic uncertainty in more than 50% of the population with a positive result. </p> <p>An alternative approach would be to avoid a missed diagnosis. High specificity tests have few false positive results and act to rule conditions 'in' (SpIN). A positive result for a highly specific triage test indicates a high likelihood of having endometriosis. This information could be used to prioritise these women for surgical treatment. A positive 'SpIN' test could also provide a clinical rationale to start targeted disease‐specific medical management in a person without a surgical diagnosis, under the assumption that disease is present. Surgical management could then be reserved for cases when conservative treatment fails. This is particularly relevant in some populations where the therapeutic benefits of surgery for endometriosis have to be carefully balanced with the disadvantages (e.g. young women, women with medical conditions or pain‐free women with a history of infertility). In this scenario we considered a sensitivity of 50% and above and a specificity of 95% and higher as suitable cutoffs for a 'SpIN' triage test. </p> <p>We evaluated urine tests for their potential to replace surgery (replacement test) or to improve the selection of women for surgery (triage test) that can either rule out (SnOUT) or rule in (SpIN) the disease. Both types of triage test are clinically useful, minimising the number of unnecessary interventions. Sequential implementation of SnOUT and SpIN tests can also optimise a diagnostic algorithm (<a href="#CD012019-fig-0001">Figure 1</a>). We did not assess any test as an add‐on test, as we sought tests that reduce the need for surgery and not tests that improve the accuracy of the currently available surgical diagnosis. </p> <div class="figure" id="CD012019-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Sequential approach to non‐invasive testing of endometriosis" data-id="CD012019-fig-0001" src="/cdsr/doi/10.1002/14651858.CD012019/media/CDSR/CD012019/image_n/nCD012019-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Sequential approach to non‐invasive testing of endometriosis</p> </div> </div> </div> </section> <section id="CD012019-sec-0040"> <h4 class="title">Alternative test(s)</h4> <p>There are no alternative tests for the diagnosis of endometriosis that are in routine clinical practice. </p> </section> </section> <section id="CD012019-sec-0041"> <h3 class="title" id="CD012019-sec-0041">Rationale</h3> <p>Many women with endometriosis suffer longstanding pelvic pain and infertility prior to a diagnosis. Surgery is the only current method of diagnosing endometriosis, but it is associated with high costs and surgical risks. A simple and reliable non‐invasive test for endometriosis, with the potential to either replace laparoscopy or to triage women in order to reduce surgery, would minimise surgical risk and reduce diagnostic delay. Endometriosis could then be detected at less advanced stages and earlier intervention instituted. This would provide the opportunity for a preventive approach for this debilitating disease. Health care and social security costs of endometriosis would be expected to be reduced by early diagnosis and more cost effective and efficient treatments. Furthermore, identifying urine biomarkers that do not pertain to endometriotic disease would help clinicians and researchers focus on clinically relevant biomarker detection. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD012019-sec-0042" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD012019-sec-0042"></div> <section id="CD012019-sec-0043"> <h3 class="title" id="CD012019-sec-0043">Primary Objectives</h3> <p>1. To provide summary estimates of the diagnostic accuracy of urinary biomarkers for the diagnosis of pelvic endometriosis (peritoneal or ovarian or deep infiltrating, or a combination thereof) compared to surgical diagnosis as a reference standard. </p> <p>2. To assess the diagnostic utility of biomarkers that could differentiate ovarian endometrioma from other ovarian masses. </p> <p>Urinary biomarkers were evaluated as replacement tests for diagnostic surgery as well as triage tests which would assist decision‐making to undertake diagnostic surgery for endometriosis. </p> </section> <section id="CD012019-sec-0044"> <h3 class="title" id="CD012019-sec-0044">Secondary objectives</h3> <p>1. To investigate the influence of heterogeneity on the diagnostic accuracy of urinary biomarkers for endometriosis. Potential sources of heterogeneity include: </p> <p> <ul id="CD012019-list-0001"> <li> <p>Characteristics of the study population: age (adolescents vs. later reproductive years); clinical presentation (subfertility, pelvic pain, ovarian mass, asymptomatic women); stage of disease (rASRM classification system); geographic location of study; </p> </li> <li> <p>Histological confirmation in conjunction with laparoscopic visualisation compared to laparoscopic visualisation alone; </p> </li> <li> <p>Changes in technology over time: year of publication; modifications applied to conventional laboratory techniques; </p> </li> <li> <p>Methodological quality: differences in the QUADAS‐2 (Quality Assessment of Diagnostic Accuracy Studies‐2) evaluation (<a href="#CD012019-tbl-0005">Table 3</a>), including a) low versus unclear or high risk; b) consecutive versus non‐consecutive enrolment; c) blinding of surgeons to the results of index tests; </p> </li> <li> <p>Study design ('single‐gate design' vs. 'two‐gate design' studies).</p> </li> </ul> </p> <div class="table" id="CD012019-tbl-0005"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Application of the QUADAS‐2 tool for assessment of methodological quality of the included studies</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p><b>Domain 1 ‐ Patient selection</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Description</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Describe methods of patient selection and included patients</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Type of bias assessed</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Selection bias, spectrum bias</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Review Question</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Women of reproductive age with clinically suspected endometriosis (symptoms, clinical examination ± presence of pelvic mass), scheduled for surgical exploration of pelvic/abdominal cavity for confirmation of the diagnosis ± treatment </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Informaton collected</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study objectives, study population, selection (inclusion and exclusion criteria), study design, clinical presentation, age, number of participants enrolled and number of participants available for analysis, setting, place and period of the study </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i><b>Signalling question 1</b> </i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i><b>Was a consecutive or random sample of patients enrolled?</b> </i> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>If a consecutive sample or a random sample of the eligible patients was included in the study </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>If non‐consecutive sample or non‐random sample of the eligible patients was included in the study </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>If this information was unclear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i><b>Signalling question 2</b> </i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i><b>Did the study avoid inappropriate exclusions?</b> </i> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>If inclusion/exclusion criteria were presented and all patients with suspected endometriosis were included, with an exception for those who a) had a history of medical conditions or were on medical therapy that would have potentially interfered with interpretation of index test (e.g. malignancy, pregnancy, autoimmune disorders, infectious diseases, treatment with hormonal or immunomodulator substances); b) refused to participate in the study; or c) were unfit for surgery </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>If the study excluded the patients based on education level, psychosocial factors, genetic testing or phenotype or excluded patients with any co‐morbidities commonly present in general population, including a population that could have undergone a testing for endometriosis in clinical setting (hypertension, asthma, obesity, benign gastro‐intestinal or renal disease, etc) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>If the study did not provide clear definition of the selection (inclusion or exclusion) criteria and 'no' judgement was not applicable </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i><b>Signalling question 3</b> </i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i><b>Was a 'two‐gate' design avoided?</b> </i> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>If the study had a single set of inclusion criteria, defined by the clinical presentation (i.e. only participants in whom the target condition is suspected) ‐ a ‘single‐gate’ study design </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>If the study had more than one set of inclusion criteria in respect to clinical presentation (i.e. participants suspected of target condition and participants with alternative diagnosis in whom the target condition would not be suspected in clinical practice) ‐ a 'two‐gate' study design </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>If it was unclear whether a 'two‐gate deign' was avoided or not</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk of bias</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Could the selection of patients have introduced bias?</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>If 'yes' classification for all the above 3 questions</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>If 'no' classification for any of the above 3 questions</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>If 'unclear' classification for 3 of the above questions and 'high risk' judgement was not applicable </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Concerns about applicability</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Are there concerns that the included patients do not match the review question?</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>If the study includes only clinically relevant population that would have undergone index test in real practice and includes representative form of target condition </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>If the study population differed from the population defined in the review question in terms of demographic features and co‐morbidity (e.g. studies with multiple sets of inclusion criteria with respect to clinical presentation including either healthy controls or alternative diagnosis controls that would not have undergone index test in real practice). Further, if target condition diagnosed in the study population was not representative of the entire spectrum of disease, such as limited spectrum of severity (e.g. only mild forms) or limited type of endometriosis (e.g. only DIE) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>If this information was unclear (e.g. severity of endometriosis was not reported)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p><b>Domain 2 ‐ Index test</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Description</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Describe the index test, how it was conducted and interpreted</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Type of bias assessed</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Test review bias, clinical review bias, interobserver variation bias</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Review Question</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Any type of urinary biomarkers</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Informaton collected</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Index test name, description of positive case definition by index test as reported, threshold for positive result, examiners (number, level of expertise, blinding), interobserver variability, conflict of interests </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i><b>Signalling question 1</b> </i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i><b>Were the index test results interpreted without knowledge of the results of the reference standard?</b> </i> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>If the operators performing or interpreting index test were unaware of the results of reference standard </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>If the operators performing or interpreting index test were not blinded to the results of reference standard </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>If this information was unclear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i><b>Signalling question 2</b> </i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i><b>If a threshold was used, was it pre‐specified?</b> </i> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>If study clearly provided a threshold for positive result and was defined before execution or interpretation of index test </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>If a threshold for positive result was not provided or not defined prior to test execution</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>If it was unclear whether a threshold was pre‐specified or not</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i><b>Signalling question 3</b> </i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i><b>Was a menstrual cycle phase considered in interpreting the index test?</b> </i> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>If all the included participants were in the same phase of menstrual cycle or if the study reported subgroup analyses per cycle phase or if study reported the pooled estimates after impact of the cycle phase on biomarker expression was not detected </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>If study included participants in different phases of menstrual cycle, but effect of cycle phase on index test was not assessed </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>If the cycle phase was not reported</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk of bias</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Could the conduct or interpretation of the index test have introduced bias?</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>If 'yes' classification for all the above 3 questions</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>If 'no' classification for any of the above 3 questions</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>If 'unclear' classification for any of the above 3 questions and 'high risk' judgement was not applicable </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Concerns about applicability</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Are there concerns that the index test, its conduct, or interpretation differ from the review question?</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>We considered all types of urinary biomarkers as eligible; therefore all the included studies were classified as 'low concern', unless 'unclear' judgement was applicable </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>We did not consider the studies where index tests other than urinary biomarkers were included (or excluded information on other index tests reported in addition to urine tests) or where index test looked at other target conditions not specified in the review (e.g. studies aimed at classifying pelvic masses as benign and malignant); therefore none of the included studies was classified as 'high concern' </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>If study did not present sufficient information on at least one of the following: laboratory method, sample handling, reagents used, experience of the test operators </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p><b>Domain 3 ‐ Reference standard</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Description</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Describe the reference standard, how it was conducted and interpreted</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Type of bias assessed</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Verification bias, bias in estimation of diagnostic accuracy due to inadequate reference standard </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Review Question</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Target condition ‐ pelvic endometriosis, ovarian endometriosis, DIE. Reference standard ‐ visualisation of endometriosis at surgery (laparoscopy or laparotomy) with or without histological confirmation </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Informaton collected</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Target condition, prevalence of target condition in the sample, reference standard, description of positive case definition by reference test as reported, examiners (number, level of expertise, blinding) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i><b>Signalling question 1</b> </i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i><b>Were the reference standards likely to correctly classify the target condition?</b> </i> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>If the study reported at least one of the following: surgical procedure was described in sufficient details; or criteria for positive reference standard were stated; or diagnosis was confirmed by histopathology; or the procedure was performed by the team with high level of expertise in diagnosis/surgical treatment of target condition, including tertiary referral centres for endometriosis </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>If reference standard did not classify target condition correctly; considering the inclusion criteria and a nature of the reference standard, none of the studies were classified as 'no' for this item </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>If information on execution of the reference standard, its interpretation or operators was unclear </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i><b>Signalling question 2</b> </i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i><b>Were the reference standard results interpreted without knowledge of the results of the index tests?</b> </i> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>If operators performing the reference test were unaware of the results of index test</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>If operators performing the reference test were aware of the results of index test</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>If this information was unclear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk of bias</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Could the reference standard, its conduct, or its interpretation have introduced bias?</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>If 'yes' classification for all the above 2 questions</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>If 'no' classification for any of the above 2 questions</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>If 'unclear' classification for any of the above 2 questions and 'high risk' judgement was not applicable </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Concerns about applicability</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Are there concerns that the target condition as defined by the reference standard does not match the question?</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Considering the inclusion criteria, all the studies were classified as 'low concern', therefore all the included studies were classified as 'low concern' </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>We excluded the studies where participants did not undergo surgery for diagnosis of endometriosis, therefore none of the included studies were classified as 'high concern' </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Only studies were laparoscopy/laparotomy served as a reference test were included; therefore none of the included studies was classified as 'unclear concern' </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p><b>Domain 4 ‐ Flow and timing</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Description</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Describe any patients who did not receive the index tests or reference standard or who were excluded from the 2 x 2 table, describe the interval and any interventions between index tests (sample collection) and the reference standard </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Type of bias assessed</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Disease progression bias, bias of diagnostic performance due to missing data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Review Question</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Less than 12 months interval between index test (sample collection) and reference standard ‐ endometriosis may progress over time, so we had chosen an arbitrary time interval of 12 months as an acceptable time interval between the sample collection and surgical confirmation of diagnosis </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Informaton collected</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Time interval between index test (sample collection) and reference standard, withdrawals (overall number reported and if were explained) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i><b>Signalling question 1</b> </i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i><b>Was there an appropriate interval between index test (sample collection) and reference standard?</b> </i> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>If time interval was reported and was less than 12 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>We excluded all the studies where time interval was longer than 12 months, therefore none of the included studies were classified as 'no' for this item </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>If time interval was not stated clearly, but authors' description allowed to assume that the interval was reasonably short </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i><b>Signalling question 2</b> </i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i><b>Did all women receive the same reference standard?</b> </i> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>If all participants underwent laparoscopy or laparotomy as a reference standard; considering the inclusion criteria, all the studies were classified as 'yes' for this item, as anticipated </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>If all participants did not undergo surgery or had alternative reference standard or if only a subset of participants had surgery as reference standard, but the information on this population was not available in isolation; considering the inclusion criteria, none of the included studies were classified as 'no' for this item </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>If this information was unclear; considering the inclusion criteria, none of the included studies were classified as 'unclear' for this item </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i><b>Signalling question 3</b> </i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i><b>Were all women included in the analysis?</b> </i> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>If all the women were included in the analysis or if women were excluded because they did not meet inclusion criteria prior to execution of index test or if the withdrawals were less than 5% of the enrolled population (arbitrary selected cut‐off) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>If any patients were excluded from the analysis because of un interpretable results, inability to undergo either index test or reference standard or for unclear reasons </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>If this information was unclear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk of bias</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Could the patient flow have introduced bias?</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>If 'yes' classification for all the above 3 questions</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>If 'no' classification for any of the above 3 questions</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>If 'unclear' classification for any of the above 3 questions and 'high risk' judgement was not applicable </p> </td> </tr> </tbody> </table> </div> <p>2. To assess biomarkers which were not affected by endometriosis and hence were unlikely to discriminate between women with and without the disease. </p> </section> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD012019-sec-0045" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD012019-sec-0045"></div> <section id="CD012019-sec-0046"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD012019-sec-0047"> <h4 class="title">Types of studies</h4> <p>Published peer‐reviewed studies that compared the results of one or several types of urinary biomarkers with the results obtained by surgical diagnosis of endometriosis. Studies were included if they were: </p> <p> <ul id="CD012019-list-0002"> <li> <p>Randomised controlled trials;</p> </li> <li> <p>Observational studies of the following designs:</p> <ul id="CD012019-list-0003"> <li> <p>‘Single‐gate design’ (studies with a single set of inclusion criteria defined by clinical presentation). All participants had clinically suspected endometriosis. </p> </li> <li> <p>‘Two‐gate design’ (studies where participants are sampled from distinct populations with respect to clinical presentation). The same study includes participants with a clinical suspicion of having the target condition (e.g. women with pelvic pain) and also participants in whom the target condition is not suspected (e.g. women admitted for tubal ligation). Two‐gate studies were eligible only where all cases and controls belonged to the same population in respect to the reference standard (i.e. all the participants were scheduled for laparoscopy) (<a href="./references#CD012019-bbs2-0060" title="RutjesAWS , ReitsmaJB , VandenbrouckeJP , GlasAS , BossuytPMM . Case–control and two‐gate designs in diagnostic accuracy studies. Clinical Chemistry2005;51(8):1335‐41. ">Rutjes 2005</a>). </p> </li> </ul> </li> <li> <p>Performed on prospectively collected samples, irrespective of the actual time of the test assay. The timing of sample collection relative to surgery is important because the surgical excision of endometriotic lesions could influence urine biomarker expression and hence bias the results. Therefore, we only included studies where urine was collected before the surgical procedure, i.e. 'prospectively collected'. The studies performed on tissue bank samples collected from prospectively recruited, well‐defined populations were considered eligible, which prevented the omission of valuable data from adequately designed studies. The time interval between sample collection and laboratory testing may influence test outcomes which could be dependent on sample storage conditions and the stability of each individual biomarker during storage and freeze/thawing. This information was not readily available for most molecules and was not addressed in this review, but will be considered in future updates if more evidence emerges. </p> </li> <li> <p>Performed in any healthcare setting;</p> </li> <li> <p>Published in any language;</p> </li> <li> <p>We did not impose a minimal limit on the number of participants in the included studies nor the number of studies that have evaluated each index test. </p> </li> </ul> </p> <p>The following studies were excluded:</p> <p> <ul id="CD012019-list-0004"> <li> <p>Study design:</p> <ul id="CD012019-list-0005"> <li> <p>Narrative or systematic reviews;</p> </li> <li> <p>Studies of retrospective design where the sample collection was performed after execution of reference test; </p> </li> <li> <p>Studies of retrospective design where the participants were selected from retrospective review of the case notes/archived samples and information on recruitment methods or study population was not available; </p> </li> <li> <p>Case reports or case series;</p> </li> </ul> </li> <li> <p>Studies reported only in abstract form or in conference proceedings where the full text was not available. This limitation was applied when we faced substantial difficulty in obtaining the information from the abstracts, which precluded a reliable assessment of eligibility and methodological quality. </p> </li> </ul> </p> </section> <section id="CD012019-sec-0048"> <h4 class="title">Participants</h4> <p>Study participants included reproductive‐aged women (puberty to menopause) with suspected endometriosis based on clinical symptoms or pelvic examination, or both, who undertook both the index test and reference standard. </p> <p>The participants were selected from populations of women undergoing abdominal surgery for the following indications: 1) clinically suspected endometriosis (pelvic pain, infertility, abnormal pelvic examination, or a combination of the above), 2) ovarian mass regardless of symptoms, 3) a mixed group, which consists of women with suspected endometriosis/ovarian mass or women with other benign gynaecological conditions (e.g. surgical sterilisation, fibroid uterus, etc). Asymptomatic women who have an incidental finding of endometriosis at surgery performed for another indication were also included </p> <p>Articles that included participants of postmenopausal age were eligible when the data for the reproductive age group was available in isolation. Studies were excluded when the study population involved participants who clearly would not undergo the index test in a clinical scenario or would not benefit from the test (e.g. women with ectopic pregnancies, gynaecological malignancy or acute pelvic inflammatory disease). We also excluded publications where only a subset of participants with a positive index test or reference standard were included in the analysis and the data for the whole cohort were not available. </p> </section> <section id="CD012019-sec-0049"> <h4 class="title">Index tests</h4> <p>Any type of urinary biomarker for endometriosis was assessed either separately or in combination with other urine tests. The assessed index tests are presented in <a href="#CD012019-tbl-0004">Table 2</a>. We included the tests performed in one or several phases of menstrual cycle. </p> <p>The combined evaluations of urinary biomarkers with other methods for diagnosing endometriosis (e.g. pelvic examination, imaging, blood or endometrial tests) are beyond the scope of this review and are presented separately in another review 'Combined tests for the non‐invasive diagnosis of endometriosis'. The studies that solely assessed specific technical aspects, qualitative descriptions of lesion appearance or inter‐observer variability of the index tests without reporting the data on diagnostic performance were excluded from the review. When the evaluated biomarker(s) showed differential expression between the groups of women with and without endometriosis, the publication was considered only if the data were reported with sufficient detail for the construction of 2 x 2 contingency tables. However, when the contingency tables were not available because the expression level of index test did not significantly differ between the groups and the inclusion criteria were otherwise met, a critical appraisal was undertaken and the study was presented in the descriptive part of the review. Thus the adequately designed studies that identified biomarkers without diagnostic value were evaluated as they provide information that is likely to focus future research on other more clinically useful biomarkers. This methodology also identified biomarkers which were associated with endometriosis in some but not other publications. Evaluations of screening or predictive accuracy tests were not included in this review. </p> <p>The diagnostic performance of an index test was considered to be high when the test reached the criteria for a replacement test (sensitivity of equal or greater than 94% with specificity of equal or greater than 79%) or triage test (sensitivity of equal or greater than 95% with specificity of equal or greater than 50% or vice versa), or approached these criteria (diagnostic estimates within 5% of the set thresholds). All other diagnostic estimates were considered to be low. </p> </section> <section id="CD012019-sec-0050"> <h4 class="title">Target conditions</h4> <p>Pelvic endometriosis, defined as endometrial tissue located in the pelvic cavity: any of the pelvic organs, peritoneum and pouch of Douglas. Three types of pelvic endometriosis were assessed: </p> <p>1. Peritoneal endometriosis, defined as endometrial deposits detected on peritoneum covering pelvic organs, pelvic side walls or pouch of Douglas; </p> <p>2. Ovarian endometriosis (endometrioma), defined as an ovarian cyst lined by endometrial tissue and appearing as an ovarian mass of varying size; </p> <p>3. Deep infiltrating endometriosis (DIE), defined as subperitoneal infiltration of endometrial implants, i.e. when the endometriotic implants penetrate the retroperitoneal space for a distance of 5 mm or more (<a href="./references#CD012019-bbs2-0047" title="KoninckxPR , MeulemanC , DemeyereS , LesaffreE , CornillieFJ . Suggestive evidence that pelvic endometriosis is a progressive disease, whereas deeply infiltrating endometriosis is associated with pelvic pain. Fertility and Sterility1991;55(4):759‐65. ">Koninckx 1991</a>). DIE may be present in multiple locations, involving either anterior or posterior pelvic compartments, or both. </p> <p>Certain rare types of endometriosis such as extrapelvic, bladder and ureteric endometriosis were not included in this review because the majority were reported in case reports or case series and laparoscopy or laparotomy are not reliable reference standards for these conditions. </p> <p>We excluded the studies where diagnosis of endometriosis was not the primary outcome of the trial (e.g. malignant vs benign masses or normal vs. abnormal pelvis) and the separate data for endometriosis were not available. </p> <p>We also excluded the studies where the findings of the index test formed the basis of selection for the reference standard, because this was likely to distort an assessment of the diagnostic value of index test. </p> <p>We included studies that recruited selected populations of women with endometriosis (i.e. those with specific rASRM stages), because there is a poor correlation between the rASRM classification and infertility and pain symptoms. Exclusion of these studies could result in a loss of potentially important diagnostic information from otherwise eligible publications. Where possible the impact of these studies was addressed in the assessments of heterogeneity. When a study analysed a large population with a wide spectrum of endometriosis and additionally reported a sub‐group analysis of the different stages of disease severity, only estimates for the entire population were considered, because a subgroup analysis does not directly address the review question regarding the clinical utility of the biomarker in detecting the disease. </p> </section> <section id="CD012019-sec-0051"> <h4 class="title">Reference standards</h4> <p>The reference standard was visualisation of endometriosis at surgery (laparoscopy or laparotomy) with or without histological confirmation, as this is currently the best available test for endometriosis. Information regarding the inter‐ and intra‐observer correlation of the reference standard was reviewed if reported. </p> <p>Only studies in which the reference test was performed within 12 months of the urine sample collection were included, on the assumption that disease status could change within a period of one year or longer, either naturally or as a result of treatment. Studies in which the participants did not undergo the reference standard or where the findings of the index test formed the basis of selection for undertaking the reference standard were not included in this review. </p> <section id="CD012019-sec-0052"> <h5 class="title">Summary of inclusion/exclusion criteria</h5> <section id="CD012019-sec-0053"> <h6 class="title">Inclusion criteria:</h6> <p> <ul id="CD012019-list-0006"> <li> <p>Types of studies:</p> <ul id="CD012019-list-0007"> <li> <p>Published peer‐reviewed;</p> </li> <li> <p>RCTs;</p> </li> <li> <p>Observational of the following design:</p> <ul id="CD012019-list-0008"> <li> <p>‘single‐gate design’ (single set of inclusion criteria defined by clinical presentation): all the participants had clinically suspected endometriosis; </p> </li> <li> <p>‘two‐gate design’ (two sets of inclusion criteria with respect to clinical presentation and one set of inclusion criteria with respect to reference standard): the participants with or without a clinical suspicion of endometriosis scheduled for abdominal surgery; </p> </li> </ul> </li> <li> <p>Performed on prospectively collected samples, including the tissue bank samples collected from prospectively recruited well‐defined population; </p> </li> <li> <p>Published in any language;</p> </li> <li> <p>Performed in any healthcare setting;</p> </li> <li> <p>Any sample size.</p> </li> </ul> </li> </ul> <ul id="CD012019-list-0009"> <li> <p>Participants:</p> <ul id="CD012019-list-0010"> <li> <p>Reproductive‐aged women;</p> </li> <li> <p>Clinically suspected endometriosis, but included</p> <ul id="CD012019-list-0011"> <li> <p>women who underwent abdominal surgery for other benign gynaecological conditions and had surgical assessment for presence/absence of endometriosis; </p> </li> <li> <p>asymptomatic women who have an incidental finding of endometriosis at surgery performed for another indication; </p> </li> </ul> </li> <li> <p>Undertook both the index test and reference standard.</p> </li> </ul> </li> <li> <p>Index tests:</p> <ul id="CD012019-list-0012"> <li> <p>One or several types of urinary biomarkers;</p> </li> <li> <p>Data reported in sufficient detail for the construction of 2 x 2 tables for the tests that showed differential expression between the groups; </p> </li> <li> <p>Biomarkers where 2 x 2 tables could not be constructed as the results did not differ between women with and without endometriosis, but all other inclusion criteria were met. </p> </li> </ul> </li> <li> <p>Target condition:</p> <ul id="CD012019-list-0013"> <li> <p>Pelvic endometriosis</p> <ul id="CD012019-list-0014"> <li> <p>peritoneal endometriosis;</p> </li> <li> <p>ovarian endometrioma;</p> </li> <li> <p>DIE;</p> </li> <li> <p>combination of the above.</p> </li> </ul> </li> </ul> </li> <li> <p>Reference standard:</p> <ul id="CD012019-list-0015"> <li> <p>Surgical visualisation of lesions for the diagnosis of endometriosis (laparoscopy or laparotomy) with or without histological verification; </p> </li> <li> <p>Performed within 12 months of the urine sample collection.</p> </li> </ul> </li> </ul> </p> </section> <section id="CD012019-sec-0054"> <h6 class="title">Exclusion criteria:</h6> <p> <ul id="CD012019-list-0016"> <li> <p>Types of studies:</p> <ul id="CD012019-list-0017"> <li> <p>Narrative or systematic reviews;</p> </li> <li> <p>Retrospective design where the index test was performed after execution of reference test; </p> </li> <li> <p>Prospectively collected samples that were selected from the archived material, but information on the study population or the selection process was unclear; </p> </li> <li> <p>Case reports or case series;</p> </li> <li> <p>Conference proceedings.</p> </li> </ul> </li> <li> <p>Participants:</p> <ul id="CD012019-list-0018"> <li> <p>Included cohort was not representative of the target population that would benefit from the test (e.g. women with known genital tract malignancy, ectopic pregnancies or acute pelvic inflammatory disease); </p> </li> <li> <p>Study included participants of postmenopausal age and the data for the reproductive age group were not available in isolation; </p> </li> <li> <p>Only participants with positive index test or positive reference standard were included in analysis. </p> </li> </ul> </li> <li> <p>Index tests:</p> <ul id="CD012019-list-0019"> <li> <p>Urinary biomarkers presented in combination with other diagnostic tests for endometriosis and separate information for urinary biomarkers was not available; </p> </li> <li> <p>Study presented only specific technical aspects of an index test or focused on the biological events, rather than diagnostic performance of the test; </p> </li> <li> <p>Study assessed screening or predictive test accuracy.</p> </li> </ul> </li> <li> <p>Target condition:</p> <ul id="CD012019-list-0020"> <li> <p>Endometriosis was not the primary outcome of the trial (e.g. malignant vs benign masses or normal vs. abnormal pelvis) </p> </li> <li> <p>Atypical, rare sites of endometriosis.</p> </li> </ul> </li> </ul> <ul id="CD012019-list-0021"> <li> <p>Reference standard:</p> <ul id="CD012019-list-0022"> <li> <p>Reference standard performed only in a subset of study/control group;</p> </li> <li> <p>Findings of the index test formed the basis of selection for the reference standard;</p> </li> <li> <p>Other than specified in inclusion criteria.</p> </li> </ul> </li> </ul> </p> </section> </section> </section> </section> <section id="CD012019-sec-0055"> <h3 class="title">Search methods for identification of studies</h3> <p>The search strategy was developed in collaboration with the Trials Search Coordinator of the Gynaecology and Fertility Review Group, following recommendations of the Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy (<a href="./references#CD012019-bbs2-0031" title="deVetHCW , EisingaA , RiphagenII , AertgeertsB , PewsnerD . Chapter 7: Searching for Studies. Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy Version 0.4 [updated September 2008]. The Cochrane Collaboration, 2008. ">de Vet 2008</a>). The searches were not limited to particular types of study design and did not have language or publication date restrictions. The search strategy incorporated words in the title, abstract, text words across the record and the medical subject headings (MeSH). All searches were performed from inception until 31 July 2015. The search strategies for each database and the number of hits per search are presented in <a href="./appendices#CD012019-sec-0090">Appendix 1</a>; <a href="./appendices#CD012019-sec-0091">Appendix 2</a>; <a href="./appendices#CD012019-sec-0092">Appendix 3</a>; <a href="./appendices#CD012019-sec-0094">Appendix 4</a>. The summary of the results is presented in <a href="#CD012019-sec-0068">Results of the search</a>. </p> <section id="CD012019-sec-0056"> <h4 class="title">Electronic searches</h4> <p>We searched the following databases to identify the published articles that assessed the diagnostic value of urinary biomarkers for endometriosis: </p> <p> <ul id="CD012019-list-0023"> <li> <p>CENTRAL;</p> </li> <li> <p>MEDLINE;</p> </li> <li> <p>EMBASE;</p> </li> <li> <p>CINAHL;</p> </li> <li> <p>PsycINFO;</p> </li> <li> <p>Web of Science;</p> </li> <li> <p>LILACS;</p> </li> <li> <p>OAIster;</p> </li> <li> <p>TRIP;</p> </li> <li> <p>Databases of the trial registers:</p> <ul id="CD012019-list-0024"> <li> <p>ClinicalTrials.gov;</p> </li> <li> <p>World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP);</p> </li> </ul> </li> <li> <p>Databases to identify reviews and guidelines as sources of references to potentially relevant studies: </p> <ul id="CD012019-list-0025"> <li> <p>MEDION;</p> </li> <li> <p>DARE;</p> </li> <li> <p>PubMed, a ‘Systematic Review’ search under the ‘Clinical Queries' link;</p> </li> </ul> </li> <li> <p>Searches for papers recently published and not yet indexed in the major databases:</p> <ul id="CD012019-list-0026"> <li> <p>PubMed (simple search for the last 6 months; the ‘related articles’ feature was used to locate additional relevant studies). </p> </li> </ul> </li> </ul> </p> </section> <section id="CD012019-sec-0057"> <h4 class="title">Searching other resources</h4> <p>The reference list of all relevant publications (retrieved full texts of the key articles and identified reviews) was handsearched. </p> <p>An intended attempt to locate the grey literature (unpublished studies and conference proceedings) was abandoned as we faced substantial difficulty in obtaining full‐text publications or further details of studies reported in an abstract form. </p> </section> </section> <section id="CD012019-sec-0058"> <h3 class="title" id="CD012019-sec-0058">Data collection and analysis</h3> <section id="CD012019-sec-0059"> <h4 class="title">Selection of studies</h4> <p>Two authors of this review (EL, VN) and four authors for the other reviews from this series (Devashana Gupta, Rabia Shaikh, Deepika Arora and Lucy Prentice) scanned the titles of studies identified by our search to remove any clearly irrelevant articles. The titles and abstracts of the remaining studies were reviewed to select potentially relevant publications. The relevant articles were then divided into four categories of endometriosis biomarkers: serum, endometrial, urinary, and combined tests. Two of the urinary biomarker review authors (EL, LH, or VN) independently reviewed each of the full‐text versions of the articles selected by title and abstract and assessed them for eligibility for inclusion, based on the criteria listed above under <a href="#CD012019-sec-0046">Criteria for considering studies for this review</a>. A single failed eligibility criterion was sufficient for a study to be excluded from the review. </p> <p>The review authors who assessed the relevance of the studies and eligibility for inclusion were not blinded to the information about each article, including the publishing journal, the names of authors, the institution and the results. Any disagreements were resolved by discussion and, if necessary, in consultation with a third review author (CF), who is an expert in methodological aspects of Cochrane systematic reviews. </p> <p>When papers updated previous publications and were performed on the same study population at different recruitment points, the most complete data set that superseded previous publications was used to avoid double counting participants or studies. Missing data were retrieved by directly contacting authors to clarify study eligibility. When potentially relevant studies were found in languages other than English, a translation was undertaken. For excluded studies, the reasons for exclusion and details of which criteria were not met were documented. The characteristics of included, excluded and awaiting classification studies are presented under <a href="./references#CD012019-sec-0109" title="">Characteristics of included studies</a>, <a href="./references#CD012019-sec-0110" title="">Characteristics of excluded studies</a> and <a href="./references#CD012019-sec-0111" title="">Characteristics of studies awaiting classification</a>, respectively. </p> </section> <section id="CD012019-sec-0060"> <h4 class="title">Data extraction and management</h4> <p>Data were extracted from eligible studies by two independent review authors (EL, LH) and any disagreement was resolved by the third review author (VN). If required, study investigators were contacted to resolve any questions regarding the data. </p> <p>To collect details from included studies, a data extraction form was specifically designed for this review and pilot tested on three studies of diagnostic accuracy tests for endometriosis. The following information was recorded for each study: </p> <p> <ul id="CD012019-list-0027"> <li> <p>General information and study design: first author, year of publication, country, language, setting, objectives, inclusion/exclusion criteria, type of enrolment. </p> </li> </ul> <ul id="CD012019-list-0028"> <li> <p>Characteristics of the study participants: age, symptoms/history/previous tests, type of target condition and its prevalence in the study population, number of participants enrolled and available for analysis, reasons for withdrawal. </p> </li> </ul> <ul id="CD012019-list-0029"> <li> <p>Features of the index test and reference standard: type, diagnostic criteria, number and experience of the operators, blinding of the operators to other tests or clinical data or both, interobserver variability, time interval between index test and reference standard. </p> </li> </ul> <ul id="CD012019-list-0030"> <li> <p>The reported number of true positives (TP), false negatives (FN), true negatives (TN) and false positives (FP) was used to construct a two‐by‐two (2 x 2) table for each index test. If these values were not reported, we attempted to reconstruct the 2 x 2 tables from the summary estimates presented in the article. </p> </li> </ul> </p> <p>Data were extracted into Review Manager® (RevMan) software, which was used to graphically display the quality assessment, the diagnostic estimates data and the descriptive analyses. </p> </section> <section id="CD012019-sec-0061"> <h4 class="title">Assessment of methodological quality</h4> <p>We used QUADAS‐2, a modified version of the QUADAS tool to assess the quality of each included study (<a href="./references#CD012019-bbs2-0073" title="WhitingPF , RutjesAW , WestwoodME , MallettS , DeeksJJ , ReitsmaJB , et al. QUADAS‐2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy Studies. Annals of Internal Medicine2011;155(8):529‐36. ">Whiting 2011</a>). </p> <p>The review‐specific QUADAS‐2 tool and explanatory document are presented in <a href="#CD012019-tbl-0005">Table 3</a>. Each paper was judged as having a 'low', 'high' or 'unclear' risk for each of four domains and concerns about applicability were assessed in three domains. We considered studies as having low methodological quality when classified at high or unclear risk of bias or at high concern regarding applicability in at least one domain. The assessment of each included study was performed independently by two reviewers (EL, LH, or VN) and disagreements were settled by a third author (CF) or by consensus. Two review authors (EL, LH) independently piloted the topic‐specific tool to rate four of the included studies with a high level of agreement. Modifications specific to the urinary biomarkers review were made to the signalling questions of the original QUADAS‐2 tool and were as following: </p> <p>1) Domain 1: an original signalling question 'Was a case control design avoided?' was rephrased as 'Was a two‐gate design avoided?'. The diagnostic studies are cross‐sectional in nature, aiming to compare the result of an index test with the result of the reference standard in same group of participants. In these studies the parameters are measured at a single point of time and the groups are classified by the outcome of the reference standard, albeit the analysis is performed retrospectively. Therefore, unlike epidemiological studies, the terminology 'cohort' and 'case‐control' is less informative for diagnostic test trials, and was substituted by 'single‐gate' and 'two‐gate' designs. This question was included because a two‐gate design has more potential to introduce selection bias. </p> <p>2) Domain 2: an additional signalling question 'Was the phase of the menstrual cycle considered in interpreting the index test?' was introduced to assess bias in the interpretation of the test results. Some biochemical markers are sensitive to fluctuations in steroid sex hormones levels across a menstrual cycle, which could result in the differential expression of endometriosis biomarkers at different cycle phases. </p> <p>The assessment of methodological quality was undertaken for each domain but a summary score to estimate the overall quality of studies was not calculated (<a href="./references#CD012019-bbs2-0072" title="WhitingPF , HarbordR , KleijnenJ . No role for quality scores in systematic reviews of diagnostic accuracy studies. BMC Medical Research Methodology2005;5:19. ">Whiting 2005</a>). </p> </section> <section id="CD012019-sec-0062"> <h4 class="title">Statistical analysis and data synthesis</h4> <p>The estimates of sensitivity and specificity were generated in forest plots and plotted in the receiver operating characteristic (ROC) space for each index test using RevMan. The diagnostic performance of each test was investigated and inter study variation in the performance of each index test was visually explored in relation to participant characteristics, study design, and study quality factors. Two or more tests evaluated in the same cohort were included as separate data sets, since the unit of analysis was the test result, not the participant. </p> <p>For studies that reported subgroup analyses per phase of the menstrual cycle, we presented the data in a clinically relevant way. For instance, pooled estimates were presented when there was no statistically significant difference in biomarker expression between cycle phases. Alternatively, where putative biomarkers demonstrated cycle‐dependent expression or were noted to be modulated by ovarian hormones, we reported the test performance either at several time points across the menstrual cycle or in the phase that demonstrated the most distinct difference between groups. </p> <p>We planned to perform the bivariate logit‐normal random effects model for all meta‐analyses with four studies or more and a fixed effect meta‐analysis of sensitivity and specificity for smaller groups of studies (two to three) in the absence of substantial heterogeneity. When the number of studies was less than four, we did not attempt to estimate the covariance, and reported this as zero. The meta‐analyses were performed using SAS NLMIXED software. Results from SAS were input into RevMan to provide plots of the estimated summary points and confidence regions, superimposed on the study‐specific estimates of sensitivity and specificity. In this review this aspect of the statistical analysis was unable to be performed due to the paucity of data for each biomarker. </p> <p>The comparative accuracy of index tests was assessed in two ways. In direct, fully paired comparisons where all the study participants received more than one index test as well as the reference standard, the estimates were plotted in RevMan. If a meta‐analysis was possible, test‐level covariates in the bivariate logit‐normal model were used to identify statistically significant differences. Otherwise the available comparative data were reported in a narrative way and illustrated using forest and ROC plots. </p> <p>When test performance was judged against the predetermined diagnostic criteria, the point estimates of sensitivity and specificity were considered as the most informative presentation of test performance. We acknowledge that tests with point estimates that did not reach the predetermined criteria but confidence intervals (CIs) which contained values above the threshold, could have diagnostic value. Furthermore tests with point estimates that reached the criteria but CIs which contained values below the threshold, could have an overestimated diagnostic value. If the range of the CIs rather than the point estimates of the data are used, the predetermined cut‐off becomes meaningless. Therefore we did not consider CIs in qualifying the test performance, but utilised this information in interpreting the reliability of the obtained data. </p> <section id="CD012019-sec-0063"> <h5 class="title">Dealing with missing data</h5> <p>Missing data was defined as any information regarding the study population, index tests or reference standard that was not available in the publication which was required to determine the eligibility of the study for inclusion, the methodological quality or to construct the results table. If missing data were identified, the authors were contacted in an attempt to obtain this information. If missing data prevented a clear judgement regarding applicability for inclusion or the construction of accurate 2 x 2 tables and the data were not available from the primary investigators (for example we were unable to locate the contact details of the authors or there was no reply from the authors or the authors replied that the requested information was unavailable), the study was excluded from the review. </p> </section> </section> <section id="CD012019-sec-0064"> <h4 class="title">Investigations of heterogeneity</h4> <p>Heterogeneity was initially assessed by visually examining the forest plots of sensitivities and specificities and the ROC plots for each index test. The potential sources of heterogeneity are stated in the <a href="#CD012019-sec-0044">Secondary objectives</a>. For diagnostic tests where there were more than five eligible studies, we initially planned to formally explore heterogeneity by using study level covariates but we were unable to do so, because of the small numbers of studies in each group. We also planned to assess the sensitivity of results to the inclusion and exclusion of outlying studies in all analyses, but refrained from doing so, again because of the small number of studies for most analyses. It is important to use caution when interpreting small meta‐analyses (few studies) with a limited total sample size. </p> </section> <section id="CD012019-sec-0065"> <h4 class="title">Sensitivity analyses</h4> <p>We planned to conduct sensitivity analyses to assess the impact of the methodological quality of included studies on the results of any meta‐analyses if sufficient data were available. Low quality studies were defined by the identification of a high risk of bias for one or more QUADAS‐2 domains. We also planned to use the ’leave‐one‐out’ procedure to assess the impact of each study on the meta‐analysis results (leading study effect). In the urinary review this was unable to be undertaken due to the paucity of studies evaluating each biomarker. </p> </section> <section id="CD012019-sec-0066"> <h4 class="title">Assessment of reporting bias</h4> <p>A comprehensive search of multiple sources for eligible studies, a search of trial registers and no language restrictions minimised the risk of reporting bias. However, publication bias generally arises when studies have a higher chance of being published if their results are positive. Therefore unpublished and published study databases and conference proceedings were initially searched and evaluated. During the process of qualifying the studies for inclusion in this review, we faced substantial difficulty in obtaining full‐text publications or further details of studies published in an abstract form. This precluded a reliable assessment of eligibility and methodological quality and it was decided not to include these publication sources in this review. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD012019-sec-0067" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD012019-sec-0067"></div> <section id="CD012019-sec-0068"> <h3 class="title" id="CD012019-sec-0068">Results of the search</h3> <p>The literature search identified 33,438 references in the following databases: MEDLINE (n = 10,328), CENTRAL (n = 226), EMBASE (n = 10,313), CINAHL (n = 1131), PsycINFO (n = 174), Web of Science (n = 7425), LILACS (n = 420), OAIster (n = 446), Trip (n = 1648), Trial registers for ongoing and registered trials (n = 523), MEDION (n = 2), DARE (n = 99), PubMed, a ‘Systematic Review’ search (n = 418), simple search PubMed (n = 267). These databases were searched from inception to 20 April ‐ 31 July 2015. The flow of the selection process is presented in <a href="#CD012019-fig-0002">Figure 2</a>. Titles were screened to exclude duplicates (n = 9312) and clearly irrelevant studies (n = 21,534). Another 2575 references were eliminated after reading the abstracts because they did not address the research question or clearly did not meet the inclusion criteria. The full texts of the remaining 16 references were retrieved and assessed for eligibility. Data from two studies required additional clarification from the authors. There were no non‐English publications requiring translation. Ultimately, eight studies were eligible according to the inclusion criteria and provided data for the review, six studies were excluded and two studies were defined as awaiting classification. In addition, one ongoing trial was identified through the clinical trials registries (<a href="./references#CD012019-sec-0112" title="">Characteristics of ongoing studies</a>), but the outcomes of this study were not yet available (ongoing, but not recruiting participants). The progress of this study will be monitored and addressed in future updates. </p> <div class="figure" id="CD012019-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Flow of the studies identified in literature search for systematic review on urinary biomarkers for a non‐invasive diagnosis of endometriosis." data-id="CD012019-fig-0002" src="/cdsr/doi/10.1002/14651858.CD012019/media/CDSR/CD012019/image_n/nCD012019-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Flow of the studies identified in literature search for systematic review on urinary biomarkers for a non‐invasive diagnosis of endometriosis. </p> </div> </div> </div> <section id="CD012019-sec-0069"> <h4 class="title">Basic features of the included studies</h4> <p>The list and details of the included studies are presented in <a href="./references#CD012019-sec-0109" title="">Characteristics of included studies</a>. The eight eligible studies included 646 participants, with a median of 73 women per study (range 39 to 147). Of these studies, five assessed urinary biomarker expression in women with and without endometriosis and included enough data to estimate a diagnostic performance of the investigated test (n = 438 participants, median 95, range 39 to 147 women). Each study evaluated one or several biomarkers. Most studies reported diagnostic estimates for biomarkers that demonstrated differential expression between women with and without endometriosis, although in one publication this assessment was undertaken for a test that demonstrated no differential expression (<a href="./references#CD012019-bbs2-0005" title="LesseyBA , SavarisRF , AliS , BrophyS , Tomazic‐AllenS , ChwaliszK . Diagnostic Accuracy of Urinary Cytokeratin 19 Fragment for Endometriosis. Reproductive Sciences 2014 Oct 08 [Epub ahead of print]. [DOI: 10.1177/1933719114553064; ISSN 1933‐7205 (Electronic)] ">Lessey 2014</a>). In three studies there was no difference in the expression between the women with and without endometriosis and the diagnostic test accuracy of the urinary biomarker was not evaluated (n = 208 participants, median 70, range 62 to 76 women). This set of studies was methodologically eligible and the biomarkers identified are unlikely to be of diagnostic utility and hence may not be worth further study. </p> <p>Four of the included studies were conducted in Asia, two in Europe and two in North America. All the studies were conducted at university hospitals, of which at least three were referral centres for endometriosis. The earliest article was published in 2004, six articles were published after 2010 and four studies were published after 2013. There were no randomised controlled trials and all the studies were observational of cross‐sectional design. Five studies were 'single‐gate', where both cases and controls were sampled from the same participant population, all of which included women with suspected endometriosis based on clinical presentation (women presenting with pelvic pain, infertility, ovarian mass, or a combination thereof). Three studies were of a 'two‐gate design' and included a wider group of participants who were undergoing surgery for various indications. All the included studies assessed women of reproductive age. Laparoscopy was the predominant surgical modality in the included studies, whereas laparotomy was co‐utilised in one study. Seven of the included studies used histopathology to confirm the surgical diagnosis. All the included studies evaluated pelvic endometriosis and the reported prevalence of endometriosis varied from 43% to 66%. Five studies included wide spectrum of endometriosis (rASRM I‐IV), two studies included only participants with moderate–severe endometriosis (rASRM stage III‐IV) and in one study the information on the severity of the disease was not available. Six studies received financial support, two of which were funded by the pharmaceutical companies, and all the authors declared no conflict of interest. No information was available from the remaining two studies. </p> </section> <section id="CD012019-sec-0070"> <h4 class="title">Basic features of the excluded studies</h4> <p>The list and descriptions of the excluded studies are presented in <a href="./references#CD012019-sec-0110" title="">Characteristics of excluded studies</a>. Based on a full text assessment, six publications were excluded, of which one was of retrospective design and the urine samples were collected after the surgical procedure. One study reported statistically significant differences in biomarker levels between the study and control groups, but contained insufficient diagnostic accuracy information for the construction of 2 x 2 contingency tables. One excluded paper presented the qualitative evaluation of urinary biomarkers and did not define a specific test for diagnostic assessment. A further three studies were excluded as they evaluated urinary excretion of the environmental toxins and their association with risk of endometriosis. For two studies there was insufficient data to confirm eligibility and these were classified as awaiting classification at the time of publication. These studies are outlined in <a href="./references#CD012019-sec-0111" title="">Characteristics of studies awaiting classification</a> and will be addressed in future updates of this review. </p> </section> </section> <section id="CD012019-sec-0071"> <h3 class="title">Methodological quality of included studies</h3> <p>The quality of the included studies is illustrated in the QUADAS‐2 results summary (<a href="#CD012019-fig-0003">Figure 3</a> and <a href="#CD012019-fig-0004">Figure 4</a>). Overall, the studies were of poor methodological quality and all studies had an unclear or high risk of bias in at least one domain. </p> <div class="figure" id="CD012019-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias and applicability concerns graph: review authors' judgements about each domain presented as percentages across included studies" data-id="CD012019-fig-0003" src="/cdsr/doi/10.1002/14651858.CD012019/media/CDSR/CD012019/image_n/nCD012019-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias and applicability concerns graph: review authors' judgements about each domain presented as percentages across included studies </p> </div> </div> </div> <div class="figure" id="CD012019-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Risk of bias and applicability concerns summary: review authors' judgements about each domain for each included study" data-id="CD012019-fig-0004" src="/cdsr/doi/10.1002/14651858.CD012019/media/CDSR/CD012019/image_n/nCD012019-AFig-FIG04.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias and applicability concerns summary: review authors' judgements about each domain for each included study </p> </div> </div> </div> <p>No studies presented a low risk of participant selection bias; five studies demonstrated an unclear risk (<a href="./references#CD012019-bbs2-0006" title="Potlog‐NahariC , StrattonP , WinkelC , Widraz , SinaiiN , ConnorsS , et al. Urine vascular endothelial growth factor‐A is not a useful marker for endometriosis. Fertility and Sterility2004; Vol. 81, issue 6:1507‐12. [DOI: 10.1016/j.fertnstert.2003.10.040; ISSN 0015‐0282] ">Potlog‐Naharia 2004</a>; <a href="./references#CD012019-bbs2-0003" title="El‐KastiMM , WrightC , FyeHK , RosemanF , KesslerBM , BeckerCM . Urinary peptide profiling identifies a panel of putative biomarkers for diagnosing and staging endometriosis. Fertility and Sterility2011; Vol. 95, issue 4:1261‐6. [DOI: 10.1016/j.fertnstert.2010.11.066; ISSN 1556‐5653] ">El‐Kasti 2011</a>; <a href="./references#CD012019-bbs2-0002" title="ChoS , ChoiYS , YimSY , YangHI , JeonYE , LeeKE , et al. Urinary vitamin D‐binding protein is elevated in patients with endometriosis. Human Reproduction2012;27(2):515‐22. ">Cho 2012</a>; <a href="./references#CD012019-bbs2-0007" title="WangL , LiuHY , ShiHH , LangJH , SunW . Urine peptide patterns for non‐invasive diagnosis of endometriosis:a preliminary prospective study. European Journal of Obstetrics &amp; Gynecology and Reproductive Biology2014;177:23‐8. [DOI: 10.1016/j.ejogrb.2014.03.011; ISSN 1872‐7654 (Electronic)] ">Wang 2014</a>; <a href="./references#CD012019-bbs2-0008" title="YunBH , LeeYS , ChonSJ , JungYS , YimSY , KimHY , et al. Evaluation of elevated urinary enolase I levels in patients with endometriosis. Biomarkers2014; Vol. 19, issue 1:16‐21. [DOI: 10.3109/1354750X.2013.863973; ISSN 1366‐5804] ">Yun 2014</a>); and three studies were assessed at high risk for this domain (<a href="./references#CD012019-bbs2-0001" title="ChoSH , OhYJ , NamA , KimHY , ParkJH , KimJH , et al. Evaluation of serum and urinary angiogenic factors in patients with endometriosis. American Journal of Reproductive Immunology2007; Vol. 58, issue 6:497‐504. [DOI: 10.1111/j.1600‐0897.2007.00535.x; ISSN 1046‐7408] ">Cho 2007</a>; <a href="./references#CD012019-bbs2-0004" title="KuesselL , Jaeger‐LanskyA , PateiskyP , RossbergN , SchulzA , SchmitzAA , et al. Cytokeratin‐19 as a biomarker in urine and in serum for the diagnosis of endometriosis‐‐a prospective study. Gynaecological Endocrinology2014; Vol. 30, issue 1:38‐41. [DOI: 10.3109/09513590.2013.856409; ISSN 1473‐0766] ">Kuessel 2014</a>; <a href="./references#CD012019-bbs2-0005" title="LesseyBA , SavarisRF , AliS , BrophyS , Tomazic‐AllenS , ChwaliszK . Diagnostic Accuracy of Urinary Cytokeratin 19 Fragment for Endometriosis. Reproductive Sciences 2014 Oct 08 [Epub ahead of print]. [DOI: 10.1177/1933719114553064; ISSN 1933‐7205 (Electronic)] ">Lessey 2014</a>). Non‐consecutive or non‐random participant selection, utilisation of a two‐gate design for participant selection and the absence of a clear definition of inclusion/exclusion criteria were the main reasons for a 'high risk' assessment of bias. </p> <p>All the studies demonstrated a high risk of index test interpretation bias (<a href="./references#CD012019-bbs2-0006" title="Potlog‐NahariC , StrattonP , WinkelC , Widraz , SinaiiN , ConnorsS , et al. Urine vascular endothelial growth factor‐A is not a useful marker for endometriosis. Fertility and Sterility2004; Vol. 81, issue 6:1507‐12. [DOI: 10.1016/j.fertnstert.2003.10.040; ISSN 0015‐0282] ">Potlog‐Naharia 2004</a>; <a href="./references#CD012019-bbs2-0001" title="ChoSH , OhYJ , NamA , KimHY , ParkJH , KimJH , et al. Evaluation of serum and urinary angiogenic factors in patients with endometriosis. American Journal of Reproductive Immunology2007; Vol. 58, issue 6:497‐504. [DOI: 10.1111/j.1600‐0897.2007.00535.x; ISSN 1046‐7408] ">Cho 2007</a>; <a href="./references#CD012019-bbs2-0003" title="El‐KastiMM , WrightC , FyeHK , RosemanF , KesslerBM , BeckerCM . Urinary peptide profiling identifies a panel of putative biomarkers for diagnosing and staging endometriosis. Fertility and Sterility2011; Vol. 95, issue 4:1261‐6. [DOI: 10.1016/j.fertnstert.2010.11.066; ISSN 1556‐5653] ">El‐Kasti 2011</a>; <a href="./references#CD012019-bbs2-0002" title="ChoS , ChoiYS , YimSY , YangHI , JeonYE , LeeKE , et al. Urinary vitamin D‐binding protein is elevated in patients with endometriosis. Human Reproduction2012;27(2):515‐22. ">Cho 2012</a>; <a href="./references#CD012019-bbs2-0004" title="KuesselL , Jaeger‐LanskyA , PateiskyP , RossbergN , SchulzA , SchmitzAA , et al. Cytokeratin‐19 as a biomarker in urine and in serum for the diagnosis of endometriosis‐‐a prospective study. Gynaecological Endocrinology2014; Vol. 30, issue 1:38‐41. [DOI: 10.3109/09513590.2013.856409; ISSN 1473‐0766] ">Kuessel 2014</a>; <a href="./references#CD012019-bbs2-0005" title="LesseyBA , SavarisRF , AliS , BrophyS , Tomazic‐AllenS , ChwaliszK . Diagnostic Accuracy of Urinary Cytokeratin 19 Fragment for Endometriosis. Reproductive Sciences 2014 Oct 08 [Epub ahead of print]. [DOI: 10.1177/1933719114553064; ISSN 1933‐7205 (Electronic)] ">Lessey 2014</a>; <a href="./references#CD012019-bbs2-0007" title="WangL , LiuHY , ShiHH , LangJH , SunW . Urine peptide patterns for non‐invasive diagnosis of endometriosis:a preliminary prospective study. European Journal of Obstetrics &amp; Gynecology and Reproductive Biology2014;177:23‐8. [DOI: 10.1016/j.ejogrb.2014.03.011; ISSN 1872‐7654 (Electronic)] ">Wang 2014</a>; <a href="./references#CD012019-bbs2-0008" title="YunBH , LeeYS , ChonSJ , JungYS , YimSY , KimHY , et al. Evaluation of elevated urinary enolase I levels in patients with endometriosis. Biomarkers2014; Vol. 19, issue 1:16‐21. [DOI: 10.3109/1354750X.2013.863973; ISSN 1366‐5804] ">Yun 2014</a>). A lack of clear pre‐specified criteria for a positive diagnosis and index test operators not being blind to the results of reference standard were the main reasons for a 'high risk' assessment. A high risk of bias for this domain was also attributed to the articles where the phase of menstrual cycle was not considered in interpreting the index test. This was considered an important criterion, since varying ovarian hormones across the cycle could influence biomarker expression and undermine the reliability of the results. Furthermore, the skill level of a test operator and interobserver variability, both of which directly affect performance of the tests, were rarely reported. As the criteria for a positive index test were variable between the studies and the index test protocols were not standardised, quality judgements for the index test were complex. </p> <p>Seven studies were at low risk of bias in the 'reference standard' domain (<a href="./references#CD012019-bbs2-0006" title="Potlog‐NahariC , StrattonP , WinkelC , Widraz , SinaiiN , ConnorsS , et al. Urine vascular endothelial growth factor‐A is not a useful marker for endometriosis. Fertility and Sterility2004; Vol. 81, issue 6:1507‐12. [DOI: 10.1016/j.fertnstert.2003.10.040; ISSN 0015‐0282] ">Potlog‐Naharia 2004</a>; <a href="./references#CD012019-bbs2-0001" title="ChoSH , OhYJ , NamA , KimHY , ParkJH , KimJH , et al. Evaluation of serum and urinary angiogenic factors in patients with endometriosis. American Journal of Reproductive Immunology2007; Vol. 58, issue 6:497‐504. [DOI: 10.1111/j.1600‐0897.2007.00535.x; ISSN 1046‐7408] ">Cho 2007</a>; <a href="./references#CD012019-bbs2-0003" title="El‐KastiMM , WrightC , FyeHK , RosemanF , KesslerBM , BeckerCM . Urinary peptide profiling identifies a panel of putative biomarkers for diagnosing and staging endometriosis. Fertility and Sterility2011; Vol. 95, issue 4:1261‐6. [DOI: 10.1016/j.fertnstert.2010.11.066; ISSN 1556‐5653] ">El‐Kasti 2011</a>; <a href="./references#CD012019-bbs2-0002" title="ChoS , ChoiYS , YimSY , YangHI , JeonYE , LeeKE , et al. Urinary vitamin D‐binding protein is elevated in patients with endometriosis. Human Reproduction2012;27(2):515‐22. ">Cho 2012</a>; <a href="./references#CD012019-bbs2-0004" title="KuesselL , Jaeger‐LanskyA , PateiskyP , RossbergN , SchulzA , SchmitzAA , et al. Cytokeratin‐19 as a biomarker in urine and in serum for the diagnosis of endometriosis‐‐a prospective study. Gynaecological Endocrinology2014; Vol. 30, issue 1:38‐41. [DOI: 10.3109/09513590.2013.856409; ISSN 1473‐0766] ">Kuessel 2014</a>; <a href="./references#CD012019-bbs2-0005" title="LesseyBA , SavarisRF , AliS , BrophyS , Tomazic‐AllenS , ChwaliszK . Diagnostic Accuracy of Urinary Cytokeratin 19 Fragment for Endometriosis. Reproductive Sciences 2014 Oct 08 [Epub ahead of print]. [DOI: 10.1177/1933719114553064; ISSN 1933‐7205 (Electronic)] ">Lessey 2014</a>; <a href="./references#CD012019-bbs2-0008" title="YunBH , LeeYS , ChonSJ , JungYS , YimSY , KimHY , et al. Evaluation of elevated urinary enolase I levels in patients with endometriosis. Biomarkers2014; Vol. 19, issue 1:16‐21. [DOI: 10.3109/1354750X.2013.863973; ISSN 1366‐5804] ">Yun 2014</a>); one study was classified at unclear risk (<a href="./references#CD012019-bbs2-0007" title="WangL , LiuHY , ShiHH , LangJH , SunW . Urine peptide patterns for non‐invasive diagnosis of endometriosis:a preliminary prospective study. European Journal of Obstetrics &amp; Gynecology and Reproductive Biology2014;177:23‐8. [DOI: 10.1016/j.ejogrb.2014.03.011; ISSN 1872‐7654 (Electronic)] ">Wang 2014</a>); and no studies demonstrated a high risk. An unclear risk of bias was assigned if there was not enough information to determine how likely the reference standard was to have correctly classified the target condition. Specifically, surgical procedures were not well described, the criteria for a positive reference standard were not stated, it was unclear if histology was utilised to confirm surgical diagnosis, or there was no information regarding the experience of the surgeons or the pathologists (or both) involved. </p> <p>Seven studies presented a low risk of bias in the 'flow and timing' domain (<a href="./references#CD012019-bbs2-0006" title="Potlog‐NahariC , StrattonP , WinkelC , Widraz , SinaiiN , ConnorsS , et al. Urine vascular endothelial growth factor‐A is not a useful marker for endometriosis. Fertility and Sterility2004; Vol. 81, issue 6:1507‐12. [DOI: 10.1016/j.fertnstert.2003.10.040; ISSN 0015‐0282] ">Potlog‐Naharia 2004</a>; <a href="./references#CD012019-bbs2-0001" title="ChoSH , OhYJ , NamA , KimHY , ParkJH , KimJH , et al. Evaluation of serum and urinary angiogenic factors in patients with endometriosis. American Journal of Reproductive Immunology2007; Vol. 58, issue 6:497‐504. [DOI: 10.1111/j.1600‐0897.2007.00535.x; ISSN 1046‐7408] ">Cho 2007</a>; <a href="./references#CD012019-bbs2-0002" title="ChoS , ChoiYS , YimSY , YangHI , JeonYE , LeeKE , et al. Urinary vitamin D‐binding protein is elevated in patients with endometriosis. Human Reproduction2012;27(2):515‐22. ">Cho 2012</a>; <a href="./references#CD012019-bbs2-0004" title="KuesselL , Jaeger‐LanskyA , PateiskyP , RossbergN , SchulzA , SchmitzAA , et al. Cytokeratin‐19 as a biomarker in urine and in serum for the diagnosis of endometriosis‐‐a prospective study. Gynaecological Endocrinology2014; Vol. 30, issue 1:38‐41. [DOI: 10.3109/09513590.2013.856409; ISSN 1473‐0766] ">Kuessel 2014</a>; <a href="./references#CD012019-bbs2-0005" title="LesseyBA , SavarisRF , AliS , BrophyS , Tomazic‐AllenS , ChwaliszK . Diagnostic Accuracy of Urinary Cytokeratin 19 Fragment for Endometriosis. Reproductive Sciences 2014 Oct 08 [Epub ahead of print]. [DOI: 10.1177/1933719114553064; ISSN 1933‐7205 (Electronic)] ">Lessey 2014</a>; <a href="./references#CD012019-bbs2-0007" title="WangL , LiuHY , ShiHH , LangJH , SunW . Urine peptide patterns for non‐invasive diagnosis of endometriosis:a preliminary prospective study. European Journal of Obstetrics &amp; Gynecology and Reproductive Biology2014;177:23‐8. [DOI: 10.1016/j.ejogrb.2014.03.011; ISSN 1872‐7654 (Electronic)] ">Wang 2014</a>; <a href="./references#CD012019-bbs2-0008" title="YunBH , LeeYS , ChonSJ , JungYS , YimSY , KimHY , et al. Evaluation of elevated urinary enolase I levels in patients with endometriosis. Biomarkers2014; Vol. 19, issue 1:16‐21. [DOI: 10.3109/1354750X.2013.863973; ISSN 1366‐5804] ">Yun 2014</a>); no studies demonstrated an unclear risk; and one study carried a high risk (<a href="./references#CD012019-bbs2-0003" title="El‐KastiMM , WrightC , FyeHK , RosemanF , KesslerBM , BeckerCM . Urinary peptide profiling identifies a panel of putative biomarkers for diagnosing and staging endometriosis. Fertility and Sterility2011; Vol. 95, issue 4:1261‐6. [DOI: 10.1016/j.fertnstert.2010.11.066; ISSN 1556‐5653] ">El‐Kasti 2011</a>). In every study all participants received the same reference standard. The time interval between the index test and the reference standard was placed as 12 months or less and the most commonly reported time interval was immediately before surgery. A high risk of bias was assigned if there were unexplained withdrawals that exceeded 5% of the enrolled population or if the reason for withdrawal could introduce selection bias regarding the samples analysed. </p> <p>Three studies presented a low concern for participant selection applicability (<a href="./references#CD012019-bbs2-0006" title="Potlog‐NahariC , StrattonP , WinkelC , Widraz , SinaiiN , ConnorsS , et al. Urine vascular endothelial growth factor‐A is not a useful marker for endometriosis. Fertility and Sterility2004; Vol. 81, issue 6:1507‐12. [DOI: 10.1016/j.fertnstert.2003.10.040; ISSN 0015‐0282] ">Potlog‐Naharia 2004</a>; <a href="./references#CD012019-bbs2-0002" title="ChoS , ChoiYS , YimSY , YangHI , JeonYE , LeeKE , et al. Urinary vitamin D‐binding protein is elevated in patients with endometriosis. Human Reproduction2012;27(2):515‐22. ">Cho 2012</a>; <a href="./references#CD012019-bbs2-0007" title="WangL , LiuHY , ShiHH , LangJH , SunW . Urine peptide patterns for non‐invasive diagnosis of endometriosis:a preliminary prospective study. European Journal of Obstetrics &amp; Gynecology and Reproductive Biology2014;177:23‐8. [DOI: 10.1016/j.ejogrb.2014.03.011; ISSN 1872‐7654 (Electronic)] ">Wang 2014</a>); and five were of high concern (<a href="./references#CD012019-bbs2-0001" title="ChoSH , OhYJ , NamA , KimHY , ParkJH , KimJH , et al. Evaluation of serum and urinary angiogenic factors in patients with endometriosis. American Journal of Reproductive Immunology2007; Vol. 58, issue 6:497‐504. [DOI: 10.1111/j.1600‐0897.2007.00535.x; ISSN 1046‐7408] ">Cho 2007</a>; <a href="./references#CD012019-bbs2-0003" title="El‐KastiMM , WrightC , FyeHK , RosemanF , KesslerBM , BeckerCM . Urinary peptide profiling identifies a panel of putative biomarkers for diagnosing and staging endometriosis. Fertility and Sterility2011; Vol. 95, issue 4:1261‐6. [DOI: 10.1016/j.fertnstert.2010.11.066; ISSN 1556‐5653] ">El‐Kasti 2011</a>; <a href="./references#CD012019-bbs2-0004" title="KuesselL , Jaeger‐LanskyA , PateiskyP , RossbergN , SchulzA , SchmitzAA , et al. Cytokeratin‐19 as a biomarker in urine and in serum for the diagnosis of endometriosis‐‐a prospective study. Gynaecological Endocrinology2014; Vol. 30, issue 1:38‐41. [DOI: 10.3109/09513590.2013.856409; ISSN 1473‐0766] ">Kuessel 2014</a>; <a href="./references#CD012019-bbs2-0005" title="LesseyBA , SavarisRF , AliS , BrophyS , Tomazic‐AllenS , ChwaliszK . Diagnostic Accuracy of Urinary Cytokeratin 19 Fragment for Endometriosis. Reproductive Sciences 2014 Oct 08 [Epub ahead of print]. [DOI: 10.1177/1933719114553064; ISSN 1933‐7205 (Electronic)] ">Lessey 2014</a>; <a href="./references#CD012019-bbs2-0008" title="YunBH , LeeYS , ChonSJ , JungYS , YimSY , KimHY , et al. Evaluation of elevated urinary enolase I levels in patients with endometriosis. Biomarkers2014; Vol. 19, issue 1:16‐21. [DOI: 10.3109/1354750X.2013.863973; ISSN 1366‐5804] ">Yun 2014</a>). A high concern in participant selection applicability was assigned if the study utilised two‐gate selection for cases and controls or if only a limited spectrum of disease was evaluated. Additional uncertainty regarding the accuracy of the index test in the entire clinically relevant population is introduced if the urine biomarker varied across participant subgroups. In our view, any sampling deviation from a representative group of the entire clinically relevant population could skew the estimates of diagnostic accuracy in any direction. </p> <p>All the studies presented a low concern of index test applicability, presenting sufficient information to conclude that the index test, its conduct or interpretation matched the review question (<a href="./references#CD012019-bbs2-0006" title="Potlog‐NahariC , StrattonP , WinkelC , Widraz , SinaiiN , ConnorsS , et al. Urine vascular endothelial growth factor‐A is not a useful marker for endometriosis. Fertility and Sterility2004; Vol. 81, issue 6:1507‐12. [DOI: 10.1016/j.fertnstert.2003.10.040; ISSN 0015‐0282] ">Potlog‐Naharia 2004</a>; <a href="./references#CD012019-bbs2-0001" title="ChoSH , OhYJ , NamA , KimHY , ParkJH , KimJH , et al. Evaluation of serum and urinary angiogenic factors in patients with endometriosis. American Journal of Reproductive Immunology2007; Vol. 58, issue 6:497‐504. [DOI: 10.1111/j.1600‐0897.2007.00535.x; ISSN 1046‐7408] ">Cho 2007</a>; <a href="./references#CD012019-bbs2-0003" title="El‐KastiMM , WrightC , FyeHK , RosemanF , KesslerBM , BeckerCM . Urinary peptide profiling identifies a panel of putative biomarkers for diagnosing and staging endometriosis. Fertility and Sterility2011; Vol. 95, issue 4:1261‐6. [DOI: 10.1016/j.fertnstert.2010.11.066; ISSN 1556‐5653] ">El‐Kasti 2011</a>; <a href="./references#CD012019-bbs2-0002" title="ChoS , ChoiYS , YimSY , YangHI , JeonYE , LeeKE , et al. Urinary vitamin D‐binding protein is elevated in patients with endometriosis. Human Reproduction2012;27(2):515‐22. ">Cho 2012</a>; <a href="./references#CD012019-bbs2-0004" title="KuesselL , Jaeger‐LanskyA , PateiskyP , RossbergN , SchulzA , SchmitzAA , et al. Cytokeratin‐19 as a biomarker in urine and in serum for the diagnosis of endometriosis‐‐a prospective study. Gynaecological Endocrinology2014; Vol. 30, issue 1:38‐41. [DOI: 10.3109/09513590.2013.856409; ISSN 1473‐0766] ">Kuessel 2014</a>; <a href="./references#CD012019-bbs2-0005" title="LesseyBA , SavarisRF , AliS , BrophyS , Tomazic‐AllenS , ChwaliszK . Diagnostic Accuracy of Urinary Cytokeratin 19 Fragment for Endometriosis. Reproductive Sciences 2014 Oct 08 [Epub ahead of print]. [DOI: 10.1177/1933719114553064; ISSN 1933‐7205 (Electronic)] ">Lessey 2014</a>; <a href="./references#CD012019-bbs2-0007" title="WangL , LiuHY , ShiHH , LangJH , SunW . Urine peptide patterns for non‐invasive diagnosis of endometriosis:a preliminary prospective study. European Journal of Obstetrics &amp; Gynecology and Reproductive Biology2014;177:23‐8. [DOI: 10.1016/j.ejogrb.2014.03.011; ISSN 1872‐7654 (Electronic)] ">Wang 2014</a>; <a href="./references#CD012019-bbs2-0008" title="YunBH , LeeYS , ChonSJ , JungYS , YimSY , KimHY , et al. Evaluation of elevated urinary enolase I levels in patients with endometriosis. Biomarkers2014; Vol. 19, issue 1:16‐21. [DOI: 10.3109/1354750X.2013.863973; ISSN 1366‐5804] ">Yun 2014</a>). </p> <p>All eight studies were of low concern for applicability in regards to the reference standard and none had a high or unclear concern (<a href="./references#CD012019-bbs2-0006" title="Potlog‐NahariC , StrattonP , WinkelC , Widraz , SinaiiN , ConnorsS , et al. Urine vascular endothelial growth factor‐A is not a useful marker for endometriosis. Fertility and Sterility2004; Vol. 81, issue 6:1507‐12. [DOI: 10.1016/j.fertnstert.2003.10.040; ISSN 0015‐0282] ">Potlog‐Naharia 2004</a>; <a href="./references#CD012019-bbs2-0001" title="ChoSH , OhYJ , NamA , KimHY , ParkJH , KimJH , et al. Evaluation of serum and urinary angiogenic factors in patients with endometriosis. American Journal of Reproductive Immunology2007; Vol. 58, issue 6:497‐504. [DOI: 10.1111/j.1600‐0897.2007.00535.x; ISSN 1046‐7408] ">Cho 2007</a>; <a href="./references#CD012019-bbs2-0003" title="El‐KastiMM , WrightC , FyeHK , RosemanF , KesslerBM , BeckerCM . Urinary peptide profiling identifies a panel of putative biomarkers for diagnosing and staging endometriosis. Fertility and Sterility2011; Vol. 95, issue 4:1261‐6. [DOI: 10.1016/j.fertnstert.2010.11.066; ISSN 1556‐5653] ">El‐Kasti 2011</a>; <a href="./references#CD012019-bbs2-0002" title="ChoS , ChoiYS , YimSY , YangHI , JeonYE , LeeKE , et al. Urinary vitamin D‐binding protein is elevated in patients with endometriosis. Human Reproduction2012;27(2):515‐22. ">Cho 2012</a>; <a href="./references#CD012019-bbs2-0004" title="KuesselL , Jaeger‐LanskyA , PateiskyP , RossbergN , SchulzA , SchmitzAA , et al. Cytokeratin‐19 as a biomarker in urine and in serum for the diagnosis of endometriosis‐‐a prospective study. Gynaecological Endocrinology2014; Vol. 30, issue 1:38‐41. [DOI: 10.3109/09513590.2013.856409; ISSN 1473‐0766] ">Kuessel 2014</a>; <a href="./references#CD012019-bbs2-0005" title="LesseyBA , SavarisRF , AliS , BrophyS , Tomazic‐AllenS , ChwaliszK . Diagnostic Accuracy of Urinary Cytokeratin 19 Fragment for Endometriosis. Reproductive Sciences 2014 Oct 08 [Epub ahead of print]. [DOI: 10.1177/1933719114553064; ISSN 1933‐7205 (Electronic)] ">Lessey 2014</a>; <a href="./references#CD012019-bbs2-0007" title="WangL , LiuHY , ShiHH , LangJH , SunW . Urine peptide patterns for non‐invasive diagnosis of endometriosis:a preliminary prospective study. European Journal of Obstetrics &amp; Gynecology and Reproductive Biology2014;177:23‐8. [DOI: 10.1016/j.ejogrb.2014.03.011; ISSN 1872‐7654 (Electronic)] ">Wang 2014</a>; <a href="./references#CD012019-bbs2-0008" title="YunBH , LeeYS , ChonSJ , JungYS , YimSY , KimHY , et al. Evaluation of elevated urinary enolase I levels in patients with endometriosis. Biomarkers2014; Vol. 19, issue 1:16‐21. [DOI: 10.3109/1354750X.2013.863973; ISSN 1366‐5804] ">Yun 2014</a>). All the included studies implemented pelvic surgery (laparoscopy or laparotomy) as a reference standard, which could be relied upon to match the review question. </p> </section> <section id="CD012019-sec-0072"> <h3 class="title" id="CD012019-sec-0072">Findings</h3> <p>A total of six urinary biomarkers were evaluated in the eight included studies, of which four biomarkers had a diagnostic evaluation in five studies (<a href="./full#CD012019-tbl-0001">summary of findings Table 1</a>). Three biomarkers were not altered by the presence of endometriosis and were evaluated in three other studies (<a href="./full#CD012019-tbl-0002">summary of findings Table 2</a>). </p> <section id="CD012019-sec-0073"> <h4 class="title">1) Enolase 1 (NNE)</h4> <p>The diagnostic performance of urinary NNE was evaluated in one study (59 women, follicular or luteal cycle phase, only moderate to severe endometriosis, rASRM III‐IV) (<a href="./references#CD012019-bbs2-0008" title="YunBH , LeeYS , ChonSJ , JungYS , YimSY , KimHY , et al. Evaluation of elevated urinary enolase I levels in patients with endometriosis. Biomarkers2014; Vol. 19, issue 1:16‐21. [DOI: 10.3109/1354750X.2013.863973; ISSN 1366‐5804] ">Yun 2014</a>). Urinary NNE expression was not influenced by cycle phase and was significantly greater (P = 0.026) in women with endometriosis when corrected for creatine excretion (NNE‐Cr). Using a cut‐off threshold of more than 0.96 ng/mgCr, the sensitivity was 0.56 (95% CI, 0.40 to 0.72), and the specificity 0.70 (95% CI, 0.46 to 0.88) and did not meet the criteria for either replacement or triage tests (<a href="#CD012019-fig-0005">Figure 5</a>). Further testing in larger studies including participants with a wider spectrum of endometriosis is needed to confirm the role of NNE in detecting endometriosis. </p> <div class="figure" id="CD012019-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="Summary ROC Plot of NNE‐Cr for detection of endometriosis utilising a cut‐off &gt; 0.96 ng/mgCr. Each point represents the pair of sensitivity and specificity for evaluation. The bars correspond to 95% CIs." data-id="CD012019-fig-0005" src="/cdsr/doi/10.1002/14651858.CD012019/media/CDSR/CD012019/image_n/nCD012019-AFig-FIG05.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Summary ROC Plot of NNE‐Cr for detection of endometriosis utilising a cut‐off &gt; 0.96 ng/mgCr. Each point represents the pair of sensitivity and specificity for evaluation. The bars correspond to 95% CIs. </p> </div> </div> </div> </section> <section id="CD012019-sec-0074"> <h4 class="title">2) Vitamin D‐binding protein (VDBP)</h4> <p>The diagnostic performance of urinary VDBP was evaluated in one study only, which included 95 women in the follicular or luteal cycle phase (<a href="./references#CD012019-bbs2-0002" title="ChoS , ChoiYS , YimSY , YangHI , JeonYE , LeeKE , et al. Urinary vitamin D‐binding protein is elevated in patients with endometriosis. Human Reproduction2012;27(2):515‐22. ">Cho 2012</a>). Even though the study included endometriosis of varying severity (rASRM I‐IV), more than 90% of women with endometriosis had moderate to severe disease (52/57). Urinary VDBP levels corrected for creatinine (VDBP‐Cr) expression were significantly greater in participants with endometriosis (P = 0.001). However, VDBP‐Cr only distinguished women with and without endometriosis in the luteal phase (P = 0.042) of the cycle. The cut‐off value of more than 87.83 ng/mgCr demonstrated a sensitivity of 0.58 (95% CI, 0.44 to 0.71) and a specificity of 0.55 (95% CI, 0.38 to 0.71) (<a href="#CD012019-fig-0006">Figure 6</a>). The results are discouraging, but further evaluation of VDBP across the spectrum of endometriosis particularly in the luteal phase may help to clarify its diagnostic role in endometriosis. </p> <div class="figure" id="CD012019-fig-0006"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 6</div> </div> <hr class="top"/><img alt="Summary ROC plot of VDBP‐Cr for detection of endometriosis utilising a cut‐off &gt;87.83 ng/mgCr. Each point represents the pair of sensitivity and specificity for the evaluation. The bars correspond to 95% CIs." data-id="CD012019-fig-0006" src="/cdsr/doi/10.1002/14651858.CD012019/media/CDSR/CD012019/image_n/nCD012019-AFig-FIG06.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Summary ROC plot of VDBP‐Cr for detection of endometriosis utilising a cut‐off &gt;87.83 ng/mgCr. Each point represents the pair of sensitivity and specificity for the evaluation. The bars correspond to 95% CIs. </p> </div> </div> </div> </section> <section id="CD012019-sec-0075"> <h4 class="title">3) MALDI‐TOF‐MS proteomics</h4> <p>Two studies, including seven data sets comprising 186 women, assessed the accuracy of proteomic techniques in detecting endometriosis (<a href="#CD012019-fig-0007">Figure 7</a>; <a href="#CD012019-fig-0008">Figure 8</a>). One study included 39 women in the follicular, peri‐ovulatory or luteal phases (<a href="./references#CD012019-bbs2-0003" title="El‐KastiMM , WrightC , FyeHK , RosemanF , KesslerBM , BeckerCM . Urinary peptide profiling identifies a panel of putative biomarkers for diagnosing and staging endometriosis. Fertility and Sterility2011; Vol. 95, issue 4:1261‐6. [DOI: 10.1016/j.fertnstert.2010.11.066; ISSN 1556‐5653] ">El‐Kasti 2011</a>). Six significant putative peptide markers distinguished controls from women with moderate to severe endometriosis (rASRM III‐IV), four of these in the peri‐ovulatory phase and two in the luteal phase. The diagnostic accuracy of two peptides only identified by their mass profile were evaluated. The peri‐ovulatory peptide mass of 1767.1 Da using a cut‐off of 35.22 or more arbitrary units (a.u.) showed a sensitivity of 0.75 (95% CI, 0.43 to 0.95) and a specificity of 0.87 (95% CI 0.60 to 0.98). The luteal peptide mass of 1824.3 Da using a cut‐off of 29.34 or more a.u. showed a sensitivity of 0.77 (95% CI, 0.46 to 0.95) and a specificity of 0.73 (95% CI, 0.45 to 0.92). The diagnostic performance of the other four peptides were not assessed. It was noted that 14 participants with minimal to mild endometriosis were excluded from this analysis. None of the biomarkers met the criteria for a replacement or triage test, but this observation provides too little data to draw conclusions regarding the diagnostic role of these urinary peptides in endometriosis. </p> <div class="figure" id="CD012019-fig-0007"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 7</div> </div> <hr class="top"/><img alt="Summary ROC plot of Proteome for detection of endometriosis. Each point represents the pair of sensitivity and specificity for each evaluation. The size of each point is proportional to the sample size and the shape designates the tests including different proteins. The bars correspond to 95% CIs of each individual evaluation. The data were not assessed by meta‐analysis." data-id="CD012019-fig-0007" src="/cdsr/doi/10.1002/14651858.CD012019/media/CDSR/CD012019/image_n/nCD012019-AFig-FIG07.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Summary ROC plot of Proteome for detection of endometriosis. Each point represents the pair of sensitivity and specificity for each evaluation. The size of each point is proportional to the sample size and the shape designates the tests including different proteins. The bars correspond to 95% CIs of each individual evaluation. The data were not assessed by meta‐analysis. </p> </div> </div> </div> <div class="figure" id="CD012019-fig-0008"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 8</div> </div> <hr class="top"/><img alt="Forest plot of proteome for detection of endometriosis. Plot shows study‐specific estimates of sensitivity and specificity (squares) with 95% CI (black line), country in which the study was conducted, menstrual cycle phase at which the test was performed and severity of the disease assessed by each study, reported as rASRM stage. FN: false negative; FP: false positive; TN: true negative; TP: true positive." data-id="CD012019-fig-0008" src="/cdsr/doi/10.1002/14651858.CD012019/media/CDSR/CD012019/image_n/nCD012019-AFig-FIG08.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of proteome for detection of endometriosis. Plot shows study‐specific estimates of sensitivity and specificity (squares) with 95% CI (black line), country in which the study was conducted, menstrual cycle phase at which the test was performed and severity of the disease assessed by each study, reported as rASRM stage. FN: false negative; FP: false positive; TN: true negative; TP: true positive. </p> </div> </div> </div> <p>Another study (122 women, follicular or luteal cycle phase, rASRM I‐IV, unclear histological confirmation) identified 36 peptides that were significantly different between the endometriosis and the control groups (<a href="./references#CD012019-bbs2-0007" title="WangL , LiuHY , ShiHH , LangJH , SunW . Urine peptide patterns for non‐invasive diagnosis of endometriosis:a preliminary prospective study. European Journal of Obstetrics &amp; Gynecology and Reproductive Biology2014;177:23‐8. [DOI: 10.1016/j.ejogrb.2014.03.011; ISSN 1872‐7654 (Electronic)] ">Wang 2014</a>). The peptide pattern did not vary between follicular and luteal phases and four peptides, that were down‐regulated in endometriosis, were further evaluated for diagnostic performance. The 2052.3 Da mass peptide demonstrated a sensitivity of 0.83 (95% CI, 0.71 to 0.92) and a specificity of 0.69 (95% CI, 0.56 to 0.80), and the 3393.9 Da mass peptide had a sensitivity of 0.85 (95% CI, 0.73 to 0.93) and a specificity of 0.71 (95% CI, 0.58 to 0.82). The other two peptides were able to be identified by their mass spectra and were a collagen alpha‐6(IV) chain precursor fragment (1579.2 Da) with a sensitivity of 0.83 (95% CI, 0.71 to 0.92) and a specificity of 0.69 (95% CI, 0.56 to 0.80) and a type VIII, IX, XV collagen alpha1 chain precursor fragment (891.6 Da) with a sensitivity of 0.82 (95% CI, 0.70 to 0.90) and a specificity of 65 (95% CI, 0.51 to 0.76).The cut‐off thresholds were not reported for any of these analyses. Three algorithms were developed using peptide peak clusters in diagnostic models, (the Genetic algorithm (GA), the decision tree algorithm (DTA), and the quick classifier algorithm (QC)). The GA algorithm showed the highest diagnostic estimates comprising five peptides of 1433.9 Da, 1599.4 Da, 2085.6 Da, 6798.0 Da, and 3217.2 Da and was further validated in a blinded test group analysis of 25 randomly selected participants, 11 of which had endometriosis. The estimates of the validation test showed a high sensitivity of 0.91 (95% CI, 0.59 to 1.00) and a high specificity of 0.93 (95% CI, 0.66 to 1.00), which approach the criteria for the replacement of SnOUT and SpIN triage tests. These results require further validation in large, independent, well‐defined populations, displaying a wide spectrum of disease, using standardised and reproducible methodologies. </p> </section> <section id="CD012019-sec-0076"> <h4 class="title">4) Cytokeratin‐19 fragments (uCYFRA 21‐1)</h4> <p>Two studies that included 174 women assessed the performance of Cytokeratin 19 (CK 19) as a biomarker in detecting endometriosis by measuring urine fragment uCYFRA 21‐1. Both studies concluded that CK 19 was not altered by the presence of endometriosis and that their levels were not affected by menstrual cycle phases (<a href="./references#CD012019-bbs2-0004" title="KuesselL , Jaeger‐LanskyA , PateiskyP , RossbergN , SchulzA , SchmitzAA , et al. Cytokeratin‐19 as a biomarker in urine and in serum for the diagnosis of endometriosis‐‐a prospective study. Gynaecological Endocrinology2014; Vol. 30, issue 1:38‐41. [DOI: 10.3109/09513590.2013.856409; ISSN 1473‐0766] ">Kuessel 2014</a>), by severity of the disease or when the levels were normalised to urine creatinine or urine protein (<a href="./references#CD012019-bbs2-0005" title="LesseyBA , SavarisRF , AliS , BrophyS , Tomazic‐AllenS , ChwaliszK . Diagnostic Accuracy of Urinary Cytokeratin 19 Fragment for Endometriosis. Reproductive Sciences 2014 Oct 08 [Epub ahead of print]. [DOI: 10.1177/1933719114553064; ISSN 1933‐7205 (Electronic)] ">Lessey 2014</a>). Only one of these studies (98 participants, cycle phase not reported, rASRM I‐IV) evaluated the diagnostic accuracy of uCYFRA 21‐1 (<a href="./references#CD012019-bbs2-0005" title="LesseyBA , SavarisRF , AliS , BrophyS , Tomazic‐AllenS , ChwaliszK . Diagnostic Accuracy of Urinary Cytokeratin 19 Fragment for Endometriosis. Reproductive Sciences 2014 Oct 08 [Epub ahead of print]. [DOI: 10.1177/1933719114553064; ISSN 1933‐7205 (Electronic)] ">Lessey 2014</a>), demonstrating a very low sensitivity of 0.11 (95% CI, 0.05 to 0.22) with a high specificity 0.94 (95% CI, 0.81 to 0.99), using a chosen cut‐off of more than 5.3 ng/ml (<a href="#CD012019-fig-0009">Figure 9</a>). This evidence suggests that the cytokeratin 19 molecule is not reliable as a diagnostic test for endometriosis, but further testing is required to confirm or refute these findings. </p> <div class="figure" id="CD012019-fig-0009"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 9</div> </div> <hr class="top"/><img alt="Summary ROC plot of CK 19 for detection of endometriosis utilising a cut‐off &gt; 5.3 ng/ml. Each point represents the pair of sensitivity and specificity for the evaluation. The bars correspond to 95% CIs." data-id="CD012019-fig-0009" src="/cdsr/doi/10.1002/14651858.CD012019/media/CDSR/CD012019/image_n/nCD012019-AFig-FIG09.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Summary ROC plot of CK 19 for detection of endometriosis utilising a cut‐off &gt; 5.3 ng/ml. Each point represents the pair of sensitivity and specificity for the evaluation. The bars correspond to 95% CIs. </p> </div> </div> </div> </section> <section id="CD012019-sec-0077"> <h4 class="title">5) Vascular endothelial growth factor (VEGF) or vascular endothelial growth factor‐A (VEGF‐A) </h4> <p>Two studies in 132 women assessed the performance of urinary VEGF in diagnosing endometriosis (<a href="./references#CD012019-bbs2-0006" title="Potlog‐NahariC , StrattonP , WinkelC , Widraz , SinaiiN , ConnorsS , et al. Urine vascular endothelial growth factor‐A is not a useful marker for endometriosis. Fertility and Sterility2004; Vol. 81, issue 6:1507‐12. [DOI: 10.1016/j.fertnstert.2003.10.040; ISSN 0015‐0282] ">Potlog‐Naharia 2004</a>; <a href="./references#CD012019-bbs2-0001" title="ChoSH , OhYJ , NamA , KimHY , ParkJH , KimJH , et al. Evaluation of serum and urinary angiogenic factors in patients with endometriosis. American Journal of Reproductive Immunology2007; Vol. 58, issue 6:497‐504. [DOI: 10.1111/j.1600‐0897.2007.00535.x; ISSN 1046‐7408] ">Cho 2007</a>). The levels were corrected to urinary creatinine in both studies, and one study showed no differences in excretion across the menstrual cycle (<a href="./references#CD012019-bbs2-0006" title="Potlog‐NahariC , StrattonP , WinkelC , Widraz , SinaiiN , ConnorsS , et al. Urine vascular endothelial growth factor‐A is not a useful marker for endometriosis. Fertility and Sterility2004; Vol. 81, issue 6:1507‐12. [DOI: 10.1016/j.fertnstert.2003.10.040; ISSN 0015‐0282] ">Potlog‐Naharia 2004</a>). There was no significant difference between the control and endometriosis groups seen in either study, and the diagnostic accuracy was not evaluated. </p> </section> <section id="CD012019-sec-0078"> <h4 class="title">6) Tumour necrosis factor‐alpha (TNF‐alpha)</h4> <p>Urinary TNF‐alpha levels were not significantly different in one study (70 participants, follicular or luteal cycle phase, rASRM I‐IV) and the diagnostic accuracy was not evaluated (<a href="./references#CD012019-bbs2-0001" title="ChoSH , OhYJ , NamA , KimHY , ParkJH , KimJH , et al. Evaluation of serum and urinary angiogenic factors in patients with endometriosis. American Journal of Reproductive Immunology2007; Vol. 58, issue 6:497‐504. [DOI: 10.1111/j.1600‐0897.2007.00535.x; ISSN 1046‐7408] ">Cho 2007</a>). </p> </section> <section id="CD012019-sec-0079"> <h4 class="title">Investigations of heterogeneity and sensitivity analyses</h4> <p>The potential sources of heterogeneity are outlined in <a href="#CD012019-sec-0044">Secondary objectives</a>. Although we attempted to assess these sources of heterogeneity, there were not enough studies evaluating each test to make this a meaningful analysis. Furthermore, the sensitivity analyses were not possible due to the small number of studies. </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD012019-sec-0080" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD012019-sec-0080"></div> <section id="CD012019-sec-0081"> <h3 class="title" id="CD012019-sec-0081">Summary of main results</h3> <p>Only a few urinary biomarkers have been assessed in small numbers of individual studies providing insufficient data to perform a meta‐analysis. No urinary test met the criteria of either replacement or triage test for detecting endometriosis. The GA algorithm, a combined test of five urinary peptides of 1433.9 Da, 1599.4 Da, 2085.6 Da, 6798.0 Da, and 3217.2 Da demonstrated the highest diagnostic estimates for detecting endometriosis, which approached but did not meet the criteria for the replacement of both the SnOUT and SpIN triage tests (<a href="./references#CD012019-bbs2-0007" title="WangL , LiuHY , ShiHH , LangJH , SunW . Urine peptide patterns for non‐invasive diagnosis of endometriosis:a preliminary prospective study. European Journal of Obstetrics &amp; Gynecology and Reproductive Biology2014;177:23‐8. [DOI: 10.1016/j.ejogrb.2014.03.011; ISSN 1872‐7654 (Electronic)] ">Wang 2014</a>). The algorithm was validated in an independent test group but, as this test was only reported in one study, meaningful conclusions regarding its value in clinical practice cannot be drawn. Certain urinary peptides identified through high‐throughput MALDI‐TOF‐MS method showed potential in detecting endometriosis. However, urinary proteome studies showed considerable heterogeneity with respect to the population studied, the way the samples were processed and the data analysis. The molecular masses of the identified differentially regulated peptides were entirely inconsistent across studies, with most remaining unidentified biologically. Establishing standardised analytical processes, consistent sets of markers and defined cut‐off thresholds would improve the assessment of urinary peptides as a diagnostic tool for endometriosis and further large‐scale studies are required before meaningful conclusions can be made. </p> <p>CK 19 and VEGF were found not associated with endometriosis in more than one study, indicating that these biomarkers are unlikely to have diagnostic value. In view of the paucity of data, further large studies are still needed to support this statement. </p> <p>There were no studies that assessed the role of urinary biomarkers in the diagnosis of ovarian endometrioma. </p> </section> <section id="CD012019-sec-0082"> <h3 class="title" id="CD012019-sec-0082">Strengths and weaknesses of the review</h3> <p>This review is part of a comprehensive review series of minimally invasive biomarkers for the diagnosis of endometriosis. A very thorough search of the current literature was undertaken and included studies written in languages other than English. Two independent reviewers extracted the data and used a modified QUADAS‐2 tooL to perform quality assessments. Stringent selection criteria ensured that eligible studies utilised prospectively collected samples and only included women of reproductive age, which minimised the risk of bias in interpreting the reference standard and index test. An additional strength of this review was that the authors of the studies were approached in an attempt to obtain any missing information required to assess eligibility and critically appraise the studies. The inclusion of studies demonstrating that biomarker levels did not significantly differ in endometriosis introduced an additional dimension to the interpretation of the results, particularly for the biomarkers with contradictory results. Furthermore, biomarkers which were consistently reported as unchanged by the disease could be excluded from the list of putative biomarkers for endometriosis. Although this has little influence on the conclusions of this review due to the paucity of the available data, the relevance of this method will increase in future updates that describe this growing body of evidence. </p> <p>The main limitation of this review is that there are only individual small studies for all the evaluated index tests. A meaningful meta‐analysis of index test performance was not possible for any urinary biomarker. There was variation between studies with respect to the included populations, the severity of endometriosis, when in the menstrual cycle phase sampling was performed and whether the urinary biomarker levels were corrected against creatinine excretion. Also, most of the included studies determined the diagnostic cut‐off thresholds using a ROC analysis without any subsequent validation in an independent cohort. Lack of validation of the diagnostic data in conjunction with the low number of studies for the majority of the presented tests contributed to the low quality of evidence presented in this review. We now have available a standardised methodology for fluid bio specimen collection, processing and storage and we recommend adhering to these standards in future diagnostic studies (<a href="./references#CD012019-bbs2-0057" title="RahmiogluN , FassbenderA , VitonisAF , TworogerSS , HummelshojL , D’HoogheTM , et al. World Endometriosis Research Foundation Endometriosis Phenome and biobanking harmonization project: III. Fluid biospecimen collection, processing, and storage in endometriosis research. Fertility and Sterility2014;102(5):1233‐43. ">Rahimoglu 2014</a>). </p> <p>Another weakness is the variation in the selection of the case and control groups with inclusion of participants that may not reflect a clinically representative population. The reported prevalence of endometriosis in most studies was generally higher (43% to 66%) than previously reported prevalences of endometriosis (6%–10% in the general female population and 35%‐50% in symptomatic women) (<a href="./references#CD012019-bbs2-0039" title="GiudiceLC , KaoLC . Endometriosis. Lancet2004;364(9447):1789‐99. ">Giudice 2004</a>). This may reflect a high level of surgical diagnostic expertise but could be due to pre‐selection of more challenging cases in tertiary referral centres and there is a high risk of participant selection bias in most of the studies. Selection bias appeared to be reduced but not eliminated by consecutively enrolling participants; however the information on method of enrolment was missing in most of the included studies. More than a third of the included studies (3/8, 38%) were of a 'two‐gate design' and included a wide group of participants who underwent surgery for various indications. Inclusion of healthy asymptomatic individuals or participants with other pathological conditions represents potential selection bias with regard to the control group which could have biased the test outcomes. Thirty‐eight percent of the studies included either women with a limited spectrum of endometriosis (n = 2) or did not provide information on the severity of target condition (n = 1). These studies were included to avoid omission of potentially valuable diagnostic information, but each of the above factors could skew the diagnostic estimates in either direction and subsequently interfere with the interpretation of the index test results. It was not possible to evaluate population and disease spectrum effects on the data because there were so few single reports for all the urinary biomarkers. </p> <p>Inappropriate assignation to the endometriosis and control groups could not be excluded in some studies and is another weakness of the review. Surgical misdiagnosis is a potential cause of bias as the number and experience of the surgical team, the surgical diagnostic criteria and the surgical methods were poorly described in most of the included studies. We now have a standardised technique for performing laparoscopy and we recommend that any future studies use this standardised method of undertaking laparoscopy (<a href="./references#CD012019-bbs2-0024" title="BeckerCM , LauferMR , StrattonP , Hummelshojl , MissmerSA , ZondervanKT , et al. World Endometriosis Research Foundation Endometriosis Phenome and biobanking harmonization project: I. Surgical phenotype data collection in endometriosis research. Fertility and Sterility2014;102(5):1213‐22. ">Becker 2014</a>). Additionally, we did not confine the studies included in this review to those that reported histological confirmation of endometriotic lesions. Although a recent ESHRE guideline stated that evidence is lacking to support laparoscopy without histology to confirm endometriosis (<a href="./references#CD012019-bbs2-0033" title="DunselmanGA , VermeulenN , BeckerC , Calhaz‐JorgeC , D'HoogheT , DeBieB , et al. ESHRE guideline: management of women with endometriosis. Human Reproduction2014;29(3):400‐12. ">Dunselman 2014</a>), the clinical significance of histological verification remains debatable. Diagnosis by surgical visualisation only remains a common clinical practice and can be considered reliable when an accurate inspection of the abdominal cavity is performed by experienced surgeons. We chose to include the studies that only reported surgical visualisation as the reference standard and we did not wish to loose potentially valuable information by excluding studies that did not confirm the diagnosis histologically; however this could impact the accuracy of assignation to the case and control groups. Only one study did not report using histology as a part of reference standard and although this could bias the reported results, the impact of including this study on the review findings is likely to be low (<a href="./references#CD012019-bbs2-0007" title="WangL , LiuHY , ShiHH , LangJH , SunW . Urine peptide patterns for non‐invasive diagnosis of endometriosis:a preliminary prospective study. European Journal of Obstetrics &amp; Gynecology and Reproductive Biology2014;177:23‐8. [DOI: 10.1016/j.ejogrb.2014.03.011; ISSN 1872‐7654 (Electronic)] ">Wang 2014</a>). </p> <p>There are no well‐established criteria for replacement or triage diagnostic tests, therefore we chose the criteria that were both realistic and clinically applicable to assist in the interpretation of the complex results. For a replacement test, we considered the threshold reported by the only systematic review on accuracy of the reference standard (laparoscopy) in detecting endometriosis to be the most objective (<a href="./references#CD012019-bbs2-0074" title="WykesCB , ClarkTJ , KhanKS . Accuracy of laparoscopy in the diagnosis of endometriosis: a systematic quantitative review. BJOG2004;111(11):1204‐12. ">Wykes 2004</a>). The meta‐analysis was published in 2004 and included four eligible studies comprising 433 women. We acknowledge the limitations associated with emphasising a single review, particularly if it does not present the latest and possibly more accurate data that reflect advances in surgical expertise and technology. Several studies on accuracy of laparoscopy in detecting endometriosis have been published in the last decade; however their results were not addressed in a systematic way. A further systematic analysis to determine the accuracy of laparoscopy was beyond the scope of this review. The criteria for triage tests utilised the common concepts of SnOUT and SpIN in medical statistics and the cut‐offs were set at levels we considered to be clinically relevant (see <a href="#CD012019-sec-0039">Role of index test(s)</a>). We encourage the readers to apply independent interpretations of the presented diagnostic estimates with using thresholds that may be more applicable to specific populations and clinical circumstances. </p> </section> <section id="CD012019-sec-0083"> <h3 class="title" id="CD012019-sec-0083">Applicability of findings to the review question</h3> <p>QUADAS‐2 assigned a low rank to clinical applicability with respect to participant selection in 63% of the studies (5/8), summarised as a high concern in all these reports. This occurred when the set of participants in the study was broader that seen in clinical practice or when the spectrum of the target condition was limited and the findings may not be applicable to the review question and to clinical practice. Applicability of the index test and reference standard was judged to be satisfactory using the QUADAS‐2 tool for all studies. However, the majority of included studies were conducted in academic institutions with a high level of expertise in laboratory techniques and the index test outcome measures may not be able to be reproduced in all institutions or extrapolated to general practice. </p> <p>Some potentially relevant well‐designed studies were excluded as they did not directly address the review question. For example we did exclude studies that reported on biomarkers with differential expression in endometriosis, but that did not provide enough information to assess the diagnostic performance of the biomarker. Some forms of endometriosis, such as bladder, ureteric or involving the extra‐pelvic sites (e.g. umbilicus, hernia sacs, abdominal wall, lung, kidney, etc.) were also excluded from the review as they are informed predominantly by case reports or small case series and diagnostic laparoscopy is not an applicable reference test for these conditions. Although these target conditions are rare, from a clinical perspective the diagnostic options for these forms of endometriosis remain unclear. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD012019-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012019/media/CDSR/CD012019/urn:x-wiley:14651858:media:CD012019:CD012019-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012019/media/CDSR/CD012019/image_t/tCD012019-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Sequential approach to non‐invasive testing of endometriosis" data-id="CD012019-fig-0001" src="/cdsr/doi/10.1002/14651858.CD012019/media/CDSR/CD012019/image_n/nCD012019-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Sequential approach to non‐invasive testing of endometriosis</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012019/full#CD012019-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012019/media/CDSR/CD012019/image_n/nCD012019-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012019-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012019/media/CDSR/CD012019/urn:x-wiley:14651858:media:CD012019:CD012019-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012019/media/CDSR/CD012019/image_t/tCD012019-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Flow of the studies identified in literature search for systematic review on urinary biomarkers for a non‐invasive diagnosis of endometriosis." data-id="CD012019-fig-0002" src="/cdsr/doi/10.1002/14651858.CD012019/media/CDSR/CD012019/image_n/nCD012019-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Flow of the studies identified in literature search for systematic review on urinary biomarkers for a non‐invasive diagnosis of endometriosis. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012019/full#CD012019-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012019/media/CDSR/CD012019/image_n/nCD012019-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012019-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012019/media/CDSR/CD012019/urn:x-wiley:14651858:media:CD012019:CD012019-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012019/media/CDSR/CD012019/image_t/tCD012019-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias and applicability concerns graph: review authors' judgements about each domain presented as percentages across included studies" data-id="CD012019-fig-0003" src="/cdsr/doi/10.1002/14651858.CD012019/media/CDSR/CD012019/image_n/nCD012019-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias and applicability concerns graph: review authors' judgements about each domain presented as percentages across included studies </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012019/full#CD012019-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012019/media/CDSR/CD012019/image_n/nCD012019-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012019-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012019/media/CDSR/CD012019/urn:x-wiley:14651858:media:CD012019:CD012019-AFig-FIG04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012019/media/CDSR/CD012019/image_t/tCD012019-AFig-FIG04.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias and applicability concerns summary: review authors' judgements about each domain for each included study" data-id="CD012019-fig-0004" src="/cdsr/doi/10.1002/14651858.CD012019/media/CDSR/CD012019/image_n/nCD012019-AFig-FIG04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Risk of bias and applicability concerns summary: review authors' judgements about each domain for each included study </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012019/full#CD012019-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012019/media/CDSR/CD012019/image_n/nCD012019-AFig-FIG04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012019-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012019/media/CDSR/CD012019/urn:x-wiley:14651858:media:CD012019:CD012019-AFig-FIG05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012019/media/CDSR/CD012019/image_t/tCD012019-AFig-FIG05.png" target="_blank"><b></b></a></p> </div><img alt="Summary ROC Plot of NNE‐Cr for detection of endometriosis utilising a cut‐off &gt; 0.96 ng/mgCr. Each point represents the pair of sensitivity and specificity for evaluation. The bars correspond to 95% CIs." data-id="CD012019-fig-0005" src="/cdsr/doi/10.1002/14651858.CD012019/media/CDSR/CD012019/image_n/nCD012019-AFig-FIG05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p>Summary ROC Plot of NNE‐Cr for detection of endometriosis utilising a cut‐off &gt; 0.96 ng/mgCr. Each point represents the pair of sensitivity and specificity for evaluation. The bars correspond to 95% CIs. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012019/full#CD012019-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012019/media/CDSR/CD012019/image_n/nCD012019-AFig-FIG05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012019-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012019/media/CDSR/CD012019/urn:x-wiley:14651858:media:CD012019:CD012019-AFig-FIG06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012019/media/CDSR/CD012019/image_t/tCD012019-AFig-FIG06.png" target="_blank"><b></b></a></p> </div><img alt="Summary ROC plot of VDBP‐Cr for detection of endometriosis utilising a cut‐off &gt;87.83 ng/mgCr. Each point represents the pair of sensitivity and specificity for the evaluation. The bars correspond to 95% CIs." data-id="CD012019-fig-0006" src="/cdsr/doi/10.1002/14651858.CD012019/media/CDSR/CD012019/image_n/nCD012019-AFig-FIG06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 6</div> <div class="figure-caption"> <p>Summary ROC plot of VDBP‐Cr for detection of endometriosis utilising a cut‐off &gt;87.83 ng/mgCr. Each point represents the pair of sensitivity and specificity for the evaluation. The bars correspond to 95% CIs. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012019/full#CD012019-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012019/media/CDSR/CD012019/image_n/nCD012019-AFig-FIG06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012019-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012019/media/CDSR/CD012019/urn:x-wiley:14651858:media:CD012019:CD012019-AFig-FIG07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012019/media/CDSR/CD012019/image_t/tCD012019-AFig-FIG07.png" target="_blank"><b></b></a></p> </div><img alt="Summary ROC plot of Proteome for detection of endometriosis. Each point represents the pair of sensitivity and specificity for each evaluation. The size of each point is proportional to the sample size and the shape designates the tests including different proteins. The bars correspond to 95% CIs of each individual evaluation. The data were not assessed by meta‐analysis." data-id="CD012019-fig-0007" src="/cdsr/doi/10.1002/14651858.CD012019/media/CDSR/CD012019/image_n/nCD012019-AFig-FIG07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 7</div> <div class="figure-caption"> <p>Summary ROC plot of Proteome for detection of endometriosis. Each point represents the pair of sensitivity and specificity for each evaluation. The size of each point is proportional to the sample size and the shape designates the tests including different proteins. The bars correspond to 95% CIs of each individual evaluation. The data were not assessed by meta‐analysis. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012019/full#CD012019-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012019/media/CDSR/CD012019/image_n/nCD012019-AFig-FIG07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012019-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012019/media/CDSR/CD012019/urn:x-wiley:14651858:media:CD012019:CD012019-AFig-FIG08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012019/media/CDSR/CD012019/image_t/tCD012019-AFig-FIG08.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of proteome for detection of endometriosis. Plot shows study‐specific estimates of sensitivity and specificity (squares) with 95% CI (black line), country in which the study was conducted, menstrual cycle phase at which the test was performed and severity of the disease assessed by each study, reported as rASRM stage. FN: false negative; FP: false positive; TN: true negative; TP: true positive." data-id="CD012019-fig-0008" src="/cdsr/doi/10.1002/14651858.CD012019/media/CDSR/CD012019/image_n/nCD012019-AFig-FIG08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 8</div> <div class="figure-caption"> <p>Forest plot of proteome for detection of endometriosis. Plot shows study‐specific estimates of sensitivity and specificity (squares) with 95% CI (black line), country in which the study was conducted, menstrual cycle phase at which the test was performed and severity of the disease assessed by each study, reported as rASRM stage. FN: false negative; FP: false positive; TN: true negative; TP: true positive. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012019/full#CD012019-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012019/media/CDSR/CD012019/image_n/nCD012019-AFig-FIG08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012019-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012019/media/CDSR/CD012019/urn:x-wiley:14651858:media:CD012019:CD012019-AFig-FIG09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012019/media/CDSR/CD012019/image_t/tCD012019-AFig-FIG09.png" target="_blank"><b></b></a></p> </div><img alt="Summary ROC plot of CK 19 for detection of endometriosis utilising a cut‐off &gt; 5.3 ng/ml. Each point represents the pair of sensitivity and specificity for the evaluation. The bars correspond to 95% CIs." data-id="CD012019-fig-0009" src="/cdsr/doi/10.1002/14651858.CD012019/media/CDSR/CD012019/image_n/nCD012019-AFig-FIG09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 9</div> <div class="figure-caption"> <p>Summary ROC plot of CK 19 for detection of endometriosis utilising a cut‐off &gt; 5.3 ng/ml. Each point represents the pair of sensitivity and specificity for the evaluation. The bars correspond to 95% CIs. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012019/full#CD012019-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012019/media/CDSR/CD012019/image_n/nCD012019-AFig-FIG09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012019-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012019/media/CDSR/CD012019/urn:x-wiley:14651858:media:CD012019:CD012019-TST-001" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012019/media/CDSR/CD012019/image_t/tCD012019-TST-001.xxx" target="_blank"><b></b></a></p> </div><img alt="NNE‐Cr (&gt; 0.96 ng/mgCr)." data-id="CD012019-fig-0010" src="/cdsr/doi/10.1002/14651858.CD012019/media/CDSR/CD012019/image_n/nCD012019-TST-001.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 1</div> <div class="figure-caption"> <p>NNE‐Cr (&gt; 0.96 ng/mgCr).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012019/references#CD012019-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012019/media/CDSR/CD012019/image_n/nCD012019-TST-001.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012019-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012019/media/CDSR/CD012019/urn:x-wiley:14651858:media:CD012019:CD012019-TST-002" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012019/media/CDSR/CD012019/image_t/tCD012019-TST-002.xxx" target="_blank"><b></b></a></p> </div><img alt="VDBP‐Cr (&gt; 87.83 ng/mgCr)." data-id="CD012019-fig-0011" src="/cdsr/doi/10.1002/14651858.CD012019/media/CDSR/CD012019/image_n/nCD012019-TST-002.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 2</div> <div class="figure-caption"> <p>VDBP‐Cr (&gt; 87.83 ng/mgCr).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012019/references#CD012019-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012019/media/CDSR/CD012019/image_n/nCD012019-TST-002.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012019-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012019/media/CDSR/CD012019/urn:x-wiley:14651858:media:CD012019:CD012019-TST-003" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012019/media/CDSR/CD012019/image_t/tCD012019-TST-003.xxx" target="_blank"><b></b></a></p> </div><img alt="Proteome by MALDI‐TOF‐MS (peptide m/z 1824.3 Da; ≥ 29.34 au)." data-id="CD012019-fig-0012" src="/cdsr/doi/10.1002/14651858.CD012019/media/CDSR/CD012019/image_n/nCD012019-TST-003.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 3</div> <div class="figure-caption"> <p>Proteome by MALDI‐TOF‐MS (peptide m/z 1824.3 Da; ≥ 29.34 au).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012019/references#CD012019-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012019/media/CDSR/CD012019/image_n/nCD012019-TST-003.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012019-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012019/media/CDSR/CD012019/urn:x-wiley:14651858:media:CD012019:CD012019-TST-004" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012019/media/CDSR/CD012019/image_t/tCD012019-TST-004.xxx" target="_blank"><b></b></a></p> </div><img alt="Proteome by MALDI‐TOF‐MS (peptide m/z 1767.1 Da; ≥ 35.22 au)." data-id="CD012019-fig-0013" src="/cdsr/doi/10.1002/14651858.CD012019/media/CDSR/CD012019/image_n/nCD012019-TST-004.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 4</div> <div class="figure-caption"> <p>Proteome by MALDI‐TOF‐MS (peptide m/z 1767.1 Da; ≥ 35.22 au).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012019/references#CD012019-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012019/media/CDSR/CD012019/image_n/nCD012019-TST-004.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012019-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012019/media/CDSR/CD012019/urn:x-wiley:14651858:media:CD012019:CD012019-TST-005" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012019/media/CDSR/CD012019/image_t/tCD012019-TST-005.xxx" target="_blank"><b></b></a></p> </div><img alt="Proteome by MALDI‐TOF‐MS (peptide m/z 2052.3 Da; cut‐off not reported)." data-id="CD012019-fig-0014" src="/cdsr/doi/10.1002/14651858.CD012019/media/CDSR/CD012019/image_n/nCD012019-TST-005.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 5</div> <div class="figure-caption"> <p>Proteome by MALDI‐TOF‐MS (peptide m/z 2052.3 Da; cut‐off not reported).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012019/references#CD012019-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012019/media/CDSR/CD012019/image_n/nCD012019-TST-005.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012019-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012019/media/CDSR/CD012019/urn:x-wiley:14651858:media:CD012019:CD012019-TST-006" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012019/media/CDSR/CD012019/image_t/tCD012019-TST-006.xxx" target="_blank"><b></b></a></p> </div><img alt="Proteome by MALDI‐TOF‐MS (peptide m/z 3393.9 Da; cut‐off not reported)." data-id="CD012019-fig-0015" src="/cdsr/doi/10.1002/14651858.CD012019/media/CDSR/CD012019/image_n/nCD012019-TST-006.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 6</div> <div class="figure-caption"> <p>Proteome by MALDI‐TOF‐MS (peptide m/z 3393.9 Da; cut‐off not reported).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012019/references#CD012019-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012019/media/CDSR/CD012019/image_n/nCD012019-TST-006.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012019-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012019/media/CDSR/CD012019/urn:x-wiley:14651858:media:CD012019:CD012019-TST-007" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012019/media/CDSR/CD012019/image_t/tCD012019-TST-007.xxx" target="_blank"><b></b></a></p> </div><img alt="Proteome by MALDI‐TOF‐MS (peptide m/z 1579.2 Da [collagen alpha 6(IV) chain precursor]; cut‐off not reported)." data-id="CD012019-fig-0016" src="/cdsr/doi/10.1002/14651858.CD012019/media/CDSR/CD012019/image_n/nCD012019-TST-007.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 7</div> <div class="figure-caption"> <p>Proteome by MALDI‐TOF‐MS (peptide m/z 1579.2 Da [collagen alpha 6(IV) chain precursor]; cut‐off not reported). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012019/references#CD012019-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012019/media/CDSR/CD012019/image_n/nCD012019-TST-007.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012019-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012019/media/CDSR/CD012019/urn:x-wiley:14651858:media:CD012019:CD012019-TST-008" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012019/media/CDSR/CD012019/image_t/tCD012019-TST-008.xxx" target="_blank"><b></b></a></p> </div><img alt="Proteome by MALDI‐TOF‐MS (peptide m/z 891.6 Da [collagen alpha1 chain precursor];; cut‐off not reported)." data-id="CD012019-fig-0017" src="/cdsr/doi/10.1002/14651858.CD012019/media/CDSR/CD012019/image_n/nCD012019-TST-008.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 8</div> <div class="figure-caption"> <p>Proteome by MALDI‐TOF‐MS (peptide m/z 891.6 Da [collagen alpha1 chain precursor];; cut‐off not reported). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012019/references#CD012019-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012019/media/CDSR/CD012019/image_n/nCD012019-TST-008.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012019-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012019/media/CDSR/CD012019/urn:x-wiley:14651858:media:CD012019:CD012019-TST-009" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012019/media/CDSR/CD012019/image_t/tCD012019-TST-009.xxx" target="_blank"><b></b></a></p> </div><img alt="Proteome by MALDI‐TOF‐MS (5 peptides m/z 1433.9 +1599.4 + 2085.6 + 6798.0 + 3217.2 Da; cut‐off not reported)." data-id="CD012019-fig-0018" src="/cdsr/doi/10.1002/14651858.CD012019/media/CDSR/CD012019/image_n/nCD012019-TST-009.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 9</div> <div class="figure-caption"> <p>Proteome by MALDI‐TOF‐MS (5 peptides m/z 1433.9 +1599.4 + 2085.6 + 6798.0 + 3217.2 Da; cut‐off not reported). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012019/references#CD012019-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012019/media/CDSR/CD012019/image_n/nCD012019-TST-009.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012019-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012019/media/CDSR/CD012019/urn:x-wiley:14651858:media:CD012019:CD012019-TST-010" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012019/media/CDSR/CD012019/image_t/tCD012019-TST-010.xxx" target="_blank"><b></b></a></p> </div><img alt="CK 19 [CYFRA 21‐1] (&gt; 5.3 ng/ml)." data-id="CD012019-fig-0019" src="/cdsr/doi/10.1002/14651858.CD012019/media/CDSR/CD012019/image_n/nCD012019-TST-010.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 10</div> <div class="figure-caption"> <p>CK 19 [CYFRA 21‐1] (&gt; 5.3 ng/ml).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012019/references#CD012019-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012019/media/CDSR/CD012019/image_n/nCD012019-TST-010.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD012019-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Biomarkers evaluated as a diagnostic test for endometriosis</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Review question</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="8" rowspan="1" valign=""> <p>What is the diagnostic accuracy of the urinary biomarkers in detecting pelvic endometriosis [peritoneal endometriosis, endometrioma, DIE]? </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Importance</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="8" rowspan="1" valign=""> <p>A simple and reliable non‐invasive test for endometriosis, with the potential to either replace syrgery or to triage patients in order to reduce surgery, would minimise surgical risk and reduce diagnostic delay </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Patients</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="8" rowspan="1" valign=""> <p>Reproductive‐aged women 1) with suspected endometriosis or 2) with persistent ovarian mass or 3) undergoing infertility workup or gynaecological laparoscopy </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Settings</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="8" rowspan="1" valign=""> <p>Hospitals (public or private of any level): outpatient clinics (general gynaecology, reproductive medicine, pelvic pain); research laboratories </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Reference standard</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="8" rowspan="1" valign=""> <p>Visualisation of endometriosis at surgery (laparoscopy or laparotomy) with or without histological confirmation </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Study design</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="8" rowspan="1" valign=""> <p>Cross sectional studies with a 'single‐gate' design (n = 4) or a 'two‐gate' design (n = 1); prospective enrolment; a single study could assess more than one test </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="5" valign=""> <p><b>Risk of bias</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="8" rowspan="1" valign=""> <p>Overall judgement: Poor quality of most of the studies (no study had a 'low risk' assessment in all 4 domains) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="8" rowspan="1" valign=""> <p>Patient selection bias: High risk ‐ 1 study; Unclear risk ‐ 4 studies; Low risk ‐ 0 studies </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="8" rowspan="1" valign=""> <p>Index test interpretation bias: High risk ‐ 5 studies; Unclear risk ‐ 0 studies; Low risk ‐ 0 studies </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="8" rowspan="1" valign=""> <p>Reference standard interpretation bias: High risk ‐ 0 studies; Unclear risk ‐ 1 study; Low risk ‐ 4 studies </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="8" rowspan="1" valign=""> <p>Flow and timing selection bias: High risk ‐ 1 study; Unclear risk ‐ 0 studies; Low risk ‐ 4 studies </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Applicability concerns</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="8" rowspan="1" valign=""> <p>Concerns regarding patient selection: High concern ‐ 3 studies; Unclear concern ‐ 0 studies; Low concern 2 studies </p> <p>Concerns regarding index test: High concern ‐ 0 studies; Unclear concern ‐ 0 studies; Low concern ‐ 5 studies </p> <p>Concerns regarding reference standard: High concern ‐ 0 studies; Unclear concern ‐ 0 studies; Low concern ‐ 5 studies </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="2" rowspan="2" valign=""> <p><b>Biomarker</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><b>N of studies;</b> </p> <p><b>N of women</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>Outcomes</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><b>Diagnostic estimates [95% CI]</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><b>Implications</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>True positives</p> <p>(endometriosis)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>False negatives (incorrectly</p> <p>classified as disease‐free)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>True negatives (disease‐free)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>False positives (incorrectly</p> <p>classified as endometriosis)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p>NNE (enolase I) cut‐off &gt; 0.96 ng/mgCr</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1; 59</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sensitivity 0.56 [0.40, 0.72]</p> <p>Specificity 0.70 [0.46, 0.88]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Insufficient evidence to draw meaningful conclusions</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p>VDBP</p> <p>cut‐off &gt; 87.83 ng/mgCr</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1; 95</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>33</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sensitivity 0.58 [0.44, 0.71]</p> <p>Specificity 0.55 [0.38, 0.71]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Insufficient evidence to draw meaningful conclusions</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p>CK 19 [CYFRA21‐1]</p> <p>cut‐off &gt; 5.3 ng/ml</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1; 98</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>56</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>33</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sensitivity 0.11 [0.05, 0.22]</p> <p>Specificity 0.94 [0.81, 0.99]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Insufficient evidence to draw meaningful conclusions</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p>Proteome:</p> <p>peptide m/z 1824.3 Da</p> <p>cut‐off ≥ 29.34 au</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1; 28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sensitivity 0.77 [0.46, 0.95]</p> <p>Specificity 0.73 [0.45, 0.92]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Insufficient evidence to draw meaningful conclusions</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p>Proteome:</p> <p>peptide m/z 1767.1 Da</p> <p>cut‐off ≥ 35.22 au</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1; 27</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sensitivity 0.75</p> <p>[0.43, 0.95]</p> <p>Specificity 0.87</p> <p>[0.60, 0.98]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Insufficient evidence to draw meaningful conclusions</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p>Proteome:</p> <p>peptide m/z 2052.3 Da</p> <p>cut‐off not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1; 122</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>43</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sensitivity 0.83</p> <p>[0.71, 0.92]</p> <p>Specificity 0.69</p> <p>[0.56, 0.80]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Insufficient evidence to draw meaningful conclusions</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p>Proteome:</p> <p>peptide m/z 3393.9 Da</p> <p>cut‐off not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1; 122</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sensitivity 0.85</p> <p>[0.73, 0.93]</p> <p>Specificity 0.71</p> <p>[0.58, 0.82]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Insufficient evidence to draw meaningful conclusions</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p>Proteome:</p> <p>peptide m/z 1579.2 Da</p> <p>[collagen alpha 6(IV) chain precursor]</p> <p>cut‐off not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1; 122</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>43</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sensitivity 0.83</p> <p>[0.71, 0.92]</p> <p>Specificity 0.69</p> <p>[0.56, 0.80]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Insufficient evidence to draw meaningful conclusions</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p>Proteome:</p> <p>peptide m/z 891.6 Da</p> <p>[collagen alpha1 chain precursor]</p> <p>cut‐off not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1; 122</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sensitiviy 0.82</p> <p>[0.70, 0.90]</p> <p>Specificity 0.65</p> <p>[0.51, 0.76]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Insufficient evidence to draw meaningful conclusions</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p>Proteome:</p> <p>5 peptides m/z 1433.9 + 1599.4 + 2085.6 + 6798.0 + 3217.2 Da cut‐off not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1; 25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sensitivity 0.91</p> <p>[0.59, 1.00]</p> <p>Specificity 0.93</p> <p>[0.66, 1.00]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Insufficient evidence to draw meaningful conclusions</p> <p>Approaches criteria for a replacement test or SnOUT/SpIN triage tests; further diagnostic test accuracy studies recommended </p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Biomarkers evaluated as a diagnostic test for endometriosis</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012019/full#CD012019-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD012019-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Biomarkers that do not distinguish between women with and without endometriosis</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Review question</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p>Which urinary biomarkers are unlikely to serve as a basis of the diagnostic test for endometriosis? </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Importance</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p>Biomarkers that do not show differential expression in women with and without endometriosis are unlikely to be diagnostically useful. Information regarding negative trials can focus research on better diagnostic targets. The biomarkers that display conflicting results (distinguish women with and without endometriosis in some, but not all, studies) can be identified and reported on. Papers that did not show differential expression of a biomarker in endometriosis but were adequately designed and that met inclusion criteria for this review were included. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Patients</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p>Reproductive aged women 1) with suspected endometriosis or 2) with persistent ovarian mass or 3) undergoing infertility workup/gynaecological laparoscopy </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Settings</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p>Hospitals (public or private of any level): outpatient clinics (general gynaecology, reproductive medicine, pelvic pain); research laboratory </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Reference standard</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p>Visualisation of endometriosis at surgery (laparoscopy or laparotomy) with or without histological confirmation </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Study design</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p>Cross‐sectional of 'single‐gate' design (n = 1) or 'two‐gate' design (n = 2); prospective enrolment; one study could assess more than one test </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="5" valign=""> <p><b>Risk of bias</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p>Overall judgement: Poor quality (no studies had 'low risk' assessment in all 4 domains)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p>Patient selection bias: High risk ‐ 2 studies; Unclear risk ‐ 1 study; Low risk ‐ 0 studies </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p>Index test interpretation bias: High risk ‐ 3 studies; Unclear risk ‐ 0 studies; Low risk ‐ 0 studies </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p>Reference standard interpretation bias: High risk ‐ 0 studies; Unclear risk ‐ 0 studies; Low risk ‐ 3 studies </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p>Flow and timing selection bias: High risk ‐ 0 studies; Unclear risk ‐ 0 studies; Low risk ‐ 3 studies </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Applicability concerns</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p>Concerns regarding patient selection: High concern ‐ 2 studies; Unclear concern ‐ 0 studies; Low concern ‐ 1 study </p> <p>Concerns regarding index test: High concern ‐ 0 studies; Unclear concern ‐ 0 studies; Low concern ‐ 3 studies </p> <p>Concerns regarding reference standard: High concern ‐ 0 studies; Unclear concern ‐ 0 studies; Low concern ‐ 3 studies </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Biomarker</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Expression levels</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>rASRM stage</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Menstrual cycle phase</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Reference</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>VEGF</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>endometriosis (n = 46)<sup>1</sup>: 1.11 ± 0.17 pg/mg Cr </p> <p>controls (n = 24): 0.76 ± 0.14 pg/mg Cr</p> <p>p ‐ NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>I‐IV</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>follicular or luteal</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012019-bbs2-0001" title="ChoSH , OhYJ , NamA , KimHY , ParkJH , KimJH , et al. Evaluation of serum and urinary angiogenic factors in patients with endometriosis. American Journal of Reproductive Immunology2007; Vol. 58, issue 6:497‐504. [DOI: 10.1111/j.1600‐0897.2007.00535.x; ISSN 1046‐7408] ">Cho 2007</a> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>VEGF</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>endometriosis (n = 40)<sup>1</sup> 83.6 ± 11.3 pg/mg Cr </p> <p>controls (n = 22): 88.5 ± 10.4 pg/mg Cr</p> <p>P = 0.77</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>I‐IV</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>follicular or luteal</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012019-bbs2-0006" title="Potlog‐NahariC , StrattonP , WinkelC , Widraz , SinaiiN , ConnorsS , et al. Urine vascular endothelial growth factor‐A is not a useful marker for endometriosis. Fertility and Sterility2004; Vol. 81, issue 6:1507‐12. [DOI: 10.1016/j.fertnstert.2003.10.040; ISSN 0015‐0282] ">Potlog‐Naharia 2004</a> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>TNF‐a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>endometriosis (n = 46)<sup>1</sup>: 0.02 ± 0.01 pg/mg Cr </p> <p>controls (n = 24): 0.01 ± 0.002 pg/mg Cr</p> <p>p ‐ NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>I‐IV</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>follicular or luteal</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012019-bbs2-0001" title="ChoSH , OhYJ , NamA , KimHY , ParkJH , KimJH , et al. Evaluation of serum and urinary angiogenic factors in patients with endometriosis. American Journal of Reproductive Immunology2007; Vol. 58, issue 6:497‐504. [DOI: 10.1111/j.1600‐0897.2007.00535.x; ISSN 1046‐7408] ">Cho 2007</a> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CK 19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>endometriosis (n = 44)<sup>2</sup>: 5.4 ± 5.3 </p> <p>controls (n = 32): 6.7 ± 9.9</p> <p>p ‐ NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>follicular or luteal</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012019-bbs2-0004" title="KuesselL , Jaeger‐LanskyA , PateiskyP , RossbergN , SchulzA , SchmitzAA , et al. Cytokeratin‐19 as a biomarker in urine and in serum for the diagnosis of endometriosis‐‐a prospective study. Gynaecological Endocrinology2014; Vol. 30, issue 1:38‐41. [DOI: 10.3109/09513590.2013.856409; ISSN 1473‐0766] ">Kuessel 2014</a> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><sup>1</sup> mean ± SEM </p> <p><sup>2</sup> mean ± SD </p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Biomarkers that do not distinguish between women with and without endometriosis</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012019/full#CD012019-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD012019-tbl-0003"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Staging of endometriosis, rASRM classification</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Peritoneum</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Endometriosis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&lt; 1 cm</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1 to 3 cm</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&gt; 3 cm</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Superficial</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Deep</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign=""> <p>Ovary</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>R Superficial</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Deep</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>L Superficial</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Deep</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Posterior Cul‐de‐sac Obliteration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Partial</p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p>Complete</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p>40</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="5" valign=""> <p>Ovary</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adhesions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&lt; 1/3 Enclosure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1/3‐2/3 Enclosure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&gt; 2/3 Enclosure</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>R Filmy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Dense</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>L Filmy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Dense</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign=""> <p>Tube</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>R Filmy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Dense</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>L Filmy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Dense</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p>* If the fimbriated end of the fallopian tube is completely enclosed, change the point assignment to 16 </p> <p><a href="./references#CD012019-bbs2-0021" title="American Society for Reproductive Medicine. Revised American Society for Reproductive Medicine classification of endometriosis: 1996. Fertility and Sterility1997;67(5):817‐21. ">American Society for Reproductive Medicine 1997</a> </p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Staging of endometriosis, rASRM classification</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012019/full#CD012019-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD012019-tbl-0004"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Urinary biomarkers for endometriosis</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Angiogenesis/Growth factors and their receptors</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>VEGF‐A (vascular endothelial growth factor ‐ A)<sup>1</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>sFlt‐1 [sVEGFR‐1] (soluble fms‐like tyrosine kinase or variant of VEGF receptor 1)<sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Cell adhesion molecules and other matrix‐related proteins</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>MMP‐2 (matrix metalloproteinase‐2)<sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>MMP‐9 (matrix metalloproteinase‐9)<sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>MMP‐9/ NGAL (matrix metalloproteinase‐9/neutrophil gelatinase‐associated lipocalin)<sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Cytokines</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>TNF‐alpha (tumour necrosis factor alfa)<sup>1</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Cytoskeleton molecules</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CK‐19 or CYFRA 21‐1 (Cytokeratin‐19)<sup>1</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>High throughput markers</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Proteome</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Oxidative stress markers</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8‐iso‐PGF2a (8‐iso‐prostaglandin F2a)<sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Other Peptides/proteins</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>VDBP (vitamin D binding protein)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NNE (enolase I)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Collagen precursors</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Prealbumin<sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Alpha 1 antitrypsin<sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Chain A solution structure of Bb' domains of human protein disulfide isomerase<sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sup>1</sup> Urinary biomarkers that did not exhibit differential expression in endometriosis </p> <p><sup>2</sup> Urinary biomarkers that exhibited differential expression in endometriosis, but for which the diagnostic estimates were not available </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Urinary biomarkers for endometriosis</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012019/full#CD012019-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD012019-tbl-0005"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Application of the QUADAS‐2 tool for assessment of methodological quality of the included studies</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p><b>Domain 1 ‐ Patient selection</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Description</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Describe methods of patient selection and included patients</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Type of bias assessed</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Selection bias, spectrum bias</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Review Question</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Women of reproductive age with clinically suspected endometriosis (symptoms, clinical examination ± presence of pelvic mass), scheduled for surgical exploration of pelvic/abdominal cavity for confirmation of the diagnosis ± treatment </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Informaton collected</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study objectives, study population, selection (inclusion and exclusion criteria), study design, clinical presentation, age, number of participants enrolled and number of participants available for analysis, setting, place and period of the study </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i><b>Signalling question 1</b> </i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i><b>Was a consecutive or random sample of patients enrolled?</b> </i> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>If a consecutive sample or a random sample of the eligible patients was included in the study </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>If non‐consecutive sample or non‐random sample of the eligible patients was included in the study </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>If this information was unclear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i><b>Signalling question 2</b> </i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i><b>Did the study avoid inappropriate exclusions?</b> </i> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>If inclusion/exclusion criteria were presented and all patients with suspected endometriosis were included, with an exception for those who a) had a history of medical conditions or were on medical therapy that would have potentially interfered with interpretation of index test (e.g. malignancy, pregnancy, autoimmune disorders, infectious diseases, treatment with hormonal or immunomodulator substances); b) refused to participate in the study; or c) were unfit for surgery </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>If the study excluded the patients based on education level, psychosocial factors, genetic testing or phenotype or excluded patients with any co‐morbidities commonly present in general population, including a population that could have undergone a testing for endometriosis in clinical setting (hypertension, asthma, obesity, benign gastro‐intestinal or renal disease, etc) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>If the study did not provide clear definition of the selection (inclusion or exclusion) criteria and 'no' judgement was not applicable </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i><b>Signalling question 3</b> </i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i><b>Was a 'two‐gate' design avoided?</b> </i> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>If the study had a single set of inclusion criteria, defined by the clinical presentation (i.e. only participants in whom the target condition is suspected) ‐ a ‘single‐gate’ study design </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>If the study had more than one set of inclusion criteria in respect to clinical presentation (i.e. participants suspected of target condition and participants with alternative diagnosis in whom the target condition would not be suspected in clinical practice) ‐ a 'two‐gate' study design </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>If it was unclear whether a 'two‐gate deign' was avoided or not</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk of bias</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Could the selection of patients have introduced bias?</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>If 'yes' classification for all the above 3 questions</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>If 'no' classification for any of the above 3 questions</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>If 'unclear' classification for 3 of the above questions and 'high risk' judgement was not applicable </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Concerns about applicability</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Are there concerns that the included patients do not match the review question?</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>If the study includes only clinically relevant population that would have undergone index test in real practice and includes representative form of target condition </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>If the study population differed from the population defined in the review question in terms of demographic features and co‐morbidity (e.g. studies with multiple sets of inclusion criteria with respect to clinical presentation including either healthy controls or alternative diagnosis controls that would not have undergone index test in real practice). Further, if target condition diagnosed in the study population was not representative of the entire spectrum of disease, such as limited spectrum of severity (e.g. only mild forms) or limited type of endometriosis (e.g. only DIE) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>If this information was unclear (e.g. severity of endometriosis was not reported)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p><b>Domain 2 ‐ Index test</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Description</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Describe the index test, how it was conducted and interpreted</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Type of bias assessed</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Test review bias, clinical review bias, interobserver variation bias</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Review Question</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Any type of urinary biomarkers</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Informaton collected</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Index test name, description of positive case definition by index test as reported, threshold for positive result, examiners (number, level of expertise, blinding), interobserver variability, conflict of interests </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i><b>Signalling question 1</b> </i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i><b>Were the index test results interpreted without knowledge of the results of the reference standard?</b> </i> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>If the operators performing or interpreting index test were unaware of the results of reference standard </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>If the operators performing or interpreting index test were not blinded to the results of reference standard </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>If this information was unclear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i><b>Signalling question 2</b> </i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i><b>If a threshold was used, was it pre‐specified?</b> </i> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>If study clearly provided a threshold for positive result and was defined before execution or interpretation of index test </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>If a threshold for positive result was not provided or not defined prior to test execution</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>If it was unclear whether a threshold was pre‐specified or not</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i><b>Signalling question 3</b> </i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i><b>Was a menstrual cycle phase considered in interpreting the index test?</b> </i> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>If all the included participants were in the same phase of menstrual cycle or if the study reported subgroup analyses per cycle phase or if study reported the pooled estimates after impact of the cycle phase on biomarker expression was not detected </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>If study included participants in different phases of menstrual cycle, but effect of cycle phase on index test was not assessed </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>If the cycle phase was not reported</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk of bias</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Could the conduct or interpretation of the index test have introduced bias?</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>If 'yes' classification for all the above 3 questions</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>If 'no' classification for any of the above 3 questions</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>If 'unclear' classification for any of the above 3 questions and 'high risk' judgement was not applicable </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Concerns about applicability</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Are there concerns that the index test, its conduct, or interpretation differ from the review question?</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>We considered all types of urinary biomarkers as eligible; therefore all the included studies were classified as 'low concern', unless 'unclear' judgement was applicable </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>We did not consider the studies where index tests other than urinary biomarkers were included (or excluded information on other index tests reported in addition to urine tests) or where index test looked at other target conditions not specified in the review (e.g. studies aimed at classifying pelvic masses as benign and malignant); therefore none of the included studies was classified as 'high concern' </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>If study did not present sufficient information on at least one of the following: laboratory method, sample handling, reagents used, experience of the test operators </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p><b>Domain 3 ‐ Reference standard</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Description</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Describe the reference standard, how it was conducted and interpreted</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Type of bias assessed</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Verification bias, bias in estimation of diagnostic accuracy due to inadequate reference standard </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Review Question</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Target condition ‐ pelvic endometriosis, ovarian endometriosis, DIE. Reference standard ‐ visualisation of endometriosis at surgery (laparoscopy or laparotomy) with or without histological confirmation </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Informaton collected</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Target condition, prevalence of target condition in the sample, reference standard, description of positive case definition by reference test as reported, examiners (number, level of expertise, blinding) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i><b>Signalling question 1</b> </i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i><b>Were the reference standards likely to correctly classify the target condition?</b> </i> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>If the study reported at least one of the following: surgical procedure was described in sufficient details; or criteria for positive reference standard were stated; or diagnosis was confirmed by histopathology; or the procedure was performed by the team with high level of expertise in diagnosis/surgical treatment of target condition, including tertiary referral centres for endometriosis </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>If reference standard did not classify target condition correctly; considering the inclusion criteria and a nature of the reference standard, none of the studies were classified as 'no' for this item </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>If information on execution of the reference standard, its interpretation or operators was unclear </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i><b>Signalling question 2</b> </i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i><b>Were the reference standard results interpreted without knowledge of the results of the index tests?</b> </i> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>If operators performing the reference test were unaware of the results of index test</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>If operators performing the reference test were aware of the results of index test</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>If this information was unclear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk of bias</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Could the reference standard, its conduct, or its interpretation have introduced bias?</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>If 'yes' classification for all the above 2 questions</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>If 'no' classification for any of the above 2 questions</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>If 'unclear' classification for any of the above 2 questions and 'high risk' judgement was not applicable </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Concerns about applicability</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Are there concerns that the target condition as defined by the reference standard does not match the question?</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Considering the inclusion criteria, all the studies were classified as 'low concern', therefore all the included studies were classified as 'low concern' </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>We excluded the studies where participants did not undergo surgery for diagnosis of endometriosis, therefore none of the included studies were classified as 'high concern' </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Only studies were laparoscopy/laparotomy served as a reference test were included; therefore none of the included studies was classified as 'unclear concern' </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p><b>Domain 4 ‐ Flow and timing</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Description</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Describe any patients who did not receive the index tests or reference standard or who were excluded from the 2 x 2 table, describe the interval and any interventions between index tests (sample collection) and the reference standard </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Type of bias assessed</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Disease progression bias, bias of diagnostic performance due to missing data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Review Question</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Less than 12 months interval between index test (sample collection) and reference standard ‐ endometriosis may progress over time, so we had chosen an arbitrary time interval of 12 months as an acceptable time interval between the sample collection and surgical confirmation of diagnosis </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Informaton collected</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Time interval between index test (sample collection) and reference standard, withdrawals (overall number reported and if were explained) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i><b>Signalling question 1</b> </i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i><b>Was there an appropriate interval between index test (sample collection) and reference standard?</b> </i> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>If time interval was reported and was less than 12 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>We excluded all the studies where time interval was longer than 12 months, therefore none of the included studies were classified as 'no' for this item </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>If time interval was not stated clearly, but authors' description allowed to assume that the interval was reasonably short </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i><b>Signalling question 2</b> </i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i><b>Did all women receive the same reference standard?</b> </i> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>If all participants underwent laparoscopy or laparotomy as a reference standard; considering the inclusion criteria, all the studies were classified as 'yes' for this item, as anticipated </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>If all participants did not undergo surgery or had alternative reference standard or if only a subset of participants had surgery as reference standard, but the information on this population was not available in isolation; considering the inclusion criteria, none of the included studies were classified as 'no' for this item </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>If this information was unclear; considering the inclusion criteria, none of the included studies were classified as 'unclear' for this item </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i><b>Signalling question 3</b> </i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i><b>Were all women included in the analysis?</b> </i> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>If all the women were included in the analysis or if women were excluded because they did not meet inclusion criteria prior to execution of index test or if the withdrawals were less than 5% of the enrolled population (arbitrary selected cut‐off) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>If any patients were excluded from the analysis because of un interpretable results, inability to undergo either index test or reference standard or for unclear reasons </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>If this information was unclear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk of bias</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Could the patient flow have introduced bias?</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>If 'yes' classification for all the above 3 questions</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>If 'no' classification for any of the above 3 questions</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>If 'unclear' classification for any of the above 3 questions and 'high risk' judgement was not applicable </p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Application of the QUADAS‐2 tool for assessment of methodological quality of the included studies</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012019/full#CD012019-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD012019-tbl-0006"> <div class="table-heading"><span class="table-label">Table Tests.</span> <span class="table-title">Data tables by test</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p>Test</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">1 NNE‐Cr (&gt; 0.96 ng/mgCr) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>59</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">2 VDBP‐Cr (&gt; 87.83 ng/mgCr) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>95</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">3 Proteome by MALDI‐TOF‐MS (peptide m/z 1824.3 Da; ≥ 29.34 au) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>28</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">4 Proteome by MALDI‐TOF‐MS (peptide m/z 1767.1 Da; ≥ 35.22 au) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>27</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">5 Proteome by MALDI‐TOF‐MS (peptide m/z 2052.3 Da; cut‐off not reported) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>122</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">6 Proteome by MALDI‐TOF‐MS (peptide m/z 3393.9 Da; cut‐off not reported) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>122</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">7 Proteome by MALDI‐TOF‐MS (peptide m/z 1579.2 Da [collagen alpha 6(IV) chain precursor]; cut‐off not reported) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>122</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">8 Proteome by MALDI‐TOF‐MS (peptide m/z 891.6 Da [collagen alpha1 chain precursor];; cut‐off not reported) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>122</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">9 Proteome by MALDI‐TOF‐MS (5 peptides m/z 1433.9 +1599.4 + 2085.6 + 6798.0 + 3217.2 Da; cut‐off not reported) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>25</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">10 CK 19 [CYFRA 21‐1] (&gt; 5.3 ng/ml) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>98</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table Tests.</span> <span class="table-title">Data tables by test</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012019/references#CD012019-tbl-0006">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD012019&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD012019-note-0004">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD012019-note-0006">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD012019-note-0003">Français</a> </li> <li class="section-language"> <a class="" href="th#CD012019-note-0005">ภาษาไทย</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br/> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738735355000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738735355000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012019\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012019\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012019\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012019"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012019\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012019\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012019\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012019\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012019\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012019"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012019\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012019\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012019\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012019"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012019\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012019\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012019\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012019"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=xNbeAU8n&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012019&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD012019';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD012019/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD012019/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012019%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740716787994"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD012019/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740716787997"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD012019/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918da80dbdcd1be3',t:'MTc0MDcxNjc4OC4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 